1
|
Chen GL, Liu Y, Gao XF, Wu KQ, Yang YK, Chen Y, Peng CG, Jin TH, Huang YB, Zhang YW, Su J, Jiang Q, Guo T, Zhao J, Peng XN, Peng JY, Li SX, Sun YL, Zhang HM, Fu YL, Luo D, Ma Y, Shen ZW, Zhang YT, Shou ZF. Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study. Diabetes Obes Metab 2024; 26:1395-1406. [PMID: 38287130 DOI: 10.1111/dom.15441] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/26/2023] [Revised: 12/14/2023] [Accepted: 12/15/2023] [Indexed: 01/31/2024]
Abstract
AIM Novel long-acting drugs for type 2 diabetes mellitus may optimize patient compliance and glycaemic control. Exendin-4-IgG4-Fc (E4F4) is a long-acting glucagon-like peptide-1 receptor agonist. This first-in-human study investigated the safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of a single subcutaneous injection of E4F4 in healthy subjects. METHODS This single-centre, randomized, double-blind, placebo-controlled phase 1 clinical trial included 96 subjects in 10 sequential cohorts that were provided successively higher doses of E4F4 (0.45, 0.9, 1.8, 3.15, 4.5, 6.3, 8.1, 10.35, 12.6 and 14.85 mg) or placebo (ChinaDrugTrials.org.cn: ChiCTR2100049732). The primary endpoint was safety and tolerability of E4F4. Secondary endpoints were pharmacokinetic, pharmacodynamic and immunogenicity profiles of E4F4. Safety data to day 15 after the final subject in a cohort had been dosed were reviewed before commencing the next dose level. RESULTS E4F4 was safe and well tolerated among healthy Chinese participants in this study. There was no obvious dose-dependent relationship between frequency, severity or causality of treatment-emergent adverse events. Cmax and area under the curve of E4F4 were dose proportional over the 0.45-14.85 mg dose range. Median Tmax and t1/2 ranged from 146 to 210 h and 199 to 252 h, respectively, across E4F4 doses, with no dose-dependent trends. For the intravenous glucose tolerance test, area under the curve of glucose in plasma from time 0 to 180 min showed a dose-response relationship in the 1.8-10.35 mg dose range, with an increased response at the higher doses. CONCLUSION E4F4 exhibited an acceptable safety profile and linear pharmacokinetics in healthy subjects. The recommended phase 2 dose is 4.5-10.35 mg once every 2 weeks.
Collapse
Affiliation(s)
- Gui-Ling Chen
- Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China
| | - Yang Liu
- China National Biotec Group Company Limited, Beijing, China
| | - Xue-Feng Gao
- Lanzhou Institute of Biological Products Company Limited, Lanzhou, China
| | - Kai-Qi Wu
- Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China
| | - Yun-Kai Yang
- China National Biotec Group Company Limited, Beijing, China
| | - Yong Chen
- Lanzhou Institute of Biological Products Company Limited, Lanzhou, China
| | - Cong-Gao Peng
- Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China
| | - Ting-Han Jin
- Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China
| | - Yu-Bao Huang
- China National Biotec Group Company Limited, Beijing, China
| | - Yao-Wen Zhang
- China National Biotec Group Company Limited, Beijing, China
| | - Jing Su
- China National Biotec Group Company Limited, Beijing, China
| | - Qi Jiang
- Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China
| | - Tong Guo
- Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China
| | - Jie Zhao
- Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China
| | - Xiang-Nan Peng
- China National Biotec Group Company Limited, Beijing, China
| | - Jing-Yu Peng
- China National Biotec Group Company Limited, Beijing, China
| | - Si-Xiu Li
- China National Biotec Group Company Limited, Beijing, China
| | - Yong-Li Sun
- China National Biotec Group Company Limited, Beijing, China
| | - Hong-Mei Zhang
- China National Biotec Group Company Limited, Beijing, China
| | - Yan-Li Fu
- Lanzhou Institute of Biological Products Company Limited, Lanzhou, China
| | - Dan Luo
- Lanzhou Institute of Biological Products Company Limited, Lanzhou, China
| | - Yaru Ma
- Lanzhou Institute of Biological Products Company Limited, Lanzhou, China
| | - Zhen-Wei Shen
- Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China
| | - Yun-Tao Zhang
- China National Biotec Group Company Limited, Beijing, China
| | - Zhang-Fei Shou
- Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, China
- Lanzhou Institute of Biological Products Company Limited, Lanzhou, China
| |
Collapse
|
2
|
Liu QQ, Wang XX, Ji H, Dou QY, Zhang HM. The efficacy and safety of PD-1 inhibitor combined with TACE in the first-line treatment of unresectable hepatocellular carcinoma. Med Oncol 2024; 41:91. [PMID: 38526607 DOI: 10.1007/s12032-024-02309-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2023] [Accepted: 01/23/2024] [Indexed: 03/26/2024]
Abstract
The application of immune checkpoint inhibitors (ICIs) has changed the treatment of advanced hepatocellular carcinoma. Transcatheter arterial chemoembolization (TACE) is a first-line treatment for intermediate hepatocellular carcinoma. Serving as a local treatment modality that can induce immunogenic cell death, the efficacy and safety of combined use with ICI have not been evaluated. Although there have been prospective studies aimed at evaluating the efficacy and safety of ICI combined with TACE in BCLC stage B HCC patients, there are few reports on the evaluation of BCLC stage C patients with distant metastasis or portal vein cancer thrombus. Data of unresectable hepatocellular carcinoma patients received PD-1 inhibitor and TACE were collected in Xijing Hospital from June 2019 to December 2022. The tumor response was evaluated according to the Solid Tumor Modified Response Evaluation Standard (mRECIST), including complete response (CR), partial response (PR), disease stability (SD), disease progression (PD), objective response rate (ORR), and disease control rate (DCR). The progression-free survival (PFS) and overall survival (OS) were used to estimate therapy efficacy. The treatment-related adverse events were evaluated based on National Cancer Institute Common Adverse Event Evaluation Criteria (CTCAE) version 5.0. A total of 42 patients with unresectable hepatocellular carcinoma were included in this study, including 34 males (80.5%) and 8 females (19.5%). The average age is 54.5 years, ranging from 34 to 72. The median follow-up time was 12.3 months, with an ORR of 42.9% and a DCR of 90.5% as of the follow-up time. The median PFS is 7.5 months (95% CI: 5.76-9.23), and the median OS has not yet been reached; 6-month PFS was 62.2%. Safety analysis showed that 41 (97.6%) patients experienced treatment-related adverse reactions, mainly including elevated AST and ALT, fever, elevated bilirubin, hypothyroidism, nausea, abdominal pain, and rash. 40 patients had grade 1/2 adverse reactions, and only one patient had grade 3 adverse reactions, manifested as intolerable rash, nausea, and vomiting. Treatment is terminated when symptomatic treatment and drug suspension cannot be alleviated. In this study, thre patients with unresectable hepatocellular carcinoma were treated with PD-1 inhibitor combined with TACE to achieve good tumor reduction effect and underwent liver cancer resection surgery. For patients with unresectable hepatocellular carcinoma, whether in BCLC stage B or stage C, effective systemic therapy (PD-1 inhibitor) combined with local therapy (TACE) can achieve a high rate of tumor regression and objective response. Some patients may even pursue surgical treatment opportunities, and the treatment-related adverse reactions are controllable, which is expected to provide new options for extending the survival of unresectable hepatocellular carcinoma patients.
Collapse
Affiliation(s)
- Qing-Qing Liu
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shaanxi, China
| | - Xiang-Xu Wang
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shaanxi, China
| | - Hongchen Ji
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shaanxi, China
| | - Qiong-Yi Dou
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shaanxi, China
| | - Hong-Mei Zhang
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, Shaanxi, China.
| |
Collapse
|
3
|
Li JT, Zhang HM, Wang W, Wei DQ. Identification of an immune-related gene signature for predicting prognosis and immunotherapy efficacy in liver cancer via cell-cell communication. World J Gastroenterol 2024; 30:1609-1620. [DOI: 10.3748/wjg.v30.i11.1609] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/13/2023] [Revised: 01/09/2024] [Accepted: 03/04/2024] [Indexed: 03/21/2024] Open
Abstract
BACKGROUND Liver cancer is one of the deadliest malignant tumors worldwide. Immunotherapy has provided hope to patients with advanced liver cancer, but only a small fraction of patients benefit from this treatment due to individual differences. Identifying immune-related gene signatures in liver cancer patients not only aids physicians in cancer diagnosis but also offers personalized treatment strategies, thereby improving patient survival rates. Although several methods have been developed to predict the prognosis and immunotherapeutic efficacy in patients with liver cancer, the impact of cell-cell interactions in the tumor microenvironment has not been adequately considered.
AIM To identify immune-related gene signals for predicting liver cancer prognosis and immunotherapy efficacy.
METHODS Cell grouping and cell-cell communication analysis were performed on single-cell RNA-sequencing data to identify highly active cell groups in immune-related pathways. Highly active immune cells were identified by intersecting the highly active cell groups with B cells and T cells. The significantly differentially expressed genes between highly active immune cells and other cells were subsequently selected as features, and a least absolute shrinkage and selection operator (LASSO) regression model was constructed to screen for diagnostic-related features. Fourteen genes that were selected more than 5 times in 10 LASSO regression experiments were included in a multivariable Cox regression model. Finally, 3 genes (stathmin 1, cofilin 1, and C-C chemokine ligand 5) significantly associated with survival were identified and used to construct an immune-related gene signature.
RESULTS The immune-related gene signature composed of stathmin 1, cofilin 1, and C-C chemokine ligand 5 was identified through cell-cell communication. The effectiveness of the identified gene signature was validated based on experimental results of predictive immunotherapy response, tumor mutation burden analysis, immune cell infiltration analysis, survival analysis, and expression analysis.
CONCLUSION The findings suggest that the identified gene signature may contribute to a deeper understanding of the activity patterns of immune cells in the liver tumor microenvironment, providing insights for personalized treatment strategies.
Collapse
Affiliation(s)
- Jun-Tao Li
- College of Mathematics and Information Science, Henan Normal University, Xinxiang 453007, Henan Province, China
| | - Hong-Mei Zhang
- College of Mathematics and Information Science, Henan Normal University, Xinxiang 453007, Henan Province, China
| | - Wei Wang
- College of Computer and Information Engineering, Henan Normal University, Xinxiang 453007, Henan Province, China
| | - Dong-Qing Wei
- State Key Laboratory of Microbial Metabolism, and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China
| |
Collapse
|
4
|
Li JX, Li ZJ, Zhang HM, Xu SS, Quan RZ, Zhang H, Lu MM, Wang XY, Ma S, Mi J, Ding H, Li XL. [The association between portal vein thrombosis and rebleeding after non-urgent endoscopic treatment of esophagogastric varices]. Zhonghua Yi Xue Za Zhi 2024; 104:682-689. [PMID: 38418167 DOI: 10.3760/cma.j.cn112137-20231110-01064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 03/01/2024]
Abstract
Objective: To investigate the association between portal vein thrombosis and rebleeding after non-urgent endoscopic treatment of esophagogastric varices. Methods: The cirrhotic patients with esophagogastric varices diagnosed in the People's Hospital of Zhengzhou University from January 2017 to March 2023 were retrospectively collected. The patients were divided into thrombotic group and non-thrombotic group according to the presence or absence of portal vein thrombosis. The failure rate of endoscopic treatment and rebleeding rate in different periods were compared between the two groups. Receiver operating characteristic (ROC) curve was used to select the best cutoff value of gastric varicose diameter that affected total rebleeding during follow-up in both groups. The influencing factors of rebleeding within 12 and 36 months in both groups were analyzed, and the influencing factors of rebleeding within 36 months in thrombus group were further analyzed. Results: A total of 106 patients were enrolled, including 53 patients in the thrombotic group [male 37, female 16, aged 18-78 (54±13) years] and 53 patients in the non-thrombotic group [male 37, female 16, aged 27-83 (55±12) years]. The follow-up time of the two groups were (20±15) and (25±15) months, respectively. The total rebleeding rate in the thrombotic group was higher than that in the non-thrombotic group [30.2% (16/53) vs 13.2% (7/53), P˂0.05]. The rebleeding rates within 6, 12, 24 and 36 months in the thrombotic group were higher than those in the non-thrombotic group [18.9% (10/53) vs 5.7% (3/53), 18.9% (10/53) vs 5.7% (3/53), 28.3% (15/53) vs 9.4% (5/53), 30.2% (16/53) vs 11.3% (6/53), all P˂0.05]. The best cut-off value of the diameter of gastric varices that affects the total rebleeding in the two groups was 10.4 mm (10 mm was selected as the best cut-off value for the convenience of practical clinical application). Hemoglobin ˂ 85 g/L (HR=0.202, 95%CI: 0.043-0.953, P=0.043), 10 mm ˂ the diameter of GV ≤ 15 mm (HR=5.321, 95%CI: 1.161-24.390, P=0.031) and endoscopic variceal ligation combined with endoscopic tissue adhesive injection (EVL+ETAI) (HR=7.172, 95%CI: 1.910-26.930, P=0.004) were the risk factors for the first gastroesophageal variceal rebleeding within 12 months after non-urgent endoscopic treatment. EVL+ETAI (HR=3.811, 95%CI: 1.441-10.084, P=0.007) and portal vein thrombosis (HR=4.026, 95%CI: 1.483-10.932, P=0.006) were the risk factors for the first gastroesophageal variceal rebleeding within 36 months after non-urgent endoscopic treatment. The study found that, 10 mm ˂ the diameter of GV ≤ 15 mm (HR=7.503, 95%CI: 1.568-35.890, P=0.012) was the risk factor for rebleeding within 36 months in the thrombotic group. Conclusion: Portal vein thrombosis is a risk factor for rebleeding after non-urgent endoscopic treatment of esophagogastric varices.
Collapse
Affiliation(s)
- J X Li
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - Z J Li
- Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - H M Zhang
- Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - S S Xu
- Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - R Z Quan
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - H Zhang
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - M M Lu
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - X Y Wang
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - S Ma
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - J Mi
- Department of Gastroenterology, People's Hospital of Zhengzhou University, Zhengzhou 450003, China
| | - H Ding
- Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou 450003, China
| | - X L Li
- Department of Gastroenterology, Henan Provincial People's Hospital, Zhengzhou 450003, China
| |
Collapse
|
5
|
Chen ZJ, Yang HG, Zhu WP, Xue CM, Zhang HM, Peng YT, Li DH, Hua HM. New aporphine alkaloids with antitumor activities from the roots of Thalictrum omeiense. J Asian Nat Prod Res 2024:1-9. [PMID: 38389314 DOI: 10.1080/10286020.2024.2317826] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Accepted: 02/08/2024] [Indexed: 02/24/2024]
Abstract
Two new aporphine alkaloids, 6aR-2'-(3-oxobutenyl)-thaliadin (1) and N-methylthalisopynine (2), along with ten known analogs (3-12), were isolated from the roots of Thalictrum omeiense W. T. Wang et S. H. Wang. Their structures were determined by extensive spectroscopic and X-ray crystallographic analyses. Compounds 1-7 and 9-12 were tested for their antiproliferative effects in vitro against two human cancer cell lines (A549 and MCF-7). Among them, compounds 1, 3, and 7 exhibited moderate inhibitory activity against the tested cell lines with IC50 values ranging from 23.73 to 34.97 μM.
Collapse
Affiliation(s)
- Zhao-Jing Chen
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China
| | - Han-Gao Yang
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China
| | - Wen-Peng Zhu
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China
| | - Chun-Mei Xue
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China
| | - Hong-Mei Zhang
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China
| | - Yu-Ting Peng
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China
| | - Da-Hong Li
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China
- State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin 300350, PR China
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, PR China
| | - Hui-Ming Hua
- School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang, Liaoning 110016, PR China
- Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, PR China
| |
Collapse
|
6
|
Duan LL, Zhao YB, Er YL, Ye PP, Wang W, Gao X, Deng X, Jin Y, Wang Y, Ji CR, Ma XY, Gao C, Zhao YH, Zhu SQ, Su SZ, Guo XE, Peng JJ, Yu Y, Yang C, Su YY, Zhao M, Guo LH, Wu YP, Luo YN, Meng RL, Xu HF, Liu HZ, Ruan HH, Xie B, Zhang HM, Liao YH, Chen Y, Wang LH. [The effect of Ba Duan Jin on the balance of community-dwelling older adults: a cluster randomized control trial]. Zhonghua Liu Xing Bing Xue Za Zhi 2024; 45:250-256. [PMID: 38413065 DOI: 10.3760/cma.j.cn112338-20230506-00283] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/29/2024]
Abstract
Objective: To assess the effectiveness of a 6-month Ba Duan Jin exercise program in improving the balance of community-dwelling older adults. Methods: A two arms, parallel-group, cluster randomized controlled trial was conducted in 1 028 community residents aged 60-80 years in 40 communities in 5 provinces of China. Participants in the intervention group (20 communities, 523 people) received Ba Duan Jin exercise 5 days/week, 1 hour/day for 6 months, and three times of falls prevention health education, and the control group (20 communities, 505 people) received falls prevention health education same as the intervention group. The Berg balance scale (BBS) score was the leading outcome indicator, and the secondary outcome indicators included the length of time of standing on one foot (with eyes open and closed), standing in a tandem stance (with eyes open and closed), the closed circle test, and the timed up to test. Results: A total of 1 028 participants were included in the final analysis, including 731 women (71.11%) and 297 men (28.89%), and the age was (69.87±5.67) years. After the 3-month intervention, compared with the baseline data, the BBS score of the intervention group was significantly higher than the control group by 3.05 (95%CI: 2.23-3.88) points (P<0.001). After the 6-month intervention, compared with the baseline data, the BBS score of the intervention group was significantly higher than the control group by 4.70 (95%CI: 4.03-5.37) points (P<0.001). Ba Duan Jin showed significant improvement (P<0.05) in all secondary outcomes after 6 months of exercise in the intervention group compared with the control group. Conclusions: This study showed that Ba Duan Jin exercise can improve balance in community-dwelling older adults aged 60-80. The longer the exercise time, the better the improvement.
Collapse
Affiliation(s)
- L L Duan
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Y B Zhao
- Shijiazhuang People's Hospital, Shijiazhuang 050031, China
| | - Y L Er
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - P P Ye
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - W Wang
- National Clinical Research Center for Cardiovascular Diseases/National Center for Cardiovascular Diseases/Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing 100037, China
| | - X Gao
- Office of Chronic Disease and Ageing Health Management, Chinese Center for Disease Control and Prevention, Beijing 102206, China
| | - X Deng
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Y Jin
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - Y Wang
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - C R Ji
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| | - X Y Ma
- Institute for Chronic and Non-communicable Disease Control and Prevention, Shijiazhuang Municipal Center for Disease Control and Prevention, Shijiazhuang 050011, China
| | - C Gao
- Institute for Chronic and Non-communicable Disease Control and Prevention, Shijiazhuang Municipal Center for Disease Control and Prevention, Shijiazhuang 050011, China
| | - Y H Zhao
- Shijiazhuang Chang'an District Center for Disease Control and Prevention, Shijiazhuang 050011, China
| | - S Q Zhu
- Department of Chronic Prevention and Control, Shijiazhuang Chang'an District Center for Disease Control and Prevention, Shijiazhuang 050011, China
| | - S Z Su
- Department of Nursing, Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang 050051, China
| | - X E Guo
- Department of Nursing, Shijiazhuang Hospital of Traditional Chinese Medicine, Shijiazhuang 050051, China
| | - J J Peng
- Department of Injury Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - Y Yu
- Department of Injury Control and Prevention, Shanghai Municipal Center for Disease Control and Prevention, Shanghai 200336, China
| | - C Yang
- Department of Cancer and Injury Control and Prevention, Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai 200136, China
| | - Y Y Su
- Department of Cancer and Injury Control and Prevention, Shanghai Pudong New Area Center for Disease Control and Prevention, Shanghai 200136, China
| | - M Zhao
- Department of Chronic and Non-communicable Disease Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China
| | - L H Guo
- Department of Chronic and Non-communicable Disease Control and Prevention, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China
| | - Y P Wu
- General Office, Cixi Municipal Center for Disease Control and Prevention of Zhejiang Province, Ningbo 315302, China
| | - Y N Luo
- General Office, Cixi Municipal Center for Disease Control and Prevention of Zhejiang Province, Ningbo 315302, China
| | - R L Meng
- Department of Chronic and Non-communicable Disease Control and Prevention, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511483, China
| | - H F Xu
- Department of Chronic and Non-communicable Disease Control and Prevention, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511483, China
| | - H Z Liu
- Guangzhou Municipal Center for Disease Control and Prevention, Guangzhou 510440, China
| | - H H Ruan
- Department of Chronic and Non-communicable Disease Control and Prevention, Chronic Disease Prevention and Control Station of Guangzhou Panyu District, Guangzhou 511400, China
| | - B Xie
- Department of Psychiatric, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen 518054, China
| | - H M Zhang
- Department of Psychiatric, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen 518054, China
| | - Y H Liao
- Department of Psychiatric, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen 518054, China
| | - Y Chen
- Department of Psychiatric, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen 518054, China
| | - L H Wang
- Division of Injury Prevention and Mental Health, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, China
| |
Collapse
|
7
|
Lin G, Wang Z, Chu Q, Hu Y, Huang D, Wang J, Yang F, Zhong W, Zhou C, Zhu B, Ai X, Cao B, Cao Y, Chen M, Chen X, Chu T, Duan J, Fan Y, Fang Y, Feng S, Feng W, Guo H, Han C, He Y, Hong S, Hu J, Huang M, Huang Y, Jiang D, Jiang K, Jiang R, Jin B, Jin S, Li J, Li M, Li Z, Li C, Lin J, Liu A, Liu SM, Yutao L, Liu Z, Liu Z, Liu Z, Liu Z, Liu Z, Lu Y, Lv T, Ma Z, Miao Q, Peng M, Pu X, Ren XB, Shan J, Shan J, Shen P, Shen B, Shi M, Song Y, Song Z, Su C, Sun J, Tian P, Wang J, Wang F, Wang H, Wang J, Wang Q, Wang W, Wang Y, Wu L, Wu F, Xia Y, Xie C, Xie C, Xin T, Xiong J, Xu H, Xu S, Xu Y, Xu B, Xu C, Yan X, Yang Z, Yao W, Yu Y, Feng Y, Yu Z, Yu Y, Yue D, Zhang H, Zhang H, Zhang L, Zhang L, Zhang Q, Zhang T, Zhang B, Zhao J, Zhao M, Zheng X, Zhong Q, Zhou J, Zhou P, Zhu Z, Zou J, Zou Z. Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer. Thorac Cancer 2024; 15:419-426. [PMID: 38219795 PMCID: PMC10864121 DOI: 10.1111/1759-7714.15209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2023] [Accepted: 12/12/2023] [Indexed: 01/16/2024] Open
Abstract
Immune checkpoint inhibitor (ICI) rechallenge in non-small cell lung cancer (NSCLC) is a promising therapeutic strategy. The situation for ICI rechallenge can be divided into three categories: adverse events (AEs); resistance to ICIs, and rechallenge becomes compulsive because of tumor relapse while the patients had completed a 2 year course of immunotherapy. However, these categories are still controversial and should be explored further. Through voting at the 6th Straits Summit Forum on Lung Cancer, in this study we summarize the consensus of 147 experts in ICI rechallenges. A total of 97.74% experts agreed to rechallenge; 48.87% experts rechallenge with the original drug, and the others rechallenge with a different drug; 40.3% agreed to rechallenge directly after progression; 88.06% experts agreed to ICI rechallenge with a combination regimen; and factors such as previous performance status score, PD-1 expression, and age should also be considered. Understanding the the clinical studies in ICI rechallenge could bring us one step closer to understanding the consensus. In patients with advanced NSCLC who have suffered recurrent or distant metastasis after immunotherapy, the option of rechallenge with ICIs is a promising treatment option.
Collapse
Affiliation(s)
- Gen Lin
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Zhijie Wang
- Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
| | - Qian Chu
- Department of Oncology, Tongji HospitalTongji Medical College, Huazhong University of Science and TechnologyWuhanChina
| | - Yi Hu
- Senior Department of OncologyChinese PLA General HospitalBeijingChina
| | - Dingzhi Huang
- Department of Thoracic OncologyTianjin Medical University Cancer Institute and HospitalTianjinChina
| | - Jun Wang
- Department of OncologyThe First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan HospitalJi'nanChina
| | - Fan Yang
- Department of Thoracic SurgeryPeking University People's HospitalBeijingChina
| | - Wenzhao Zhong
- Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical SciencesGuangzhouChina
| | - Chengzhi Zhou
- Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory DiseasesThe First Affiliated Hospital of Guangzhou Medical UniversityGuangzhouChina
| | - Bo Zhu
- Institute of Cancer, Xinqiao HospitalArmy Medical UniversityChongqingChina
| | - Xinghao Ai
- Shanghai Lung Cancer Center, Shanghai Chest HospitalShanghai Jiao Tong University School of MedicineShanghaiChina
| | - Baoshan Cao
- Department of Medical Oncology and Radiation Sickness, Cancer CenterPeking University Third HospitalBeijingChina
| | - Yabing Cao
- Department of oncologyKiang Wu HospitalMacauChina
| | - Mingqiu Chen
- Department of Thoracic Radiation OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Xiaohui Chen
- Department of Thoracic SurgeryClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Tianqing Chu
- Respiratory Department, Shanghai Chest HospitalShanghai Jiao Tong University School of MedicineShanghaiChina
| | - Jianchun Duan
- Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
| | - Yun Fan
- Department of Medical OncologyZhejiang Cancer HospitalHangzhouChina
| | - Yong Fang
- Department of Medical Oncology, Sir Run Run Shaw HospitalZhenjiang University School of MedicineHangzhouChina
| | - Shuitu Feng
- Department of Medical OncologyFudan University Shanghai Cancer Center Xiamen HospitalXiamenChina
| | - Weineng Feng
- Department of Pulmonary OncologyThe First People's Hospital of FoshanFoshanChina
| | - Hui Guo
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anChina
| | - Chengbo Han
- Department of OncologyShengjing Hospital of China Medical UniversityShenyangChina
| | - Yong He
- Department of Respiratory Medicine, Xinqiao HospitalArmy Medical UniversityChongqingChina
| | - Shaodong Hong
- State Key Laboratory of Oncology in Southern ChinaSun Yat‐sen University Cancer CenterGuangzhouChina
| | - Jie Hu
- Shanghai Geriatric Center, Zhongshan HospitalFudan UniversityShanghaiChina
| | - Meijuan Huang
- Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology, Cancer Center, West China HospitalSichuan UniversityChengduChina
| | - Yan Huang
- State Key Laboratory of Oncology in Southern ChinaSun Yat‐sen University Cancer CenterGuangzhouChina
| | - Da Jiang
- Department of OncologyThe Fourth Affiliated Hospital of Hebei Medical UniversityShijiazhuangChina
| | - Kan Jiang
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Richeng Jiang
- Department of Thoracic OncologyTianjin Medical University Cancer Institute and HospitalTianjinChina
| | - Bo Jin
- Department of Medical OncologyThe First affiliated hospital of China Medical UniversityShenyangChina
| | - Shi Jin
- National Cancer Center/National Clinical Research Cencer for Cancer/Cancer Hospital &Shenzhen HospitalChinese Academy of Medical Sciences and Perking Union Medical CollegeShenzhenChina
| | - Jisheng Li
- Department of Medical OncologyQilu Hospital of Shandong UniversityJi'nanChina
| | - Min Li
- Department of Respiratory Medicine, Xiangya HospitalCentral South UniversityChangshaChina
| | - Ziming Li
- Shanghai Lung Cancer Center, Shanghai Chest HospitalShanghai Jiao Tong University School of MedicineShanghaiChina
| | - Chao Li
- Department of PathologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Jie Lin
- Department of Medical OncologyThe Second Affiliated Hospital of Kunming Medical UniversityKunmingChina
| | - Anwen Liu
- Department of Medical OncologyThe Second Affiliated Hospital of Nanchang UniversityNanchangChina
| | - Si‐Yang Maggie Liu
- Department of Hematology, First Affiliated HospitalJi'nan UniversityGuangzhouChina
| | - Liu Yutao
- Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
| | - Zhefeng Liu
- Senior Department of OncologyChinese PLA General HospitalBeijingChina
| | - Zhe Liu
- Department of Medical Oncology, Beijing Chest HospitalCapital Medical UniversityBeijingChina
| | - Zhenhua Liu
- Department of OncologyShengli Clinical Medical College of Fujian Medical University, Fujian Provincial HospitalFuzhouChina
| | - Zhentian Liu
- Department of Thoracic OncologyJiangxi Cancer HospitalNanchangChina
| | - Zhigang Liu
- Cancer CenterThe 10th Affiliated Hospital of Southern Medical UniversityDongguanChina
| | - Yuping Lu
- Department of Abdominal OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Tangfeng Lv
- Department of Respiratory Medicine, Affiliated Jinling HospitalMedical School of Nanjing UniversityNanjingChina
| | - Zhiyong Ma
- Department of Respiratory MedicineHenan cancer Hospital, Affiliated Cancer Hospital of Zhengzhou UniversityZhengzhouChina
| | - Qian Miao
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Min Peng
- Cancer cenrterRenmin Hospital of Wuhan UniversityWuhanChina
| | - Xingxiang Pu
- Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of MedicineCentral South UniversityChangshaChina
| | - Xiu Bao Ren
- Department of BiotherapyTianjin Medical University Cancer Institute and HospitalTianjinChina
| | - Jianzhen Shan
- Department of Medical OncologyThe First Affiliated Hospital of Zhejiang UniversityZhejiangChina
| | - Jinlu Shan
- Department of Medical Oncology, Daping HospitalArmy Medical UniversityChongqingChina
| | - Peng Shen
- Department of Oncology, Nanfang HospitalSouthern Medical UniversityGuangzhouChina
| | - Bo Shen
- Department of Medical OncologyJiangsu Cancer Hospital, Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical UniversityNanjingChina
| | - Meiqi Shi
- Department of Medical OncologyJiangsu Cancer Hospital, Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical UniversityNanjingChina
| | - Yong Song
- Department of Respiratory Medicine, Affiliated Jinling HospitalMedical School of Nanjing UniversityNanjingChina
| | - Zhengbo Song
- Department of Clinical TrialZhejiang Cancer HospitalHangzhouChina
| | - ChunXia Su
- Department of OncologyShanghai Pulmonary Hospital & Thoracic Cancer Institute, Tongji University School of MedicineShanghaiChina
| | - Jianguo Sun
- Institute of Cancer, Xinqiao HospitalArmy Medical UniversityChongqingChina
| | - Panwen Tian
- Precision Medicine Key Laboratory of Sichuan Province, Department of Pulmonary and Critical Care Medicine, Lung Cancer Center, West China HospitalSichuan UniversityChengduChina
| | - Jinliang Wang
- Senior Department of OncologyChinese PLA General HospitalBeijingChina
| | - Feng Wang
- Department of Thoracic SurgeryClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Huijuan Wang
- Department of Respiratory MedicineHenan cancer Hospital, Affiliated Cancer Hospital of Zhengzhou UniversityZhengzhouChina
| | - Jialei Wang
- Department of Thoracic Medical OncologyFudan University Shanghai Cancer CenterShanghaiChina
| | - Qian Wang
- Department of Respiratory MedicineAffiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese MedicineNanjingChina
| | - Wenxian Wang
- Department of Medical OncologyZhejiang Cancer HospitalHangzhouChina
| | - Yan Wang
- Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina
| | - Lin Wu
- Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of MedicineCentral South UniversityChangshaChina
| | - Fang Wu
- Department of Oncology, The Second Xiangya HospitalCentral South UniversityChangshaChina
| | - Yang Xia
- Department of Respiratory and Critical Care MedicineSecond Affiliated Hospital of Zhejiang University School of MedicineHangzhouChina
| | - Congying Xie
- Department of Radiation and Medical OncologySecond Affiliated Hospital of Wenzhou Medical UniversityWenzhouChina
| | - Conghua Xie
- Department of Pulmonary OncologyZhongnan Hospital of Wuhan UniversityWuhanChina
| | - Tao Xin
- Department of OncologyThe Second Affiliated Hospital of Harbin Medical UniversityHarbinChina
| | - Jianping Xiong
- Department of OncologyThe First Affiliated Hospital of Nanchang UniversityNanchangChina
| | - Haipeng Xu
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Song Xu
- Department of Lung Cancer SurgeryTianjin Medical University General HospitalTianjinChina
| | - Yiquan Xu
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Bin Xu
- Cancer cenrterRenmin Hospital of Wuhan UniversityWuhanChina
| | - Chunwei Xu
- Department of Respiratory Medicine, Affiliated Jinling HospitalMedical School of Nanjing UniversityNanjingChina
| | - Xiaolong Yan
- Department of Thoracic Surgery, Tangdu HospitalAir Force Medical UniversityXi'anChina
| | - Zhenzhou Yang
- Department of Cancer CenterThe Second Affiliated Hospital of Chongqing Medical UniversityChongqingChina
| | - Wenxiu Yao
- Department of Medical Oncology, Sichuan Cancer HospitalUniversity of Electronic Science and Technology of ChinaChengduChina
| | - Yao Yu
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anChina
| | - Ye Feng
- Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation ResearchThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityXiamenChina
| | - Zongyang Yu
- Department of Respiratory MedicineThe 900th Hospital of the Joint Logistic Support Force, People's Liberation Army of ChinaFuzhouChina
| | - Yongfeng Yu
- Shanghai Lung Cancer Center, Shanghai Chest HospitalShanghai Jiao Tong University School of MedicineShanghaiChina
| | - Dongsheng Yue
- Department of Lung CancerTianjin Medical University Cancer Institute and HospitalTianjinChina
| | - Haibo Zhang
- Department of OncologyGuangdong Provicial Hospital of Chinese MedicineGuangzhouChina
| | - HongMei Zhang
- Department of Clinical Oncology, Xijing HospitalAir Force Medical UniversityXi'anChina
| | - Li Zhang
- Department of Oncology, Tongji HospitalTongji Medical College, Huazhong University of Science and TechnologyWuhanChina
| | - Longfeng Zhang
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Qiuyu Zhang
- Institute of ImmunotherapyFujian Medical UniversityFuzhouChina
| | - Tongmei Zhang
- Department of Medical Oncology, Beijing Chest HospitalCapital Medical UniversityBeijingChina
| | - Bicheng Zhang
- Cancer cenrterRenmin Hospital of Wuhan UniversityWuhanChina
| | - Jun Zhao
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department I of Thoracic OncologyPeking University Cancer Hospital and InstituteBeijingChina
| | - Mingfang Zhao
- Department of Medical OncologyThe First affiliated hospital of China Medical UniversityShenyangChina
| | - Xiaobin Zheng
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Qiaofeng Zhong
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| | - Jin Zhou
- Department of Medical Oncology, Sichuan Cancer HospitalUniversity of Electronic Science and Technology of ChinaChengduChina
| | - Penghui Zhou
- State Key Laboratory of Oncology in Southern ChinaSun Yat‐sen University Cancer CenterGuangzhouChina
| | - Zhengfei Zhu
- Department of Radiation OncologyFudan University Shanghai Cancer CenterShanghaiChina
| | - Juntao Zou
- Department of Respiratory MedicineThe First Affiliated Hospital of Nanchang UniversityNanchangChina
| | - Zihua Zou
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouChina
| |
Collapse
|
8
|
Tang H, Shan PC, Zhang HM. [Mid-term effects of unicompartmental knee arthroplasty combined with anterior cruciate ligament reconstruction for the medial compartment osteoarthritis with anterior cruciate ligament deficiency by proportioning with the pure medial compartment osteoarthritis]. Zhonghua Yi Xue Za Zhi 2024; 104:350-356. [PMID: 38281803 DOI: 10.3760/cma.j.cn112137-20230830-00338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 01/30/2024]
Abstract
Objective: To evaluate the mid-term efficacy of one-stage unicompartmental knee arthroplasty (UKA) combined with anterior cruciate ligament (ACL) reconstruction in the treatment of medial compartment osteoarthritis (OA) with ACL deficiency. Methods: Retrospective cohort study. The clinical data of 13 patients (14 knees) who underwent UKA with ACL reconstruction for knee medial compartment OA combined with ACL deficiency in Wangjing Hospital of China Academy of Chinese Medical Sciences from January 2012 to January 2020 were retrospective analyzed. A 1∶1 proportioning study was conducted with 13 patients (14 knees) who underwent UKA due to medial compartment OA with intact ACL during the same period. The matching conditions were the same gender, age, surgical side, anesthesia method, comorbidities, and imaging lesions. There were 26 patients (28 knees) in the two groups, including 6 males (6 knees) and 20 females (22 knees), aged (58.9±4.2) years. The range of motion (ROM) and Oxford Knee Score (OKS) were used to evaluate the knee joint function at the last follow-up. The anteroposterior, lateral and axial X-ray films of the knee joint and the weight-bearing full-length X-ray films of the lower limbs were taken during follow-up. The hip knee ankle (HKA) angle, the posterior slope angle (PSA) of tibial prosthesis, and the anterior tibial translation (ATT) were recorded and compared between the two groups. The progression of lateral compartment OA, prosthesis loosening, and dislocation were evaluated. The mid-term follow-up clinical efficacy of the two surgical methods was compared, and the etiology of the patients was analyzed to verify the clinical efficacy and patient selection of one-stage UKA combined with ACL reconstruction. Results: The follow-up time of the two groups was (7.14±2.45) years. At the last follow-up, there was no significant difference in joint ROM between the combined group and the UKA group (120.90°±2.95° vs 122.29°±3.22°, P=0.260). There was no significant difference in OKS score between the two groups [(42.50±1.99) vs (43.21±2.26), P=0.380]. There was no significant difference in HKA angle and ATT distance between the two groups before operation (both P>0.05). At the last follow-up, the results were better than those before operation, and the differences were statistically significant (both P<0.05). At the last follow-up, there was no significant difference in HKA Angle between the combined group and the simple group (177.79°±1.25 ° vs 177.86°±1.29°, P=0.880). Tibial prosthesis PSA and ATT distance were not significantly different between the two groups [(4.57°±0.94° vs 4.50°±1.34°and (0.21±0.89) mm vs (0.14±1.35) mm, both P>0.05)]. There was no prosthesis loosening and obvious progression of lateral compartment OA in both groups at the last follow-up. Conclusion: For young patients with medial compartment OA secondary to ACL deficiency, UKA combined with ACL reconstruction is recommended, it can obtain good mid-term results.
Collapse
Affiliation(s)
- H Tang
- Department of Orthopedics, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China
| | - P C Shan
- Department of Orthopedics, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China
| | - H M Zhang
- Department of Orthopedics, Wangjing Hospital, China Academy of Chinese Medical Sciences, Beijing 100102, China
| |
Collapse
|
9
|
Zhang YL, Zhang HM, Xu JX, Zhou QY, Wang H, Pan XC. Survey and clinical considerations of gender identity in lower primary school children. World J Psychiatry 2024; 14:36-43. [PMID: 38327883 PMCID: PMC10845219 DOI: 10.5498/wjp.v14.i1.36] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/14/2023] [Revised: 11/22/2023] [Accepted: 12/19/2023] [Indexed: 01/19/2024] Open
Abstract
BACKGROUND Gender consciousness directly affects the development of gender identity, which is a continuous and lifelong process. Meanwhile, hospitalization is a part of many children's lives and has an impact on their gender development. AIM To investigate the current situation of gender identity in lower primary school children by conducting a survey of 202 hospitalized children in the lower grades and to provide a theoretical basis and foundation for the cultivation of gender identity and medical treatment of children based on the results. This study aims to inspire clinical medical staff to scientifically and reasonably arrange hospital wards for lower primary school children and pay attention to gender protection during the medical treatment process and to help children shape a unified and clear gender identity, which will enable them to better integrate into society and promote their personality development. METHODS The gender consciousness scale for elementary and middle school students was used for the survey. RESULTS Gender identity was already present in lower primary school children. The children's gender roles and gender equality consciousness were strong, exceeding the critical value, but their gender characteristics, gender identity, and gender ideal consciousness were weak. Children aged 6 had the weakest gender identity, and girls had significantly stronger gender identity than boys. CONCLUSION Gender identity is already present in lower primary school children, providing a basis and inspiration for the cultivation of gender identity and medical treatment of lower primary school children. Clinical medical staff should be aware of and understand these results and should scientifically and reasonably arrange hospital wards for lower primary school children.
Collapse
Affiliation(s)
- Ya-Lin Zhang
- Department of Pediatrics, Hangzhou Ninth People’s Hospital, Hangzhou 311225, Zhejiang Province, China
| | - Hong-Mei Zhang
- Department of Nursing, Hangzhou Children’s Hospital, Hangzhou 310014, Zhejiang Province, China
| | - Jing-Xia Xu
- Department of Nursing, Hangzhou Children’s Hospital, Hangzhou 310014, Zhejiang Province, China
| | - Qi-Ying Zhou
- Pediatric Intensive Care Unit, Hangzhou Children’s Hospital, Hangzhou 310014, Zhejiang Province, China
| | - He Wang
- Out-patient infection, Hangzhou Children’s Hospital, Hangzhou 310014, Zhejiang Province, China
| | - Xiao-Cheng Pan
- Traditional Chinese Medicine Ward, Hangzhou Children’s Hospital, Hangzhou 310014, Zhejiang Province, China
| |
Collapse
|
10
|
Kong X, Wan SJ, Chen TB, Jiang L, Xing YJ, Bai YP, Hua Q, Yao XM, Zhao YL, Zhang HM, Wang DG, Su Q, Lv K. Increased serum extrachromosomal circular DNA SORBS1 circle level is associated with insulin resistance in patients with newly diagnosed type 2 diabetes mellitus. Cell Mol Biol Lett 2024; 29:12. [PMID: 38212723 PMCID: PMC10785328 DOI: 10.1186/s11658-023-00530-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Accepted: 12/21/2023] [Indexed: 01/13/2024] Open
Abstract
BACKGROUND Extrachromosomal circular DNAs (eccDNAs) exist in human blood and somatic cells, and are essential for oncogene plasticity and drug resistance. However, the presence and impact of eccDNAs in type 2 diabetes mellitus (T2DM) remains inadequately understood. METHODS We purified and sequenced the serum eccDNAs obtained from newly diagnosed T2DM patients and normal control (NC) subjects using Circle-sequencing. We validated the level of a novel circulating eccDNA named sorbin and SH3-domain- containing-1circle97206791-97208025 (SORBS1circle) in 106 newly diagnosed T2DM patients. The relationship between eccDNA SORBS1circle and clinical data was analyzed. Furthermore, we explored the source and expression level of eccDNA SORBS1circle in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model. RESULTS A total of 22,543 and 19,195 eccDNAs were found in serum samples obtained from newly diagnosed T2DM patients and NC subjects, respectively. The T2DM patients had a greater distribution of eccDNA on chromosomes 1, 14, 16, 17, 18, 19, 20 and X. Additionally, 598 serum eccDNAs were found to be upregulated, while 856 eccDNAs were downregulated in T2DM patients compared with NC subjects. KEGG analysis demonstrated that the genes carried by eccDNAs were mainly associated with insulin resistance. Moreover, it was validated that the eccDNA SORBS1circle was significantly increased in serum of newly diagnosed T2DM patients (106 T2DM patients vs. 40 NC subjects). The serum eccDNA SORBS1circle content was positively correlated with the levels of glycosylated hemoglobin A1C (HbA1C) and homeostasis model assessment of insulin resistance (HOMA-IR) in T2DM patients. Intracellular eccDNA SORBS1circle expression was significantly enhanced in the high glucose and palmitate (HG/PA)-induced hepatocyte (HepG2 cell) insulin resistance model. Moreover, the upregulation of eccDNA SORBS1circle in the HG/PA-treated HepG2 cells was dependent on generation of apoptotic DNA fragmentation. CONCLUSIONS These results provide a preliminary understanding of the circulating eccDNA patterns at the early stage of T2DM and suggest that eccDNA SORBS1circle may be involved in the development of insulin resistance.
Collapse
Affiliation(s)
- Xiang Kong
- Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Wuhu, 241002, China
- Geriatric Endocrinology Unit, Department of Gerontology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, 241001, China
- Central Laboratory of Yijishan Hospital, Wuhu, 241001, China
| | - Shu-Jun Wan
- Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Wuhu, 241002, China
- Central Laboratory of Yijishan Hospital, Wuhu, 241001, China
| | - Tian-Bing Chen
- Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Wuhu, 241002, China
- Central Laboratory of Yijishan Hospital, Wuhu, 241001, China
| | - Lan Jiang
- Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Wuhu, 241002, China
- Central Laboratory of Yijishan Hospital, Wuhu, 241001, China
| | - Yu-Jie Xing
- Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Wuhu, 241002, China
- Geriatric Endocrinology Unit, Department of Gerontology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, 241001, China
| | - Ya-Ping Bai
- Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Wuhu, 241002, China
| | - Qiang Hua
- Department of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, 241001, China
| | - Xin-Ming Yao
- Department of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, 241001, China
| | - Yong-Li Zhao
- Department of Endocrinology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, 241001, China
| | - Hong-Mei Zhang
- Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China
| | - De-Guo Wang
- Geriatric Endocrinology Unit, Department of Gerontology, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, Wuhu, 241001, China.
| | - Qing Su
- Department of Endocrinology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China.
| | - Kun Lv
- Anhui Provincial Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wannan Medical College, Wuhu, 241002, China.
- Central Laboratory of Yijishan Hospital, Wuhu, 241001, China.
| |
Collapse
|
11
|
Tang SH, Tang X, Liu L, Peng L, Zhang HM, Zhang H, Long T, Wu PL, Zhang XP. Role of NF-κB p65/TNF-α in Cell Apoptosis in the Fetal Membranes of Pregnant Women with Preterm Premature Rupture of Membranes. Ann Clin Lab Sci 2024; 54:26-34. [PMID: 38514058] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/23/2024]
Abstract
OBJECTIVE This study aimed to investigate the roles of nuclear factor-kappa B p65 (NF-[Formula: see text]B p65) and tumor necrosis factor-α (TNF-α) in cell apoptosis occurring in the fetal membranes of pregnant women who experience preterm premature rupture of membranes (PPROM). METHODS This was a case-control study involving 57 pregnant women who delivered in the obstetric department of Affiliated Loudi Hospital, Hengyang Medical School, University of South China, from June 2021 to June 2022. Samples of fetal membrane tissue were collected from pregnant women with PPROM (n=27) and pregnant women who had normal deliveries (control group; n=30). The membrane tissue morphology of both groups was observed, and the expression of NF-[Formula: see text]B p65, p-NF-[Formula: see text]B p65, TNF-α, and caspase-3 was detected. Apoptosis in fetal membranes was examined. RESULTS Morphological evaluation of the fetal membrane tissues obtained from patients with PPROM revealed an abnormal structure with a thin collagen fiber layer and cells with a largely vacuolar cytoplasm. There was a positive correlation between the expression of p-NF-[Formula: see text]B p65/NF-[Formula: see text]B p65 and cell apoptosis (r1 =0.89, R2 =0.805, P=0.00). Furthermore, TNF-α was positively correlated with fetal membrane cell apoptosis (r2 =0.93, R2=0.881, P=0.00). CONCLUSION NF-[Formula: see text]B p65 is involved in the occurrence of PPROM by promoting the expression of TNF-α, which upregulates caspase-3 to cause apoptosis of fetal membrane cells.
Collapse
Affiliation(s)
- Shi-Huan Tang
- Department of Reproduction Medicine Center, The Affiliated Loudi Hospital, Hengyang Medical School, University of South China, Loudi, Hunan, China
| | - Xian Tang
- Department of Reproduction Medicine Center, The Affiliated Loudi Hospital, Hengyang Medical School, University of South China, Loudi, Hunan, China
| | - Ling Liu
- Department of Reproduction Medicine Center, The Affiliated Loudi Hospital, Hengyang Medical School, University of South China, Loudi, Hunan, China
| | - Lu Peng
- Department of Reproduction Medicine Center, The Affiliated Loudi Hospital, Hengyang Medical School, University of South China, Loudi, Hunan, China
| | - Hong-Mei Zhang
- Department of Reproduction Medicine Center, The Affiliated Loudi Hospital, Hengyang Medical School, University of South China, Loudi, Hunan, China
| | - Hui Zhang
- Department of Reproduction Medicine Center, The Affiliated Loudi Hospital, Hengyang Medical School, University of South China, Loudi, Hunan, China
| | - Ting Long
- Department of Technical Medical, Loudi Vocational and Technical Medical College, Loudi, Hunan, China
| | - Pei-Ling Wu
- Department of Reproduction Medicine Center, The Affiliated Loudi Hospital, Hengyang Medical School, University of South China, Loudi, Hunan, China
| | - Xian-Ping Zhang
- Department of Reproduction Medicine Center, The Affiliated Loudi Hospital, Hengyang Medical School, University of South China, Loudi, Hunan, China
| |
Collapse
|
12
|
Huang D, Lin G, Chu Q, Hu Y, Wang J, Wang Z, Yang F, Zhong W, Zhou C, Zhu B, Ai X, Cao B, Cao Y, Chen M, Chen X, Chu T, Duan J, Fan Y, Fang Y, Feng S, Feng W, Guo H, Han C, He Y, Hong S, Hu J, Huang M, Huang Y, Jiang D, Jiang K, Jiang R, Jin B, Jin S, Li J, Li M, Li Z, Li C, Lin J, Liu A, Liu SM, Liu Y, Liu Z, Liu Z, Liu Z, Liu Z, Liu Z, Lu Y, Lv T, Ma Z, Miao Q, Peng M, Pu X, Ren XB, Shan J, Shan J, Shen P, Shen B, Shi M, Song Y, Song Z, Su C, Sun J, Tian P, Wang J, Wang F, Wang H, Wang J, Wang Q, Wang W, Wang Y, Wu L, Wu F, Xia Y, Xie C, Xie C, Xin T, Xiong J, Xu H, Xu S, Xu Y, Xu B, Xu C, Yan X, Yang Z, Yao W, Yu Y, Feng Y, Yu Z, Yu Y, Yue D, Zhang H, Zhang H, Zhang L, Zhang L, Zhang Q, Zhang T, Zhang B, Zhao J, Zhao M, Zheng X, Zhong F, Zhou J, Zhou P, Zhu Z, Zou J, Zou Z. Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer. Thorac Cancer 2023; 14:3421-3429. [PMID: 37963454 PMCID: PMC10693946 DOI: 10.1111/1759-7714.15157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2023] [Accepted: 10/29/2023] [Indexed: 11/16/2023] Open
Abstract
Immune checkpoint inhibitors (PD-1/PD-L1 and CTLA-4 blockade) have revolutionized the treatment landscape in non-small cell lung cancer (NSCLC). Secondary resistance to immunotherapy (IO), which poses a substantial challenge in clinical settings, occurs in several initial responders. Currently, new treatment approaches have been extensively evaluated in investigational studies for these patients to tackle this difficult problem; however, the lack of consistency in clinical definition, uniform criteria for enrollment in clinical trials, and interpretation of results remain significant hurdles to progress. Thus, our expert panel comprehensively synthesized data from current studies to propose a practical clinical definition of secondary resistance to immunotherapy in NSCLC in metastatic and neoadjuvant settings. In addition to patients who received IO alone (including IO-IO combinations), we also generated a definition for patients treated with chemotherapy plus IO. This consensus aimed to provide guidance for clinical trial design and facilitate future discussions with investigators. It should be noted that additional updates in this consensus are required when new data is available.
Collapse
Affiliation(s)
- Dingzhi Huang
- Department of Thoracic OncologyTianjin Medical University Cancer Institute and HospitalTianjinPeople's Republic of China
| | - Gen Lin
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouPeople's Republic of China
| | - Qian Chu
- Department of Oncology, Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanPeople's Republic of China
| | - Yi Hu
- Senior Department of OncologyChinese PLA General HospitalBeijingPeople's Republic of China
| | - Jun Wang
- Department of OncologyThe First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan HospitalJi'nanPeople's Republic of China
| | - Zhijie Wang
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingPeople's Republic of China
| | - Fan Yang
- Department of Thoracic SurgeryPeking University People HospitalBeijingPeople's Republic of China
| | - Wenzhao Zhong
- Guangdong Lung Cancer Institute, Guangdong Provincial People's HospitalGuangdong Academy of Medical SciencesGuangzhouPeople's Republic of China
| | - Chengzhi Zhou
- Pulmonary and Critical Care Medicine, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, State Key Laboratory of Respiratory DiseasesThe First Affiliated Hospital of Guangzhou Medical UniversityGuangzhouPeople's Republic of China
| | - Bo Zhu
- Institute of Cancer, Xinqiao HospitalArmy Medical UniversityChongqingPeople's Republic of China
| | - Xinghao Ai
- Shanghai Lung Cancer Center, Shanghai Chest HospitalShanghai Jiao Tong University School of MedicineShanghaiPeople's Republic of China
| | - Baoshan Cao
- Cancer centerPeking University Third Hospital/ Department of medical oncology and radiation sickness, Peking University Third HospitalBeijingPeople's Republic of China
| | - Yabing Cao
- Department of oncologyKiang Wu HospitalMacauPeople's Republic of China
| | - Mingqiu Chen
- Department of Thoracic Radiation Oncology, Clinical Oncology School of Fujian Medical UniversityFujian Cancer HospitalFuzhouPeople's Republic of China
| | - Xiaohui Chen
- Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical UniversityFujian Cancer HospitalFuzhouPeople's Republic of China
| | - Tianqing Chu
- Respiratory Department, Shanghai Chest HospitalShanghai Jiao Tong University School of MedicineShanghaiPeople's Republic of China
| | - Jianchun Duan
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingPeople's Republic of China
| | - Yun Fan
- Department of Medical OncologyZhejiang Cancer HospitalHangzhouPeople's Republic of China
| | - Yong Fang
- Department of Medical Oncology, Sir Run Run Shaw HospitalZhenjiang University School of MedicineHangzhouPeople's Republic of China
| | - Shuitu Feng
- Department of Medical OncologyFudan University Shanghai Cancer Center Xiamen HospitalXiamenPeople's Republic of China
| | - Weineng Feng
- Department of Pulmonary OncologyThe First People's Hospital of FoshanFoshanPeople's Republic of China
| | - Hui Guo
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anPeople's Republic of China
| | - Chengbo Han
- Department of OncologyShengjing Hospital of China Medical UniversityShenyangPeople's Republic of China
| | - Yong He
- Department of Respiratory Medicine, Xinqiao HospitalArmy Medical UniversityChongqingPeople's Republic of China
| | - Shaodong Hong
- State Key Laboratory of Oncology in Southern ChinaSun Yat‐sen University Cancer CenterGuangzhouPeople's Republic of China
| | - Jie Hu
- Zhongshan Hospital, Fudan UniversityShanghai Geriatric CenterShanghaiPeople's Republic of China
| | - Meijuan Huang
- Division of Thoracic Tumor Multimodality Treatment and Department of Medical Oncology, Cancer Center, West China HospitalSichuan UniversityChengduPeople's Republic of China
| | - Yan Huang
- State Key Laboratory of Oncology in Southern ChinaSun Yat‐sen University Cancer CenterGuangzhouPeople's Republic of China
| | - Da Jiang
- Department of OncologyThe Fourth Affiliated Hospital of Hebei Medical UniversityShijiazhuangPeople's Republic of China
| | - Kan Jiang
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouPeople's Republic of China
| | - Richeng Jiang
- Department of Thoracic OncologyTianjin Medical University Cancer Institute and HospitalTianjinPeople's Republic of China
| | - Bo Jin
- Department of Medical OncologyThe First affiliated hospital of China Medical UniversityShenyangPeople's Republic of China
| | - Shi Jin
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital &Shenzhen HospitalChinese Academy of Medical Sciences and Perking Union Medical CollegeShenzhenPeople's Republic of China
| | - Jisheng Li
- Department of Medical OncologyQilu Hospital of Shandong UniversityJi'nanPeople's Republic of China
| | - Min Li
- Department of Respiratory Medicine, Xiangya HospitalCentral South UniversityChangshaPeople's Republic of China
| | - Ziming Li
- Shanghai Lung Cancer Center, Shanghai Chest HospitalShanghai Jiao Tong University School of MedicineShanghaiPeople's Republic of China
| | - Chao Li
- Department of PathologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouPeople's Republic of China
| | - Jie Lin
- Department of Medical OncologyThe Second Affiliated Hospital of Kunming Medical UniversityKunmingPeople's Republic of China
| | - Anwen Liu
- Department of Medical OncologyThe Second Affiliated Hospital of Nanchang UniversityNanchangPeople's Republic of China
| | - Si‐Yang Maggie Liu
- Department of Hematology, First Affiliated HospitalJi'nan UniversityGuangzhouPeople's Republic of China
| | - Yutao Liu
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingPeople's Republic of China
| | - Zhefeng Liu
- Senior Department of OncologyChinese PLA General HospitalBeijingPeople's Republic of China
| | - Zhe Liu
- Department of Medical Oncology, Beijing Chest HospitalCapital Medical UniversityBeijingPeople's Republic of China
| | - Zhenhua Liu
- Department of Oncology, Shengli Clinical Medical College of Fujian Medical UniversityFujian Provincial HospitalFuzhouPeople's Republic of China
| | - Zhentian Liu
- Department of Thoracic Oncology,Jiangxi Cancer HospitalNanchangPeople's Republic of China
| | - Zhigang Liu
- Cancer CenterThe 10th Affiliated Hospital of Southern Medical UniversityDongguanPeople's Republic of China
| | - Yuping Lu
- Department of Abdominal OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouPeople's Republic of China
| | - Tangfeng Lv
- Department of Respiratory Medicine, Affiliated Jinling HospitalMedical School of Nanjing UniversityNanjingPeople's Republic of China
| | - Zhiyong Ma
- Department of Respiratory MedicineHenan Cancer Hospital /Affiliated Cancer Hospital of Zhengzhou UniversityZhengzhouPeople's Republic of China
| | - Qian Miao
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouPeople's Republic of China
| | - Min Peng
- Cancer centerRenmin Hospital of Wuhan UniversityWuhanPeople's Republic of China
| | - Xingxiang Pu
- Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of MedicineCentral South UniversityChangshaPeople's Republic of China
| | - Xiu Bao Ren
- Department of BiotherapyTianjin Medical University Cancer Institute and HospitalTianjinPeople's Republic of China
| | - Jianzhen Shan
- Department of Medical OncologyThe First Affiliated Hospital of Zhejiang UniversityZhejiangPeople's Republic of China
| | - Jinlu Shan
- Department of Medical Oncology, Daping HospitalArmy Medical UniversityChongqingPeople's Republic of China
| | - Peng Shen
- Department of Oncology, Nanfang HospitalSouthern Medical UniversityGuangzhouPeople's Republic of China
| | - Bo Shen
- Department of Medical OncologyJiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical UniversityNanjingPeople's Republic of China
| | - Meiqi Shi
- Department of Medical OncologyJiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and Affiliated Cancer Hospital of Nanjing Medical UniversityNanjingPeople's Republic of China
| | - Yong Song
- Department of Respiratory Medicine, Affiliated Jinling HospitalMedical School of Nanjing UniversityNanjingPeople's Republic of China
| | - Zhengbo Song
- Department of Clinical TrialZhejiang Cancer HospitalHangzhouPeople's Republic of China
| | - ChunXia Su
- Department of Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer InstituteTongji University School of MedicineShanghaiPeople's Republic of China
| | - Jianguo Sun
- Institute of Cancer, Xinqiao HospitalArmy Medical UniversityChongqingPeople's Republic of China
| | - Panwen Tian
- Department of Pulmonary and Critical Care Medicine, Lung Cancer Center, West China HospitalSichuan University, Precision Medicine Key Laboratory of Sichuan ProvinceChengduPeople's Republic of China
| | - Jinliang Wang
- Senior Department of OncologyChinese PLA General HospitalBeijingPeople's Republic of China
| | - Feng Wang
- Department of Thoracic Surgery, Clinical Oncology School of Fujian Medical UniversityFujian Cancer HospitalFuzhouPeople's Republic of China
| | - Huijuan Wang
- Department of Respiratory MedicineHenan Cancer Hospital /Affiliated Cancer Hospital of Zhengzhou UniversityZhengzhouPeople's Republic of China
| | - Jialei Wang
- Department of Thoracic Medical OncologyFudan University Shanghai Cancer CenterShanghaiPeople's Republic of China
| | - Qian Wang
- Department of Respiratory Medicine, Affiliated Hospital of Nanjing University of Chinese MedicineJiangsu Province Hospital of Chinese MedicineNanjingPeople's Republic of China
| | - Wenxian Wang
- Department of Medical OncologyZhejiang Cancer HospitalHangzhouPeople's Republic of China
| | - Yan Wang
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingPeople's Republic of China
| | - Lin Wu
- Department of Thoracic Medical Oncology, Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of MedicineCentral South UniversityChangshaPeople's Republic of China
| | - Fang Wu
- Department of Oncology, The Second Xiangya HospitalCentral South UniversityChangshaPeople's Republic of China
| | - Yang Xia
- Department of Respiratory and Critical Care MedicineSecond Affiliated Hospital of Zhejiang University School of MedicineHangzhouPeople's Republic of China
| | - Congying Xie
- Department of Radiation and Medical OncologySecond Affiliated Hospital of Wenzhou Medical UniversityWenzhouPeople's Republic of China
| | - Conghua Xie
- Department of Pulmonary OncologyZhongnan Hospital of Wuhan UniversityWuhanPeople's Republic of China
| | - Tao Xin
- Department of OncologyThe Second Affiliated Hospital of Harbin Medical UniversityHarbinPeople's Republic of China
| | - Jianping Xiong
- Department of OncologyThe First Affiliated Hospital of Nanchang UniversityNanchangPeople's Republic of China
| | - Haipeng Xu
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouPeople's Republic of China
| | - Song Xu
- Department of Lung Cancer SurgeryTianjin Medical University General HospitalTianjinPeople's Republic of China
| | - Yiquan Xu
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouPeople's Republic of China
| | - Bin Xu
- Cancer centerRenmin Hospital of Wuhan UniversityWuhanPeople's Republic of China
| | - Chunwei Xu
- Department of Respiratory Medicine, Affiliated Jinling HospitalMedical School of Nanjing UniversityNanjingPeople's Republic of China
| | - Xiaolong Yan
- Department of Thoracic Surgery, Tangdu HospitalAir Force Medical UniversityXi'anPeople's Republic of China
| | - Zhenzhou Yang
- Department of Cancer CenterThe Second Affiliated Hospital of Chongqing Medical UniversityChongqingPeople's Republic of China
| | - Wenxiu Yao
- Department of Medical Oncology, Sichuan Cancer HospitalUniversity of Electronic Science and Technology of ChinaChengduPeople's Republic of China
| | - Yao Yu
- Department of Medical OncologyThe First Affiliated Hospital of Xi'an Jiaotong UniversityXi'anPeople's Republic of China
| | - Ye Feng
- Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation ResearchThe First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen UniversityXiamenPeople's Republic of China
| | - Zongyang Yu
- Department of Respiratory Medicine, The 900th Hospital of the Joint Logistic Support ForcePeople's Liberation Army of ChinaFuzhouPeople's Republic of China
| | - Yongfeng Yu
- Shanghai Lung Cancer Center, Shanghai Chest HospitalShanghai Jiao Tong University School of MedicineShanghaiPeople's Republic of China
| | - Dongsheng Yue
- Department of Lung CancerTianjin Medical University Cancer Institute and HospitalTianjinPeople's Republic of China
| | - Haibo Zhang
- Department of OncologyGuangdong Provincial Hospital of Chinese MedicineGuangzhouPeople's Republic of China
| | - HongMei Zhang
- Department of Clinical Oncology, Xijing HospitalAir Force Medical UniversityXi'anPeople's Republic of China
| | - Li Zhang
- Department of Oncology, Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanPeople's Republic of China
| | - Longfeng Zhang
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouPeople's Republic of China
| | - Qiuyu Zhang
- Institute of ImmunotherapyFujian Medical UniversityFuzhouPeople's Republic of China
| | - Tongmei Zhang
- Department of Medical Oncology, Beijing Chest HospitalCapital Medical UniversityBeijingPeople's Republic of China
| | - Bicheng Zhang
- Cancer centerRenmin Hospital of Wuhan UniversityWuhanPeople's Republic of China
| | - Jun Zhao
- Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Department I of Thoracic OncologyPeking University Cancer Hospital and InstituteBeijingPeople's Republic of China
| | - Mingfang Zhao
- Department of Medical OncologyThe First affiliated hospital of China Medical UniversityShenyangPeople's Republic of China
| | - Xiaobin Zheng
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouPeople's Republic of China
| | - Fengqiao Zhong
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouPeople's Republic of China
| | - Jin Zhou
- Department of Medical Oncology, Sichuan Cancer HospitalUniversity of Electronic Science and Technology of ChinaChengduPeople's Republic of China
| | - Penghui Zhou
- State Key Laboratory of Oncology in Southern ChinaSun Yat‐sen University Cancer CenterGuangzhouPeople's Republic of China
| | - Zhengfei Zhu
- Department of Radiation OncologyFudan University Shanghai Cancer CenterShanghaiPeople's Republic of China
| | - Juntao Zou
- Department of Respiratory MedicineThe First Affiliated Hospital of Nanchang UniversityNanchangPeople's Republic of China
| | - Zihua Zou
- Department of Thoracic OncologyClinical Oncology School of Fujian Medical University, Fujian Cancer HospitalFuzhouPeople's Republic of China
| |
Collapse
|
13
|
Zhang HM, Ke HT, Ahmed MR, Li YJ, Nabi G, Li MH, Zhang JY, Liu D, Zhao LX, Liu BR. Endoscopic transgastric fenestration versus percutaneous drainage for management of (peri)pancreatic fluid collections adjacent to gastric wall (with video). World J Gastroenterol 2023; 29:5557-5565. [PMID: 37970477 PMCID: PMC10642437 DOI: 10.3748/wjg.v29.i40.5557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/24/2023] [Revised: 10/01/2023] [Accepted: 10/23/2023] [Indexed: 10/27/2023] Open
Abstract
BACKGROUND Percutaneous drainage (PCD) and endoscopic approaches have largely replaced surgical drainage as the initial approach for (peri) pancreatic fluid collections (PFC)s, while complications associated with endoscopic stent implantation are common. AIM To introduce a novel endoscopic therapy named endoscopic transgastric fenestration (ETGF), which involves resection of tissue by endoscopic accessory between gastric and PFCs without stent implantation, and to evaluate its efficacy and safety compared with PCD for the management of PFCs adjacent to the gastric wall. METHODS Patients diagnosed with PFCs adjacent to the gastric wall and who subsequently received ETGF or PCD were restrospectively enrolled. Indications for intervention were consistent with related guidelines. We analyzed patients baseline characteristics, technical and clinical success rate, recurrence and reintervention rate, procedure-related complications and adverse events. RESULTS Seventy-two eligible patients were retrospectively identified (ETGF = 34, PCD = 38) from October 2017 to May 2021. Patients in the ETGF group had a significantly higher clinical success rate than those in the PCD group (97.1 vs 76.3%, P = 0.01). There were no statistically significant differences regarding recurrence, reintervention and incidence of complication between the two groups. While long-term catheter drainage was very common in the PCD group. CONCLUSION Compared with PCD, ETGF has a higher clinical success rate in the management of PFCs adjacent to the gastric wall. ETGF is an alternative effective strategy for the treatment of PFCs adjacent to the gastric wall.
Collapse
Affiliation(s)
- Hong-Mei Zhang
- Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China
| | - Hui-Ting Ke
- Department of Ultrasound, Ezhou Central Hospital, Ezhou 436099, Hubei Province, China
| | - Md Robin Ahmed
- Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China
| | - Ya-Juan Li
- Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China
| | - Ghulam Nabi
- Institute of Nature Conservation, Polish Academy of Sciences, Krakow 31120, Poland
| | - Mu-Han Li
- Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China
| | - Ji-Yu Zhang
- Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China
| | - Dan Liu
- Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China
| | - Li-Xia Zhao
- Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China
| | - Bing-Rong Liu
- Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450000, Henan Province, China
- State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou University, Zhengzhou 450052, Henan Province, China
| |
Collapse
|
14
|
Zhang HM, Li BQ, Zhu Y, Liu SX, Wei RH. Time trends in myopia and high myopia prevalence in young university adults in China. Int J Ophthalmol 2023; 16:1676-1681. [PMID: 37854374 PMCID: PMC10559017 DOI: 10.18240/ijo.2023.10.18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Accepted: 08/03/2023] [Indexed: 10/20/2023] Open
Abstract
AIM To investigate time trends in myopia and high myopia prevalence over 6y among young university adults in China. METHODS This is a 6-year series cross-sectional study from 2016 to 2021. Totally 4910 freshmen were enrolled and completed a questionnaire concerning age, gender, and disease history. Students with eye diseases were excluded after a detailed eye examination. The refractive status was measured by non-cycloplegic objective refraction and ocular parameters were measured by Lenstar 900. The examination followed the same protocol each year. Trends over time in myopia and high myopia prevalence, as well as ocular biometry parameters, were analyzed. RESULTS From 2016 to 2021, the axial length (AL) and corneal radius (CR) increased significantly (P=0.002 for AL; P=0.04 for CR). However, the spherical equivalent (SE) and the ratio of axial length to the corneal radius (AL/CR) did not change significantly (P=0.59 for SE; P=0.24 for AL/CR). The frequency of AL ≥26.0 mm increased from 26.6% in 2016 to 29.3% in 2021 (P=0.05 for trend). The prevalence of myopia and high myopia did not change significantly in our study (P≥0.18). Compared to a similar cross-sectional study conducted 10 years ago, the prevalence of myopia decreased significantly (94.9% vs 91.8%, P<0.001). Whereas the prevalence of high myopia increased largely (18.12% vs 27.6%, P<0.001). CONCLUSION The prevalence of high myopia increases in young university adults during 10y period. Myopia control should begin earlier in childhood. However, these interventions are still needed for high myopia even in young adulthood.
Collapse
Affiliation(s)
- Hong-Mei Zhang
- Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China
| | - Bing-Qin Li
- Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China
| | - Yun Zhu
- Department of Epidemiology and Biostatistics, Tianjin Medical University, Tianjin 300070, China
| | - Sheng-Xin Liu
- Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
| | - Rui-Hua Wei
- Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin 300384, China
| |
Collapse
|
15
|
Cao Z, Aharonian F, An Q, Axikegu, Bai YX, Bao YW, Bastieri D, Bi XJ, Bi YJ, Cai JT, Cao Q, Cao WY, Cao Z, Chang J, Chang JF, Chen AM, Chen ES, Chen L, Chen L, Chen L, Chen MJ, Chen ML, Chen QH, Chen SH, Chen SZ, Chen TL, Chen Y, Cheng N, Cheng YD, Cui MY, Cui SW, Cui XH, Cui YD, Dai BZ, Dai HL, Dai ZG, Danzengluobu, Della Volpe D, Dong XQ, Duan KK, Fan JH, Fan YZ, Fang J, Fang K, Feng CF, Feng L, Feng SH, Feng XT, Feng YL, Gabici S, Gao B, Gao CD, Gao LQ, Gao Q, Gao W, Gao WK, Ge MM, Geng LS, Giacinti G, Gong GH, Gou QB, Gu MH, Guo FL, Guo XL, Guo YQ, Guo YY, Han YA, He HH, He HN, He JY, He XB, He Y, Heller M, Hor YK, Hou BW, Hou C, Hou X, Hu HB, Hu Q, Hu SC, Huang DH, Huang TQ, Huang WJ, Huang XT, Huang XY, Huang Y, Huang ZC, Ji XL, Jia HY, Jia K, Jiang K, Jiang XW, Jiang ZJ, Jin M, Kang MM, Ke T, Kuleshov D, Kurinov K, Li BB, Li C, Li C, Li D, Li F, Li HB, Li HC, Li HY, Li J, Li J, Li J, Li K, Li WL, Li WL, Li XR, Li X, Li YZ, Li Z, Li Z, Liang EW, Liang YF, Lin SJ, Liu B, Liu C, Liu D, Liu H, Liu HD, Liu J, Liu JL, Liu JY, Liu MY, Liu RY, Liu SM, Liu W, Liu Y, Liu YN, Lu R, Luo Q, Lv HK, Ma BQ, Ma LL, Ma XH, Mao JR, Min Z, Mitthumsiri W, Mu HJ, Nan YC, Neronov A, Ou ZW, Pang BY, Pattarakijwanich P, Pei ZY, Qi MY, Qi YQ, Qiao BQ, Qin JJ, Ruffolo D, Sáiz A, Semikoz D, Shao CY, Shao L, Shchegolev O, Sheng XD, Shu FW, Song HC, Stenkin YV, Stepanov V, Su Y, Sun QN, Sun XN, Sun ZB, Tam PHT, Tang QW, Tang ZB, Tian WW, Wang C, Wang CB, Wang GW, Wang HG, Wang HH, Wang JC, Wang K, Wang LP, Wang LY, Wang PH, Wang R, Wang W, Wang XG, Wang XY, Wang Y, Wang YD, Wang YJ, Wang ZH, Wang ZX, Wang Z, Wang Z, Wei DM, Wei JJ, Wei YJ, Wen T, Wu CY, Wu HR, Wu S, Wu XF, Wu YS, Xi SQ, Xia J, Xia JJ, Xiang GM, Xiao DX, Xiao G, Xin GG, Xin YL, Xing Y, Xiong Z, Xu DL, Xu RF, Xu RX, Xu WL, Xue L, Yan DH, Yan JZ, Yan T, Yang CW, Yang F, Yang FF, Yang HW, Yang JY, Yang LL, Yang MJ, Yang RZ, Yang SB, Yao YH, Yao ZG, Ye YM, Yin LQ, Yin N, You XH, You ZY, Yu YH, Yuan Q, Yue H, Zeng HD, Zeng TX, Zeng W, Zha M, Zhang BB, Zhang F, Zhang HM, Zhang HY, Zhang JL, Zhang LX, Zhang L, Zhang PF, Zhang PP, Zhang R, Zhang SB, Zhang SR, Zhang SS, Zhang X, Zhang XP, Zhang YF, Zhang Y, Zhang Y, Zhao B, Zhao J, Zhao L, Zhao LZ, Zhao SP, Zheng F, Zhou B, Zhou H, Zhou JN, Zhou M, Zhou P, Zhou R, Zhou XX, Zhu CG, Zhu FR, Zhu H, Zhu KJ, Zuo X. Measurement of Ultra-High-Energy Diffuse Gamma-Ray Emission of the Galactic Plane from 10 TeV to 1 PeV with LHAASO-KM2A. Phys Rev Lett 2023; 131:151001. [PMID: 37897763 DOI: 10.1103/physrevlett.131.151001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/04/2023] [Revised: 07/08/2023] [Accepted: 08/18/2023] [Indexed: 10/30/2023]
Abstract
The diffuse Galactic γ-ray emission, mainly produced via interactions between cosmic rays and the interstellar medium and/or radiation field, is a very important probe of the distribution, propagation, and interaction of cosmic rays in the Milky Way. In this Letter, we report the measurements of diffuse γ rays from the Galactic plane between 10 TeV and 1 PeV energies, with the square kilometer array of the Large High Altitude Air Shower Observatory (LHAASO). Diffuse emissions from the inner (15°10 TeV). The energy spectrum in the inner Galaxy regions can be described by a power-law function with an index of -2.99±0.04, which is different from the curved spectrum as expected from hadronic interactions between locally measured cosmic rays and the line-of-sight integrated gas content. Furthermore, the measured flux is higher by a factor of ∼3 than the prediction. A similar spectrum with an index of -2.99±0.07 is found in the outer Galaxy region, and the absolute flux for 10≲E≲60 TeV is again higher than the prediction for hadronic cosmic ray interactions. The latitude distributions of the diffuse emission are consistent with the gas distribution, while the longitude distributions show clear deviation from the gas distribution. The LHAASO measurements imply that either additional emission sources exist or cosmic ray intensities have spatial variations.
Collapse
Affiliation(s)
- Zhen Cao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - F Aharonian
- Dublin Institute for Advanced Studies, 31 Fitzwilliam Place, 2 Dublin, Ireland
- Max-Planck-Institut for Nuclear Physics, P.O. Box 103980, 69029 Heidelberg, Germany
| | - Q An
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Axikegu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y X Bai
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y W Bao
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - D Bastieri
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - X J Bi
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y J Bi
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J T Cai
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Q Cao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - W Y Cao
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Zhe Cao
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - J Chang
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J F Chang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - A M Chen
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - E S Chen
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Liang Chen
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - Lin Chen
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Long Chen
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M J Chen
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M L Chen
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - Q H Chen
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - S H Chen
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - S Z Chen
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - T L Chen
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - Y Chen
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - N Cheng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y D Cheng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M Y Cui
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S W Cui
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - X H Cui
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - Y D Cui
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Z Dai
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - H L Dai
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - Z G Dai
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Danzengluobu
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - D Della Volpe
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, 24 Quai Ernest Ansermet, 1211 Geneva, Switzerland
| | - X Q Dong
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - K K Duan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J H Fan
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y Z Fan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Fang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - K Fang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C F Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Feng
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S H Feng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X T Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - Y L Feng
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - S Gabici
- APC, Université Paris Cité, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, 119 75205 Paris, France
| | - B Gao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C D Gao
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Q Gao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Q Gao
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - W Gao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W K Gao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M M Ge
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - L S Geng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - G Giacinti
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - G H Gong
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - Q B Gou
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M H Gu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - F L Guo
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - X L Guo
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Q Guo
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y Y Guo
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y A Han
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - H H He
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H N He
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Y He
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - X B He
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - Y He
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M Heller
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, 24 Quai Ernest Ansermet, 1211 Geneva, Switzerland
| | - Y K Hor
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B W Hou
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C Hou
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X Hou
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - H B Hu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Q Hu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S C Hu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D H Huang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - T Q Huang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W J Huang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - X T Huang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X Y Huang
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y Huang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z C Huang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - X L Ji
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - H Y Jia
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - K Jia
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - K Jiang
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - X W Jiang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z J Jiang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - M Jin
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M M Kang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - T Ke
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Kuleshov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - K Kurinov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - B B Li
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - Cheng Li
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Cong Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - F Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - H B Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H C Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H Y Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Jian Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Jie Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - K Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W L Li
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - W L Li
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - X R Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Xin Li
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Y Z Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Zhe Li
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Zhuo Li
- School of Physics, Peking University, 100871 Beijing, China
| | - E W Liang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Y F Liang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - S J Lin
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Liu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - C Liu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Liu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - H Liu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H D Liu
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - J Liu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J L Liu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J Y Liu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M Y Liu
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - R Y Liu
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - S M Liu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - W Liu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y Liu
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y N Liu
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - R Lu
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Q Luo
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - H K Lv
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B Q Ma
- School of Physics, Peking University, 100871 Beijing, China
| | - L L Ma
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X H Ma
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J R Mao
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - Z Min
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W Mitthumsiri
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - H J Mu
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - Y C Nan
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - A Neronov
- APC, Université Paris Cité, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, 119 75205 Paris, France
| | - Z W Ou
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Y Pang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - P Pattarakijwanich
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - Z Y Pei
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - M Y Qi
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y Q Qi
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - B Q Qiao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J J Qin
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - D Ruffolo
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - A Sáiz
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - D Semikoz
- APC, Université Paris Cité, CNRS/IN2P3, CEA/IRFU, Observatoire de Paris, 119 75205 Paris, France
| | - C Y Shao
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - L Shao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - O Shchegolev
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - X D Sheng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - F W Shu
- Center for Relativistic Astrophysics and High Energy Physics, School of Physics and Materials Science & Institute of Space Science and Technology, Nanchang University, 330031 Nanchang, Jiangxi, China
| | - H C Song
- School of Physics, Peking University, 100871 Beijing, China
| | - Yu V Stenkin
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - V Stepanov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - Y Su
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Q N Sun
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - X N Sun
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Z B Sun
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - P H T Tam
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - Q W Tang
- Center for Relativistic Astrophysics and High Energy Physics, School of Physics and Materials Science & Institute of Space Science and Technology, Nanchang University, 330031 Nanchang, Jiangxi, China
| | - Z B Tang
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - W W Tian
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - C Wang
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - C B Wang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - G W Wang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - H G Wang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - H H Wang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - J C Wang
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - K Wang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - L P Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Y Wang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - P H Wang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - R Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - W Wang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - X G Wang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - X Y Wang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - Y Wang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y D Wang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y J Wang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z H Wang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Z X Wang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Zhen Wang
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - Zheng Wang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - D M Wei
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J J Wei
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y J Wei
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - T Wen
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - C Y Wu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H R Wu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - S Wu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X F Wu
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y S Wu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - S Q Xi
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J Xia
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J J Xia
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - G M Xiang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - D X Xiao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - G Xiao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - G G Xin
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y L Xin
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Xing
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - Z Xiong
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D L Xu
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - R F Xu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - R X Xu
- School of Physics, Peking University, 100871 Beijing, China
| | - W L Xu
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - L Xue
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - D H Yan
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - J Z Yan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - T Yan
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C W Yang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - F Yang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - F F Yang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - H W Yang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - J Y Yang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - L L Yang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - M J Yang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - R Z Yang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - S B Yang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Y H Yao
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Z G Yao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y M Ye
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - L Q Yin
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - N Yin
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X H You
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z Y You
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y H Yu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Q Yuan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - H Yue
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H D Zeng
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - T X Zeng
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - W Zeng
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - M Zha
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B B Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - F Zhang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H M Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - H Y Zhang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J L Zhang
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - L X Zhang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Li Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - P F Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - P P Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - R Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S B Zhang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - S R Zhang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S S Zhang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - X P Zhang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y F Zhang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Yi Zhang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Yong Zhang
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B Zhao
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - J Zhao
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - L Zhao
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - L Z Zhao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S P Zhao
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - F Zheng
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - B Zhou
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H Zhou
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - J N Zhou
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - M Zhou
- Center for Relativistic Astrophysics and High Energy Physics, School of Physics and Materials Science & Institute of Space Science and Technology, Nanchang University, 330031 Nanchang, Jiangxi, China
| | - P Zhou
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - R Zhou
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - X X Zhou
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - C G Zhu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - F R Zhu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H Zhu
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - K J Zhu
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, 230026 Hefei, China
| | - X Zuo
- Key Laboratory of Particle Astrophyics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| |
Collapse
|
16
|
Zheng ZQ, Liu YY, Luo WW, Zhang HW, Wang YY, Wang H, Li XM, Chen HP, Li Y, Jin WD, Huang H, Guan YT, Zhang HM, Li SK, Ren JA, Wang PG. [Investigation and factor analysis of postoperative surgical site infections in emergency abdominal surgery in China from 2018 to 2021 based on Chinese SSI Surveillance]. Zhonghua Wei Chang Wai Ke Za Zhi 2023; 26:827-836. [PMID: 37709690 DOI: 10.3760/cma.j.cn441530-20230619-00216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 09/16/2023]
Abstract
Objective: We investigated the incidence of surgical site infection (SSI) following emergency abdominal surgery (EAS) in China and further explored its risk factors, providing a reference for preventing and controlling SSI after EAS. Methods: This was an observational study. Data of patients who had undergone EAS and been enrolled in the Chinese SSI Surveillance Program during 2018-2021were retrospectively analyzed. All included patients had been followed up for 30 days after surgery. The analyzed data consisted of relevant patient characteristics and perioperative clinical data, including preoperative hemoglobin, albumin, and blood glucose concentrations, American Society of Anesthesiologists (ASA) score, grade of surgical incision, intestinal preparation, skin preparation, location of surgical site, approach, and duration. The primary outcome was the incidence of SSI occurring within 30 days following EAS. SSI was defined as both superficial and deep incisional infections and organ/space infections, diagnoses being supported by results of microbiological culture of secretions and pus. Secondary outcomes included 30-day postoperative mortality rates, length of stay in the intensive care unit (ICU), duration of postoperative hospitalization, and associated costs. The patients were classified into two groups, SSI and non-SSI, based on whether an infection had been diagnosed. Univariate and multivariate logistic regression analyses were performed to identify risk factors associated with SSI following EAS. Results: The study cohort comprised 5491 patients who had undergone EAS, comprising 3169 male and 2322 female patients. SSIs were diagnosed in 168 (3.1%) patients after EAS (SSI group); thus, the non-SSI group consisted of 5323 patients. The SSIs comprised superficial incision infections in 69 (41.1%), deep incision infections in 51 (30.4%), and organ or space infections in 48 (28.6%). Cultures of secretions and pus were positive in 115 (68.5%) cases. The most frequently detected organism was Escherichia coli (47/115; 40.9%). There were no significant differences in sex or body mass index between the SSI and non-SSI groups (both P>0.05). However, the proportion of individuals aged 60 years or older was significantly greater in the SSI than in the non-SSI group (49.4% [83/168] vs. 27.5% [1464/5323), χ2=38.604, P<0.001). Compared with the non-SSI group, the SSI group had greater proportions of patients with diabetes (11.9% [20/168] vs. 4.8% [258/5323], χ2=16.878, P<0.001), hypertension (25.6% [43/168] vs. 12.2% [649/5323], χ2=26.562, P<0.001); hemoglobin <110 g/L (27.4% [46/168] vs. 13.1% [697/5323], χ2=28.411, P<0.001), and albuminemia <30 g/L (24.4% [41/168] vs. 5.9% [316/5323], χ2=91.352, P<0.001), and a reduced rate of preoperative skin preparation (66.7% [112/168] vs. 75.9% [4039/5323], χ2=7.491, P=0.006). Furthermore, fewer patients in the SSI group had preoperative ASA scores of between one and two (56.0% [94/168] vs. 88.7% [4724/5323], χ2=162.869, P<0.001) in the non-SSI group. The incidences of contaminated and infected incisions were greater in the SSI group (63.1% [106/168] vs. 38.6% [2056/5323], χ2=40.854, P<0.001). There was a significant difference in surgical site distribution between the SSI and non-SSI groups (small intestine 29.8% [50/168] vs. 10.6% [565/5323], colorectal 26.2% [44/168] vs. 5.6% [298/5 323], and appendix 24.4% [41/168] vs. 65.1% [3465/5323]) χ2=167.897, P<0.001), respectively. There was a significantly lower proportion of laparoscope or robotic surgery in the non-SSI group (24.4 % [41/168] vs. 74.2% [3949/5323], χ2=203.199, P<0.001); the percentage of operations of duration less than 2 hours was significantly lower in the SSI than non-SSI group (35.7% [60/168] vs. 77.4% [4119/5323], χ2=155.487, P<0.001). As to clinical outcomes, there was a higher 30-day postoperative mortality rate (3.0%[5/168] vs. 0.2%[10/5323], χ2=36.807, P<0.001) and higher postoperative ICU occupancy rate (41.7% [70/168] vs. 19.7% [1046/5323], χ2=48.748, P<0.001) in the SSI group. The median length of stay in the ICU (0[2] vs. 0[0] days, U=328597.000, P<0.001), median total length of stay after surgery (16[13] vs. 6[5] days, U=128146.000, P<0.001), and median hospitalization cost (ten thousand yuan, 4.7[4.4] vs. 1.7[1.8], U=175965.000, P<0.001) were all significantly greater in the SSI group. Multivariate logistic regression analysis revealed that the absence of skin preparation before surgery (OR=2.435,95%CI: 1.690-3.508, P<0.001), preoperative albuminemia <30 g/L (OR=1.680, 95%CI: 1.081-2.610, P=0.021), contaminated or infected incisions (OR=3.031, 95%CI: 2.151-4.271, P<0.001), and laparotomy (OR=3.436, 95% CI: 2.123-5.564, P<0.001) were independent risk factors of SSI. Operative duration less than 2 hours (OR=0.465, 95%CI: 0.312-0.695, P<0.001) and ASA score of 1-2 (OR=0.416, 95% CI: 0.289-0.601, P<0.001) were identified as independent protective factors for SSI. Conclusions: It is important to consider the nutritional status in the perioperative period of patients undergoing EAS. Preoperative skin preparation should be conducted and, whenever possible, laparoscope or robot-assisted surgery. Duration of surgery should be as short as possible while maintaining surgery quality and improving patient care.
Collapse
Affiliation(s)
- Z Q Zheng
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - Y Y Liu
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - W W Luo
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - H W Zhang
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - Y Y Wang
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - H Wang
- Department of Gastrointestinal Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - X M Li
- Department of Hepatopancreatobiliary Surgery, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou 450007, China
| | - H P Chen
- Department of Nosocomial Infection Management, Jinchen General Hospital, Jinchen 048006, China
| | - Y Li
- Department of General Surgery, Zigong First People's Hospital, Zigong 643000, China
| | - W D Jin
- Department of General Surgery, General Hospital of Central Theater Command of PLA, Wuhan 430070, China
| | - H Huang
- Department of General Surgery, The First Hospital of Shanxi Medical University, Taiyuan 030001, China
| | - Y T Guan
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - H M Zhang
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - S K Li
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| | - J A Ren
- Research Institute of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210002, China
| | - P G Wang
- Department of Emergency Surgery, The Affiliated Hospital of Qingdao University, Qingdao 266000, China
| |
Collapse
|
17
|
Ren YJ, Xu H, Zhou XH, Sheng XF, Zhao YY, Zhang HM, He BH, Su X, Lyu J. [Association between internet use and healthy lifestyles in urban adults in Hangzhou, China]. Zhonghua Liu Xing Bing Xue Za Zhi 2023; 44:1426-1433. [PMID: 37743277 DOI: 10.3760/cma.j.cn112338-20230303-00121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Subscribe] [Scholar Register] [Indexed: 09/26/2023]
Abstract
Objective: To explore the association between internet use and healthy lifestyles in urban adults. Methods: From May to August, 2022, a face-to-face questionnaire survey was conducted in residents aged 18-64 years selected in the urban area of Hangzhou by integrated cluster stratified random sampling and Kish grid method. The information about internet use included the internet use time in the past 7 days and 12 kinds of internet use contents. Using factor analysis and K-means clustering, three types of internet use were summarized, i.e. general type, video game type and working/learning type. Healthy lifestyles were defined as active physical activity, healthy diet habit, non-smoking, non-drinking, healthy weight, and healthy waist circumference. The correlations between internet use and healthy lifestyles were evaluated by using binary logistic regression and multinomial logistic regression analyses. Results: A total of 1 624 participants were included. After adjusting for potential confounding factors, the longer internet use time group (≥8.5 h/d) was less likely to have healthy weight (OR=0.59, 95%CI:0.41-0.85) and 5-6 healthy lifestyles (OR=0.55, 95%CI: 0.32-0.96) compared with those with shorter internet use time group (<2.5 h/d). For different types of internet use, it was found that compared with working/learning type group, the general type group was less likely to have healthy diet habits (OR=0.63, 95%CI: 0.46-0.86), non-drinking (OR=0.68, 95%CI: 0.47-0.99), healthy waist circumference (OR=0.59, 95%CI: 0.42-0.84) and 5-6 healthy lifestyles (OR=0.40, 95%CI: 0.23-0.69), the video game type group was less likely to have active physical activity (OR=0.73, 95%CI: 0.55-0.97) and healthy diet habits (OR=0.79, 95%CI: 0.62-0.99). Conclusion: Too long internet use (≥8.5 h/d), general type and video game type of internet use were associated with unhealthy lifestyles.
Collapse
Affiliation(s)
- Y J Ren
- Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - H Xu
- Hangzhou Municipal Center for Disease Control and Prevention, Hangzhou 310021, China
| | - X H Zhou
- Gongshu District Center for Disease Control and Prevention of Hangzhou, Hangzhou 310011, China
| | - X F Sheng
- Gongshu District Center for Disease Control and Prevention of Hangzhou, Hangzhou 310011, China
| | - Y Y Zhao
- Gongshu District Center for Disease Control and Prevention of Hangzhou, Hangzhou 310011, China
| | - H M Zhang
- Xihu District Center for Disease Control and Prevention of Hangzhou, Hangzhou 310030, China
| | - B H He
- Gongshu District Center for Disease Control and Prevention of Hangzhou, Hangzhou 310011, China
| | - X Su
- Xihu District Center for Disease Control and Prevention of Hangzhou, Hangzhou 310030, China
| | - J Lyu
- Key Laboratory of Epidemiology of Major Diseases, Ministry of Education/Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing 100191, China
| |
Collapse
|
18
|
Zhang GM, Huang Q, Chen G, Yuan M, Zheng CW, Zhang HM, Xu HX. A novel method for age identification of mountain-cultivated ginseng. Microsc Res Tech 2023; 86:1197-1205. [PMID: 37515361 DOI: 10.1002/jemt.24393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2023] [Revised: 06/28/2023] [Accepted: 07/16/2023] [Indexed: 07/30/2023]
Abstract
Panax ginseng, a slow-growing perennial herb, is the most praised and popular traditional medicinal herb. Mountain-cultivated ginseng (MCG) and cultivated ginseng (CG) both belong to Panax ginseng C. A. Meyer. The market price and medical effects of this popular health product are closely related to its age. It is widely acknowledged that CG is typically harvested after 4-6 years of growth, but MCG is often collected after 10 years. Until now, the age identification of MCG or mountain wild ginseng (MWG) has remained a major challenge. In this study, we established a novel and rapid method for staining xylem vessels with phloroglucinol and identifying the "annual growth rings" of ginseng by utilizing a stereoscope, which serves as a reliable indicator of the age of MCG. Statistical analysis of the ring radius and the ring density of MCG aged from 1 to 20 years shows that the secondary xylem of MCG increases rapidly in the first 3 years but then gradually slows down from 4 to 10 years, and minor fluctuation is observed in the next 10 years. Meanwhile, the space between the growth rings (ring density) becomes increasingly small with age. This straightforward staining approach can reveal the age of MCG with remarkable clarity and can distinguish MCG from CG. RESEARCH HIGHLIGHTS: A novel rapid staining method for Panax ginseng was established. The age of mountain-cultivated ginseng (MCG) can be identified by microscopic techniques. MCG and cultivated ginseng (CG) can be discriminated by microstructure characteristics.
Collapse
Affiliation(s)
- Gong-Min Zhang
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Qing Huang
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Gan Chen
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Man Yuan
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Chang-Wu Zheng
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Hong-Mei Zhang
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| | - Hong-Xi Xu
- Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China
| |
Collapse
|
19
|
Di DX, Ai Q, Yan Q, Li Y, Zhang HM, Chen L, Tang XN. [Effect of Bushen Chushi() decoction combined with platelet-rich plasma on regulating TGF-β1 and Smad-1 expression in serum of knee osteoarthritis patient]. Zhongguo Gu Shang 2023; 36:647-53. [PMID: 37475629 DOI: 10.12200/j.issn.1003-0034.2023.07.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 07/22/2023]
Abstract
OBJECTIVE To investigate the effect of Bushen Chushi decoction combined with platelet-rich plasma(PRP) to treat knee osteoarthritis(KOA) in early and middle stage and its regulation on TGF-β1 and Smad-1 expression in serum. METHODS Total of 45 patients with KOA in early and middle stage from May 2020 to April 2022 were treated and divided into control group and observation group. In control group, there were 30 patients including 12 males and 18 females, aged from 43 to 69 years old with an average of(57.3±6.5) years old and disease duration ranged from 1.5 to 5.0 years with an average of(3.8±1.7) years, and there were 8 cases in gradeⅠ, 13 cases in gradeⅡ, and 9 cases in grade Ⅲ according to Kellgren-Lawrence Grade, PRP 5 ml was injected into knee joint on the first day of No1, 3 week together for 2 times. In the observation group, there were 15 cases including 7 males and 8 females, aged from 45 to 70 years old with an average of (56.7±6.2) years old and disease duration ranged from 1.8 to 5.7 years with an average of (4.0±1.8) years, there were 4 cases in gradeⅠ, 9 cases in gradeⅡand 4 cases in grade Ⅲ according to the Kellgren-Lawrence Grade, PRP 5 ml were injected into knee joints that the time and frequency were the same as those in the control group, and at the same time Bushen Chushi decoction orally were taken 1 dose per day with a total of 28 doses. All patients were treated for four weeks. Visual analogue scale(VAS) and Lequesne MG score before and after treatment were used to evaluate improvement of knee pain and joint function. The TGF-β1 and Smad-1 levels in serum were measured before and after treatment in two groups. The incidence of complications in two groups was observed. RESULTS All patients were followed up for 26 to 30 days with an average of (28.0±0.6) days. There was no significant difference in VAS and knee Lequesne MG scores between two groups before treatment(P>0.05). The scores of VAS and knee Lequesne MG on the first day after treatment in both groups were lower than those before treatment(P<0.05). The VAS and knee Lequesne MG scores in observation group were lower than those in control group(P<0.05) on the first day after treatment. The TGF-β1 level in serum after treatment were higher significantly than that before treatment in two groups(P<0.05). After treatment, TGF-β1 level in serum in observation group were lower than those in control group with statistically significant differences(P<0.05). The Smad-1 levels in serum after treatment in observation group were higher significantly than that in control group(P<0.05). The levels of Smad-1 were not statistically significant between before and after treatment(P>0.05). There was no significant difference in postopertaive complications between two groups (P>0.05). CONCLUSION The efficacy of Bushen Chushi decoction combined with PRP in treatment of early and middle KOA is better than that of PRP injection alone. The combined treatment could reduce TGF-β1 level and increase Smad-1 level in serum, which may be a mechanism to inhibit inflammation and alleviate cartilage degeneration to some extent.
Collapse
Affiliation(s)
- Dong-Xue Di
- The First Department of Bone and Joint, Wangjing Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100102
| | - Qi Ai
- The First Department of Bone and Joint, Wangjing Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100102
| | - Qi Yan
- The First Department of Bone and Joint, Wangjing Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100102
| | - Yan Li
- The First Department of Bone and Joint, Wangjing Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100102
| | - Hong-Mei Zhang
- The First Department of Bone and Joint, Wangjing Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100102
| | - Ling Chen
- The First Department of Bone and Joint, Wangjing Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100102
| | - Xin-Ning Tang
- The First Department of Bone and Joint, Wangjing Hospital, Chinese Academy of Chinese Medical Sciences, Beijing 100102
| |
Collapse
|
20
|
Cao Z, Aharonian F, An Q, Bai LX, Bai YX, Bao YW, Bastieri D, Bi XJ, Bi YJ, Cai JT, Cao Q, Cao WY, Cao Z, Chang J, Chang JF, Chen ES, Chen L, Chen L, Chen L, Chen MJ, Chen ML, Chen QH, Chen SH, Chen SZ, Chen TL, Chen Y, Cheng HL, Cheng N, Cheng YD, Cui SW, Cui XH, Cui YD, Dai BZ, Dai HL, Dai ZG, Della Volpe D, Dong XQ, Duan KK, Fan JH, Fan YZ, Fang J, Fang K, Feng CF, Feng L, Feng SH, Feng XT, Feng YL, Gao B, Gao CD, Gao LQ, Gao Q, Gao W, Gao WK, Ge MM, Geng LS, Gong GH, Gou QB, Gu MH, Guo FL, Guo XL, Guo YQ, Guo YY, Han YA, He HH, He HN, He JY, He XB, He Y, Heller M, Hor YK, Hou BW, Hou C, Hou X, Hu HB, Hu Q, Hu SC, Huang DH, Huang TQ, Huang WJ, Huang XT, Huang XY, Huang Y, Huang ZC, Ji XL, Jia HY, Jia K, Jiang K, Jiang XW, Jiang ZJ, Jin M, Kang MM, Ke T, Kuleshov D, Kurinov K, Li BB, Li C, Li C, Li D, Li F, Li HB, Li HC, Li HY, Li J, Li J, Li J, Li K, Li WL, Li WL, Li XR, Li X, Li YZ, Li Z, Li Z, Liang EW, Liang YF, Lin SJ, Liu B, Liu C, Liu D, Liu H, Liu HD, Liu J, Liu JL, Liu JL, Liu JS, Liu JY, Liu MY, Liu RY, Liu SM, Liu W, Liu Y, Liu YN, Long WJ, Lu R, Luo Q, Lv HK, Ma BQ, Ma LL, Ma XH, Mao JR, Min Z, Mitthumsiri W, Nan YC, Ou ZW, Pang BY, Pattarakijwanich P, Pei ZY, Qi MY, Qi YQ, Qiao BQ, Qin JJ, Ruffolo D, Sáiz A, Shao CY, Shao L, Shchegolev O, Sheng XD, Song HC, Stenkin YV, Stepanov V, Su Y, Sun QN, Sun XN, Sun ZB, Tam PHT, Tang ZB, Tian WW, Wang C, Wang CB, Wang GW, Wang HG, Wang HH, Wang JC, Wang JS, Wang K, Wang LP, Wang LY, Wang PH, Wang R, Wang W, Wang XG, Wang XY, Wang Y, Wang YD, Wang YJ, Wang ZH, Wang ZX, Wang Z, Wang Z, Wei DM, Wei JJ, Wei YJ, Wen T, Wu CY, Wu HR, Wu S, Wu XF, Wu YS, Xi SQ, Xia J, Xia JJ, Xiang GM, Xiao DX, Xiao G, Xin GG, Xin YL, Xing Y, Xiong Z, Xu DL, Xu RF, Xu RX, Xue L, Yan DH, Yan JZ, Yan T, Yang CW, Yang F, Yang FF, Yang HW, Yang JY, Yang LL, Yang MJ, Yang RZ, Yang SB, Yao YH, Yao ZG, Ye YM, Yin LQ, Yin N, You XH, You ZY, Yu YH, Yuan Q, Yue H, Zeng HD, Zeng TX, Zeng W, Zeng ZK, Zha M, Zhang B, Zhang BB, Zhang F, Zhang HM, Zhang HY, Zhang JL, Zhang LX, Zhang L, Zhang PF, Zhang PP, Zhang R, Zhang SB, Zhang SR, Zhang SS, Zhang X, Zhang XP, Zhang YF, Zhang Y, Zhang Y, Zhao B, Zhao J, Zhao L, Zhao LZ, Zhao SP, Zheng F, Zheng JH, Zhou B, Zhou H, Zhou JN, Zhou P, Zhou R, Zhou XX, Zhu CG, Zhu FR, Zhu H, Zhu KJ, Zuo X. A tera-electron volt afterglow from a narrow jet in an extremely bright gamma-ray burst. Science 2023:eadg9328. [PMID: 37289911 DOI: 10.1126/science.adg9328] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2023] [Accepted: 05/25/2023] [Indexed: 06/10/2023]
Abstract
Some gamma-ray bursts (GRBs) have a tera-electron volt (TeV) afterglow, but the early onset of this has not been observed. We report observations with the Large High Altitude Air Shower Observatory of the bright GRB 221009A, which serendipitously occurred within the instrument field of view. More than 64,000 photons >0.2 TeV were detected within the first 3000 seconds. The TeV flux began several minutes after the GRB trigger, then rose to a peak about 10 seconds later. This was followed by a decay phase, which became more rapid ~650 seconds after the peak. We interpret the emission using a model of a relativistic jet with half-opening angle ~0.8°. This is consistent with the core of a structured jet and could explain the high isotropic energy of this GRB.
Collapse
Affiliation(s)
- Zhen Cao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - F Aharonian
- Dublin Institute for Advanced Studies, 31 Fitzwilliam Place, 2 Dublin, Ireland
- Max-Planck-Institute for Nuclear Physics, P.O. Box 103980, 69029 Heidelberg, Germany
| | - Q An
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - L X Bai
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Y X Bai
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y W Bao
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, Nanjing 210023, China
| | - D Bastieri
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - X J Bi
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y J Bi
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J T Cai
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Q Cao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - W Y Cao
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Zhe Cao
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - J Chang
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J F Chang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - E S Chen
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Liang Chen
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - Lin Chen
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Long Chen
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M J Chen
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M L Chen
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - Q H Chen
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - S H Chen
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - S Z Chen
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - T L Chen
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - Y Chen
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, Nanjing 210023, China
| | - H L Cheng
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - N Cheng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y D Cheng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - S W Cui
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - X H Cui
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - Y D Cui
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Z Dai
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - H L Dai
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - Z G Dai
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - D Della Volpe
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, 24 Quai Ernest Ansermet, 1211 Geneva, Switzerland
| | - X Q Dong
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - K K Duan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J H Fan
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y Z Fan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Fang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - K Fang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C F Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Feng
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S H Feng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X T Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - Y L Feng
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - B Gao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C D Gao
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Q Gao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Q Gao
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - W Gao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W K Gao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M M Ge
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - L S Geng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - G H Gong
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - Q B Gou
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M H Gu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - F L Guo
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - X L Guo
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Q Guo
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y Y Guo
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y A Han
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - H H He
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H N He
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Y He
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - X B He
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - Y He
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M Heller
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, 24 Quai Ernest Ansermet, 1211 Geneva, Switzerland
| | - Y K Hor
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B W Hou
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C Hou
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X Hou
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - H B Hu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Q Hu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S C Hu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D H Huang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - T Q Huang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W J Huang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - X T Huang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X Y Huang
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y Huang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z C Huang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - X L Ji
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - H Y Jia
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - K Jia
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - K Jiang
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - X W Jiang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z J Jiang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - M Jin
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M M Kang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - T Ke
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Kuleshov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - K Kurinov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - B B Li
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - Cheng Li
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Cong Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - F Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - H B Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H C Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H Y Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Jian Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Jie Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - K Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W L Li
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - W L Li
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - X R Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Xin Li
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Y Z Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Zhe Li
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Zhuo Li
- School of Physics, Peking University, 100871 Beijing, China
| | - E W Liang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Y F Liang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - S J Lin
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Liu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - C Liu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D Liu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - H Liu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H D Liu
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - J Liu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J L Liu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J L Liu
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - J S Liu
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - J Y Liu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M Y Liu
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - R Y Liu
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, Nanjing 210023, China
| | - S M Liu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - W Liu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y Liu
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y N Liu
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - W J Long
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - R Lu
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Q Luo
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - H K Lv
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B Q Ma
- School of Physics, Peking University, 100871 Beijing, China
| | - L L Ma
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X H Ma
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J R Mao
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - Z Min
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - W Mitthumsiri
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - Y C Nan
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z W Ou
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Y Pang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - P Pattarakijwanich
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - Z Y Pei
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - M Y Qi
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y Q Qi
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - B Q Qiao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J J Qin
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - D Ruffolo
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - A Sáiz
- Department of Physics, Faculty of Science, Mahidol University, 10400 Bangkok, Thailand
| | - C Y Shao
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - L Shao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - O Shchegolev
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - X D Sheng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H C Song
- School of Physics, Peking University, 100871 Beijing, China
| | - Y V Stenkin
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - V Stepanov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - Y Su
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Q N Sun
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - X N Sun
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Z B Sun
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - P H T Tam
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - Z B Tang
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - W W Tian
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - C Wang
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - C B Wang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - G W Wang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - H G Wang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - H H Wang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - J C Wang
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - J S Wang
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - K Wang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, Nanjing 210023, China
| | - L P Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Y Wang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - P H Wang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - R Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - W Wang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - X G Wang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - X Y Wang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, Nanjing 210023, China
| | - Y Wang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y D Wang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y J Wang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z H Wang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Z X Wang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Zhen Wang
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - Zheng Wang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - D M Wei
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J J Wei
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y J Wei
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - T Wen
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - C Y Wu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H R Wu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - S Wu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X F Wu
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y S Wu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - S Q Xi
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J Xia
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J J Xia
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - G M Xiang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - D X Xiao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - G Xiao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - G G Xin
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y L Xin
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Xing
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - Z Xiong
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - D L Xu
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - R F Xu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - R X Xu
- School of Physics, Peking University, 100871 Beijing, China
| | - L Xue
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - D H Yan
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - J Z Yan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - T Yan
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - C W Yang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - F Yang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - F F Yang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - H W Yang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - J Y Yang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - L L Yang
- School of Physics and Astronomy (Zhuhai) & School of Physics (Guangzhou) & Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - M J Yang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - R Z Yang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - S B Yang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Y H Yao
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Z G Yao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y M Ye
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - L Q Yin
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - N Yin
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X H You
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Z Y You
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y H Yu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Q Yuan
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - H Yue
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H D Zeng
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - T X Zeng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - W Zeng
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Z K Zeng
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - M Zha
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B Zhang
- Nevada Center for Astrophysics, University of Nevada, Las Vegas, NV 89154, USA
- Department of Physics and Astronomy, University of Nevada, Las Vegas, NV 89154, USA
| | - B B Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - F Zhang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H M Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, Nanjing 210023, China
| | - H Y Zhang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - J L Zhang
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - L X Zhang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - L Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - P F Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - P P Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - R Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S B Zhang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - S R Zhang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S S Zhang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - X Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, Nanjing 210023, China
| | - X P Zhang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - Y F Zhang
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Zhang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Yong Zhang
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - B Zhao
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - J Zhao
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - L Zhao
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - L Z Zhao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S P Zhao
- Key Laboratory of Dark Matter and Space Astronomy & Key Laboratory of Radio Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - F Zheng
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - J H Zheng
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
- Key Laboratory of Modern Astronomy and Astrophysics (Nanjing University), Ministry of Education, Nanjing 210023, China
| | - B Zhou
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| | - H Zhou
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - J N Zhou
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - P Zhou
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - R Zhou
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - X X Zhou
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - C G Zhu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - F R Zhu
- School of Physical Science and Technology & School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H Zhu
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - K J Zhu
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - X Zuo
- Key Laboratory of Particle Astrophysics & Experimental Physics Division & Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Tianfu Cosmic Ray Research Center, 610000 Chengdu, Sichuan, China
| |
Collapse
|
21
|
Zhang HM. [The inscription of Treatise on Febrile Diseases by Zhao Kaimei and the position of its attached official dispatch and name by the Imperial College of the Northern Song Dynasty]. Zhonghua Yi Shi Za Zhi 2023; 53:136-140. [PMID: 37474329 DOI: 10.3760/cma.j.cn112155-20221125-00170] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 07/22/2023]
Abstract
The Treatise on Febrile Diseases (Shang Han Lun) inscripted and published by Zhao Kaimei in the Ming Dynasty was believed to be reprinted from the version of the Northern Song Dynasty, based on its official dispatch, at the beginning of the book, in the third year of the Yuanyou Period of the Northern Song Dynasty. However, the authenticity of the official dispatch remained controversial among scholars of medical history and literature. This paper reports on an investigation of the formation process of the official dispatch, classifies the titles recorded after the inscription, makes comparisons with the medical books inscripted in the same period, and analyzes the causes of the official dispatch and the title in Treatise on Febrile Diseases inscripted by Zhao Kaimei. It was found that the inscription, the official dispatch and the titles were authentic and that the position of the official dispatch was moved from the end of the book to the beginning of the book.
Collapse
Affiliation(s)
- H M Zhang
- Department of Chinese Language and Literature, Peking University ,Beijing 100091,China
| |
Collapse
|
22
|
Ai L, Liu QQ, Li Y, Wang Y, Zhang HM. The Role of HBx Protein in Diseases Beyond the Liver. Infect Drug Resist 2023; 16:3225-3232. [PMID: 37249958 PMCID: PMC10224689 DOI: 10.2147/idr.s405316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2023] [Accepted: 04/29/2023] [Indexed: 05/31/2023] Open
Abstract
HBX gene is essential for HBV replication, evading the surveillance of the immune system by integrating its sequence into the human genome. It also exists stably in human cells by inhibiting the expression and activity of mismatch repair-related pathway genes. Previous reviews have comprehensively summarized the role of HBx in liver-related diseases. Our article complements the summary of research on HBx in diseases other than liver disease. Through a comprehensive literature search and reading, we found that HBx is expressed in the kidney, placenta, lung and other organs of HBV-infected patients, and is closely related to the occurrence and development of diseases such as nephritis, diffuse large B-cell lymphoma, and gastric cancer. However, in the clinical treatment of these diseases, HBV infection and the role of HBx have not attracted sufficient attention, and there is no corresponding treatment strategy. Therefore, more research on HBx in diseases other than the liver is particularly necessary, and we hope that our article can provide some insight into the treatment of related diseases.
Collapse
Affiliation(s)
- Liping Ai
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, People’s Republic of China
| | - Qing-Qing Liu
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, People’s Republic of China
| | - Yize Li
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, People’s Republic of China
| | - Yuanyuan Wang
- Nephrology Department, Affiliated Hospital of Northwest Minzu University / Second Provincial People’s Hospital of Gansu, Lanzhou, Gansu, People’s Republic of China
| | - Hong-Mei Zhang
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, People’s Republic of China
| |
Collapse
|
23
|
Zhang H, Zhu FY, He XJ, Tang SH, Long T, Peng L, Zhang HM, Zou ZZ, Xiong Z, Zhang XP. The influence and mechanistic action of sperm DNA fragmentation index on the outcomes of assisted reproduction technology. Open Life Sci 2023; 18:20220597. [PMID: 37215498 PMCID: PMC10199326 DOI: 10.1515/biol-2022-0597] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/08/2022] [Revised: 03/18/2023] [Accepted: 03/19/2023] [Indexed: 05/24/2023] Open
Abstract
We investigated the influence of DNA fragmentation index (DFI) on in vitro fertilization (IVF), embryo transfer (ET), and intracytoplasmic sperm injection (ICSI). We analyzed the semen parameters of 61 cycles in infertile couples undergoing IVF-ET and ICSI and determined DFI by sperm chromatin dispersion testing. Based on DFI, the patients were differentiated into a control group (DFI < 25%, n = 35) and a test group (DFI ≥ 25%, n = 26). Flow cytometry and immunofluorescence were used to investigate the extent of sperm reactive oxygen species (ROS) and apoptosis. We also investigated the effect of DFI on pregnancy outcomes of IVF-ET/ICSI. DFI was negatively related to sperm motility and positively correlated with ROS and apoptosis (P < 0.05). Abnormally elevated DFI reduced the rate of transplantable, high-quality embryos, implantation, clinical pregnancy, delivery, and live birth after IVF-ET, and increased the chance of early abortion per transfer cycle (P < 0.05). However, there was no significant correlation between DFI and fertilization rate, cleavage rate, transplantable rate, high-quality embryo rate, implantation rate, clinical pregnancy rate, early abortion rate, delivery rate and live birth rate when assisted by ICSI (P > 0.05). Sperm DNA integrity is crucial for fertilization and the development of healthy offspring. ROS may increase the level of DFI by inducing apoptosis in sperm.
Collapse
Affiliation(s)
- Hui Zhang
- Department of Reproductive Medicine Center, Loudi Affiliated Hospital, Hengyang Medical School, University of South China, Loudi, 417000, China
| | - Fei-Yue Zhu
- Department of Hematology, Loudi Affiliated Hospital, Hengyang Medical School, University of South China, Loudi, 417000, China
| | - Xiao-Juan He
- Department of Hematology, Loudi Affiliated Hospital, Hengyang Medical School, University of South China, Loudi, 417000, China
| | - Shi-Huan Tang
- Department of Reproductive Medicine Center, Loudi Affiliated Hospital, Hengyang Medical School, University of South China, Loudi, 417000, China
| | - Ting Long
- Department of Reproductive Medicine Center, Loudi Affiliated Hospital, Hengyang Medical School, University of South China, Loudi, 417000, China
| | - Lu Peng
- Department of Reproductive Medicine Center, Loudi Affiliated Hospital, Hengyang Medical School, University of South China, Loudi, 417000, China
| | - Hong-Mei Zhang
- Department of Reproductive Medicine Center, Loudi Affiliated Hospital, Hengyang Medical School, University of South China, Loudi, 417000, China
| | - Zong-Zhi Zou
- Department of Nephropathy Endocrinology, The Second Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, 410000, China
| | - Zhu Xiong
- Department of Pediatric Orthopedics, Shenzhen Children’s Hospital of China Medical University, Guangdong, 518034, China
| | - Xian-Ping Zhang
- Department of Reproductive Medicine Center, Loudi Affiliated Hospital, Hengyang Medical School, University of South China, Loudi, 417000, China
| |
Collapse
|
24
|
Li F, Yang JJ, Sun ZY, Wang L, Qi LY, A S, Liu YQ, Zhang HM, Dang LF, Wang SJ, Luo CX, Nian WF, O’Conner S, Ju LZ, Quan WP, Li XK, Wang C, Wang DP, You HL, Cheng ZK, Yan J, Tang FC, Yang DC, Xia CW, Gao G, Wang Y, Zhang BC, Zhou YH, Guo X, Xiang SH, Liu H, Peng TB, Su XD, Chen Y, Ouyang Q, Wang DH, Zhang DM, Xu ZH, Hou HW, Bai SN, Li L. Plant-on-chip: Core morphogenesis processes in the tiny plant Wolffia australiana. PNAS Nexus 2023; 2:pgad141. [PMID: 37181047 PMCID: PMC10169700 DOI: 10.1093/pnasnexus/pgad141] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/15/2022] [Revised: 04/10/2023] [Accepted: 04/17/2023] [Indexed: 05/16/2023]
Abstract
A plant can be thought of as a colony comprising numerous growth buds, each developing to its own rhythm. Such lack of synchrony impedes efforts to describe core principles of plant morphogenesis, dissect the underlying mechanisms, and identify regulators. Here, we use the minimalist known angiosperm to overcome this challenge and provide a model system for plant morphogenesis. We present a detailed morphological description of the monocot Wolffia australiana, as well as high-quality genome information. Further, we developed the plant-on-chip culture system and demonstrate the application of advanced technologies such as single-nucleus RNA-sequencing, protein structure prediction, and gene editing. We provide proof-of-concept examples that illustrate how W. australiana can decipher the core regulatory mechanisms of plant morphogenesis.
Collapse
Affiliation(s)
- Feng Li
- The High School Affiliated to Renmin University of China, Beijing 100080, China
- Center of Quantitative Biology, Peking University, Beijing 100871, China
- State Key Laboratory of Protein & Plant Gene Research, Peking University, Beijing 100871, China
- College of Life Sciences, Peking University, Beijing 100871, China
| | - Jing-Jing Yang
- Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan 430072, China
| | - Zong-Yi Sun
- GrandOmics Biosciences Ltd., Wuhan 430076, China
| | - Lei Wang
- Department of Biological Sciences, Mississippi State University, Mississippi State, MS 39762, USA
| | - Le-Yao Qi
- The High School Affiliated to Renmin University of China, Beijing 100080, China
| | - Sina A
- The High School Affiliated to Renmin University of China, Beijing 100080, China
| | - Yi-Qun Liu
- College of Life Sciences, Peking University, Beijing 100871, China
| | - Hong-Mei Zhang
- College of Life Sciences, Peking University, Beijing 100871, China
| | - Lei-Fan Dang
- College of Life Sciences, Peking University, Beijing 100871, China
| | - Shu-Jing Wang
- Center of Quantitative Biology, Peking University, Beijing 100871, China
| | - Chun-Xiong Luo
- Center of Quantitative Biology, Peking University, Beijing 100871, China
| | - Wei-Feng Nian
- The High School Affiliated to Renmin University of China, Beijing 100080, China
| | - Seth O’Conner
- Department of Biological Sciences, Mississippi State University, Mississippi State, MS 39762, USA
| | - Long-Zhen Ju
- GrandOmics Biosciences Ltd., Wuhan 430076, China
| | | | - Xiao-Kang Li
- GrandOmics Biosciences Ltd., Wuhan 430076, China
| | - Chao Wang
- GrandOmics Biosciences Ltd., Wuhan 430076, China
| | - De-Peng Wang
- GrandOmics Biosciences Ltd., Wuhan 430076, China
| | - Han-Li You
- Key Laboratory of Plant Functional Genomics of the Ministry of Education, Jiangsu Co-Innovation Center for Modern Production Technology of Grain Crops, Yangzhou University, Yangzhou 225009, China
| | - Zhu-Kuan Cheng
- Key Laboratory of Plant Functional Genomics of the Ministry of Education, Jiangsu Co-Innovation Center for Modern Production Technology of Grain Crops, Yangzhou University, Yangzhou 225009, China
| | - Jia Yan
- College of Life Sciences, Peking University, Beijing 100871, China
| | - Fu-Chou Tang
- College of Life Sciences, Peking University, Beijing 100871, China
| | - De-Chang Yang
- State Key Laboratory of Protein & Plant Gene Research, Peking University, Beijing 100871, China
- College of Life Sciences, Peking University, Beijing 100871, China
- Biomedical Pioneering Innovative Center (BIOPIC) and Beijing Advanced Innovation Center for Genomics (ICG), Beijing 100871, China
- Center for Bioinformatics (CBI), Peking University, Beijing 100871, China
| | - Chu-Wei Xia
- State Key Laboratory of Protein & Plant Gene Research, Peking University, Beijing 100871, China
- College of Life Sciences, Peking University, Beijing 100871, China
- Biomedical Pioneering Innovative Center (BIOPIC) and Beijing Advanced Innovation Center for Genomics (ICG), Beijing 100871, China
- Center for Bioinformatics (CBI), Peking University, Beijing 100871, China
| | - Ge Gao
- State Key Laboratory of Protein & Plant Gene Research, Peking University, Beijing 100871, China
- College of Life Sciences, Peking University, Beijing 100871, China
- Biomedical Pioneering Innovative Center (BIOPIC) and Beijing Advanced Innovation Center for Genomics (ICG), Beijing 100871, China
- Center for Bioinformatics (CBI), Peking University, Beijing 100871, China
| | - Yan Wang
- Key Laboratory of Plant Functional Genomics of the Ministry of Education, Jiangsu Co-Innovation Center for Modern Production Technology of Grain Crops, Yangzhou University, Yangzhou 225009, China
| | - Bao-Cai Zhang
- Key Laboratory of Plant Functional Genomics of the Ministry of Education, Jiangsu Co-Innovation Center for Modern Production Technology of Grain Crops, Yangzhou University, Yangzhou 225009, China
| | - Yi-Hua Zhou
- Key Laboratory of Plant Functional Genomics of the Ministry of Education, Jiangsu Co-Innovation Center for Modern Production Technology of Grain Crops, Yangzhou University, Yangzhou 225009, China
| | - Xing Guo
- State Key Laboratory of Agricultural Genomics, BGI-Shenzhen, Shenzhen 518083, China
| | - Sun-Huan Xiang
- State Key Laboratory of Agricultural Genomics, BGI-Shenzhen, Shenzhen 518083, China
| | - Huan Liu
- State Key Laboratory of Agricultural Genomics, BGI-Shenzhen, Shenzhen 518083, China
| | - Tian-Bo Peng
- State Key Laboratory of Protein & Plant Gene Research, Peking University, Beijing 100871, China
- College of Life Sciences, Peking University, Beijing 100871, China
| | - Xiao-Dong Su
- State Key Laboratory of Protein & Plant Gene Research, Peking University, Beijing 100871, China
- College of Life Sciences, Peking University, Beijing 100871, China
| | - Yong Chen
- PASTEUR, Département de chimie, École normale supérieure, PSL University, Sorbonne Université, CNRS, 24 rue Lhomond, Paris 75005, France
| | - Qi Ouyang
- Center of Quantitative Biology, Peking University, Beijing 100871, China
- School of Physics, Peking University, Beijing 100871, China
| | - Dong-Hui Wang
- State Key Laboratory of Protein & Plant Gene Research, Peking University, Beijing 100871, China
- College of Life Sciences, Peking University, Beijing 100871, China
| | - Da-Ming Zhang
- Institute of Botany, Chinese Academy of Sciences, Beijing 100093, China
| | - Zhi-Hong Xu
- State Key Laboratory of Protein & Plant Gene Research, Peking University, Beijing 100871, China
- College of Life Sciences, Peking University, Beijing 100871, China
| | - Hong-Wei Hou
- Institute of Hydrobiology, Chinese Academy of Sciences, Wuhan 430072, China
| | - Shu-Nong Bai
- Center of Quantitative Biology, Peking University, Beijing 100871, China
- State Key Laboratory of Protein & Plant Gene Research, Peking University, Beijing 100871, China
- College of Life Sciences, Peking University, Beijing 100871, China
| | - Ling Li
- Department of Biological Sciences, Mississippi State University, Mississippi State, MS 39762, USA
| |
Collapse
|
25
|
Tang B, Chen WJ, Jiang LD, Zhu SH, Song B, Chao YG, Song TJ, He W, Liu Y, Zhang HM, Chai WZ, Yin MG, Zhu R, Liu LX, Wu J, Ding X, Shang XL, Duan J, Xu QH, Zhang H, Wang XM, Huang QB, Gong RC, Li ZZ, Lu MS, Wang XT. [Expert consensus on late stage of critical care management]. Zhonghua Nei Ke Za Zhi 2023; 62:480-493. [PMID: 37096274 DOI: 10.3760/cma.j.cn112138-20221005-00731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Subscribe] [Scholar Register] [Indexed: 04/26/2023]
Abstract
We wished to establish an expert consensus on late stage of critical care (CC) management. The panel comprised 13 experts in CC medicine. Each statement was assessed based on the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) principle. Then, the Delphi method was adopted by 17 experts to reassess the following 28 statements. (1) ESCAPE has evolved from a strategy of delirium management to a strategy of late stage of CC management. (2) The new version of ESCAPE is a strategy for optimizing treatment and comprehensive care of critically ill patients (CIPs) after the rescue period, including early mobilization, early rehabilitation, nutritional support, sleep management, mental assessment, cognitive-function training, emotional support, and optimizing sedation and analgesia. (3) Disease assessment to determine the starting point of early mobilization, early rehabilitation, and early enteral nutrition. (4) Early mobilization has synergistic effects upon the recovery of organ function. (5) Early functional exercise and rehabilitation are important means to promote CIP recovery, and gives them a sense of future prospects. (6) Timely start of enteral nutrition is conducive to early mobilization and early rehabilitation. (7) The spontaneous breathing test should be started as soon as possible, and a weaning plan should be selected step-by-step. (8) The waking process of CIPs should be realized in a planned and purposeful way. (9) Establishment of a sleep-wake rhythm is the key to sleep management in post-CC management. (10) The spontaneous awakening trial, spontaneous breathing trial, and sleep management should be carried out together. (11) The depth of sedation should be adjusted dynamically in the late stage of CC period. (12) Standardized sedation assessment is the premise of rational sedation. (13) Appropriate sedative drugs should be selected according to the objectives of sedation and drug characteristics. (14) A goal-directed minimization strategy for sedation should be implemented. (15) The principle of analgesia must be mastered first. (16) Subjective assessment is preferred for analgesia assessment. (17) Opioid-based analgesic strategies should be selected step-by-step according to the characteristics of different drugs. (18) There must be rational use of non-opioid analgesics and non-drug-based analgesic measures. (19) Pay attention to evaluation of the psychological status of CIPs. (20) Cognitive function in CIPs cannot be ignored. (21) Delirium management should be based on non-drug-based measures and rational use of drugs. (22) Reset treatment can be considered for severe delirium. (23) Psychological assessment should be conducted as early as possible to screen-out high-risk groups with post-traumatic stress disorder. (24) Emotional support, flexible visiting, and environment management are important components of humanistic management in the intensive care unit (ICU). (25) Emotional support from medical teams and families should be promoted through"ICU diaries"and other forms. (26) Environmental management should be carried out by enriching environmental content, limiting environmental interference, and optimizing the environmental atmosphere. (27) Reasonable promotion of flexible visitation should be done on the basis of prevention of nosocomial infection. (28) ESCAPE is an excellent project for late stage of CC management.
Collapse
Affiliation(s)
- B Tang
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - W J Chen
- Department of Neurosurgery ICU, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| | - L D Jiang
- Department of Neurosurgery ICU, Xuanwu Hospital, Capital Medical University, Beijing 100053, China
| | - S H Zhu
- Department of Critical Care Medicine, the Seventh Medical Center of PLA General Hospital, Beijing 100700, China
| | - B Song
- Department of Critical Care Medicine, the Seventh Medical Center of PLA General Hospital, Beijing 100700, China
| | - Y G Chao
- Department of Critical Care Medicine, the First Affiliated Hospital of Tsinghua University, Beijing 100016, China
| | - T J Song
- Department of Critical Care Medicine, the First Affiliated Hospital of Tsinghua University, Beijing 100016, China
| | - W He
- Department of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - Y Liu
- Department of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - H M Zhang
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - W Z Chai
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - M G Yin
- Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China
| | - R Zhu
- Department of Critical Care Medicine, the First Hospital of China Medical Uinversity, Shenyang 110001, China
| | - L X Liu
- Department of Critical Care Medicine, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - J Wu
- Department of Critical Care Medicine, Ruijin Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200025, China
| | - X Ding
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - X L Shang
- Department of Critical Care Medicine, Fujian Provincial Hospital, Fuzhou 350001, China
| | - J Duan
- Department of Critical Care Medicine, China-Japan Friendship Hospital, Beijing 100029, China
| | - Q H Xu
- Department of Critical Care Medicine, Zhejiang Hospital, Hangzhou 310013, China
| | - H Zhang
- Department of Neurosurgery, the First Hospital of China Medical University, Shenyang 110001, China
| | - X M Wang
- Department of Critical Care Medicine, Xuzhou Central Hospital, Xuzhou 221009, China
| | - Q B Huang
- Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan 250012, China
| | - R C Gong
- Department of Critical Care Medicine, Affiliated Hospital of Taiwan Kaohsiung University, China
| | - Z Z Li
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - M S Lu
- Department of Health Care and Medical, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences,Beijing 100730, China
| | - X T Wang
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| |
Collapse
|
26
|
Lu Y, Pan W, Deng S, Dou Q, Wang X, An Q, Wang X, Ji H, Hei Y, Chen Y, Yang J, Zhang HM. Redefining the Incidence and Profile of Fluoropyrimidine-Associated Cardiotoxicity in Cancer Patients: A Systematic Review and Meta-Analysis. Pharmaceuticals (Basel) 2023; 16:ph16040510. [PMID: 37111268 PMCID: PMC10146083 DOI: 10.3390/ph16040510] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Revised: 03/14/2023] [Accepted: 03/21/2023] [Indexed: 04/01/2023] Open
Abstract
Aim: The cardiac toxicity that occurs during administration of anti-tumor agents has attracted increasing concern. Fluoropyrimidines have been used for more than half a century, but their cardiotoxicity has not been well clarified. In this study, we aimed to assess the incidence and profile of fluoropyrimidine-associated cardiotoxicity (FAC) comprehensively based on literature data. Methods: A systematic literature search was performed using PubMed, Embase, Medline, Web of Science, and Cochrane library databases and clinical trials on studies investigating FAC. The main outcome was a pooled incidence of FAC, and the secondary outcome was specific treatment-related cardiac AEs. Random or fixed effects modeling was used for pooled meta-analyses according to the heterogeneity assessment. PROSPERO registration number: (CRD42021282155). Results: A total of 211 studies involving 63,186 patients were included, covering 31 countries or regions in the world. The pooled incidence of FAC, by meta-analytic, was 5.04% for all grades and 1.5% for grade 3 or higher. A total of 0.29% of patients died due to severe cardiotoxicities. More than 38 cardiac AEs were identified, with cardiac ischemia (2.24%) and arrhythmia (1.85%) being the most frequent. We further performed the subgroup analyses and meta-regression to explore the source of heterogeneity, and compare the cardiotoxicity among different study-level characteristics, finding that the incidence of FAC varied significantly among different publication decades, country/regions, and genders. Patients with esophagus cancer had the highest risk of FAC (10.53%), while breast cancer patients had the lowest (3.66%). The treatment attribute, regimen, and dosage were significantly related to FAC. When compared with chemotherapeutic drugs or targeted agents, such a risk was remarkably increased (χ2 = 10.15, p < 0.01; χ2 = 10.77, p < 0.01). The continuous 5-FU infusion for 3–5 consecutive days with a high dosage produced the highest FAC incidence (7.3%) compared with other low-dose administration patterns. Conclusions: Our study provides comprehensive global data on the incidence and profile of FAC. Different cancer types and treatment appear to have varying cardiotoxicities. Combination therapy, high cumulative dose, addition of anthracyclines, and pre-existing heart disease potentially increase the risk of FAC.
Collapse
Affiliation(s)
- Yajie Lu
- Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
- The State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, Air Force Medical University, Xi’an 710032, China
- Correspondence: (Y.L.); (H.-M.Z.)
| | - Wei Pan
- Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
| | - Shizhou Deng
- Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
| | - Qiongyi Dou
- Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
| | - Xiangxu Wang
- Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
| | - Qiang An
- The Department of Biomedical Engineering, Air Force Medical University, Xi’an 710032, China
| | - Xiaowen Wang
- Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
| | - Hongchen Ji
- Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
| | - Yue Hei
- Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
| | - Yan Chen
- Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
| | - Jingyue Yang
- Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
| | - Hong-Mei Zhang
- Department of Clinical Oncology, Xijing Hospital, Air Force Medical University, Xi’an 710032, China
- Correspondence: (Y.L.); (H.-M.Z.)
| |
Collapse
|
27
|
Wang XX, Deng SZ, Wu LH, Liu QQ, Zheng G, Du K, Dou QY, Zheng J, Zhang HM. Cuproptosis-Mediated Patterns Characterized by Distinct Tumor Microenvironment and Predicted the Immunotherapy Response for Gastric Cancer. ACS Omega 2023; 8:10851-10862. [PMID: 37008098 PMCID: PMC10061503 DOI: 10.1021/acsomega.2c07052] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Accepted: 02/28/2023] [Indexed: 05/26/2023]
Abstract
Cuproptosis is a newly discovered programmed cell death process, and several cuproptosis-related genes have been reported to regulate cancer cell proliferation and progression. The association between cuproptosis and tumor microenvironment in gastric cancer (GC) remains unclear. This study aimed to explore multiomics characteristics of cuproptosis-related genes regulating tumor microenvironment and provide strategies for prognosis and prediction of immunotherapy response in GC patients. We collected 1401 GC patients from the TCGA and 5 GEO data sets and identified three different cuproptosis-mediated patterns, each of which shared a distinct tumor microenvironment and different overall survival. The GC patients with high cuproptosis levels were enriched in CD8+ T cells and had a better prognosis. Whereas, the low cuproptosis level patients were associated with inhibitory immune cell infiltration and had the worst prognosis. In addition, we constructed a 3-gene (AHCYL2, ANKRD6 and FDGFRB) cuproptosis-related prognosis signature (CuPS) via Lasso-Cox and multivariate Cox regression analysis. The GC patients in the low-CuPS subgroup had higher TMB levels, MSI-H fractions, and PD-L1 expression, which suggests a better immunotherapy response. Therefore, the CuPS might have the potential value for predicting prognosis and immunotherapy sensitivity in GC patients.
Collapse
Affiliation(s)
- Xiang-Xu Wang
- Department
of Clinical Oncology, Xijing Hospital, Fourth
Military Medical University, Xi’an, Shaanxi 710032, P. R. China
| | - Shi-Zhou Deng
- Department
of Clinical Oncology, Xijing Hospital, Fourth
Military Medical University, Xi’an, Shaanxi 710032, P. R. China
| | - Li-Hong Wu
- Xijing
986 Hospital Department, Fourth Military
Medical University, Xi’an, Shaanxi 710032, P. R. China
| | - Qing-Qing Liu
- Department
of Clinical Oncology, Xijing Hospital, Fourth
Military Medical University, Xi’an, Shaanxi 710032, P. R. China
| | - Gaozan Zheng
- Division
of Digestive Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, Shaanxi 710032, P. R. China
| | - Kunli Du
- Division
of Digestive Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, Shaanxi 710032, P. R. China
| | - Qiong-Yi Dou
- Department
of Clinical Oncology, Xijing Hospital, Fourth
Military Medical University, Xi’an, Shaanxi 710032, P. R. China
| | - Jianyong Zheng
- Division
of Digestive Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi’an, Shaanxi 710032, P. R. China
| | - Hong-Mei Zhang
- Department
of Clinical Oncology, Xijing Hospital, Fourth
Military Medical University, Xi’an, Shaanxi 710032, P. R. China
| |
Collapse
|
28
|
Zhu ZJ, Wei L, Zhang HM, Qu W, Zeng ZG, Sun LY, Liu Y. [Utilizing ultra-small volume graft in auxiliary liver transplantation for portal hypertension]. Zhonghua Wai Ke Za Zhi 2023; 61:220-226. [PMID: 36650968 DOI: 10.3760/cma.j.cn112139-20220802-00334] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Objective: To examine the clinical effect of auxiliary liver transplantation with ultra-small volume graft in the treatment of portal hypertension. Methods: Twelve cases of portal hypertension treated by auxiliary liver transplantation with small volume graft at Liver Transplantation Center,Beijing Friendship Hospital, Capital Medical University between December 2014 and March 2022 were studied retrospectively. There were 8 males and 4 females,aged 14 to 66 years. Model for end-stage liver disease scores were 1 to 15 points and Child scores were 6 to 11 points. The grafts was derived from living donors in 9 cases,from split cadaveric donors in 2 cases,from whole cadaveric liver of child in 1 case. The graft recipient body weight ratios of 3 cadaveric donor livers were 0.79% to 0.90%, and of 9 living donor livers were 0.31% to 0.55%.In these cases, ultra-small volume grafts were implanted. The survivals of patient and graft, complications, portal vein blood flow of residual liver and graft, abdominal drainage and biochemical indexes of liver function were observed. Results: All the grafts and patients survived. Complications included outflow tract torsion in 2 cases, acute rejection in 1 case, bile leakage in 1 case, and thyroid cancer at the later stage of follow-up in 1 case, all of which were cured. The torsion of outflow tract was attributed to the change of anastomotic angle after the growth of donor liver. After the improvement of anastomotic method, the complication did not recur in the later stage. There was no complication of portal hypertension. The measurement of ultrasonic portal vein blood flow velocity showed that the blood flow of residual liver decreased significantly in the early stage after operation, and maintained a very low blood flow velocity or occlusion in the long term after operation, and the blood flow of transplanted liver was stable. Conclusions: Auxiliary liver transplantation can implant ultra-small donor liver through compensation of residual liver. This method may promote the development of living donor left lobe donation and split liver transplantation. However, the auxiliary liver transplantation is complex, and it is difficult to control the complications. Therefore, this method is currently limited to centers that are skilled in living related liver transplantation and that have complete ability to monitor and deal with complications.
Collapse
Affiliation(s)
- Z J Zhu
- Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University; Clinical Center for Pediatric Liver Transplantation; National Clinical Research Center of Digestive Diseases, Beijing 101100,China
| | - L Wei
- Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University; Clinical Center for Pediatric Liver Transplantation; National Clinical Research Center of Digestive Diseases, Beijing 101100,China
| | - H M Zhang
- Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University; Clinical Center for Pediatric Liver Transplantation; National Clinical Research Center of Digestive Diseases, Beijing 101100,China
| | - W Qu
- Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University; Clinical Center for Pediatric Liver Transplantation; National Clinical Research Center of Digestive Diseases, Beijing 101100,China
| | - Z G Zeng
- Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University; Clinical Center for Pediatric Liver Transplantation; National Clinical Research Center of Digestive Diseases, Beijing 101100,China
| | - L Y Sun
- Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University; Clinical Center for Pediatric Liver Transplantation; National Clinical Research Center of Digestive Diseases, Beijing 101100,China
| | - Y Liu
- Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University; Clinical Center for Pediatric Liver Transplantation; National Clinical Research Center of Digestive Diseases, Beijing 101100,China
| |
Collapse
|
29
|
Li J, Zhao G, Zhang HM, Zhu FF. Probiotic adjuvant treatment in combination with scaling and root planing in chronic periodontitis: a systematic review and meta-analysis. Benef Microbes 2023; 14:95-107. [PMID: 36856123 DOI: 10.3920/bm2022.0056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/02/2023]
Abstract
This systematic review and meta-analysis assessed the impact of probiotic supplementation on treating chronic periodontal (CP) disease based on clinical and microbiological findings. Four databases were searched: Medline, Embase, Cochrane Library, and the Web of Science databases. The references to relevant studies were also manually searched. Analyses were conducted using the Review Manager 5.2 software, while the quality of randomised controlled trials was assessed with the Cochrane Risk of Bias tool. In total, 19 studies were included in the meta-analysis. Pooled results revealed that the adjuvant use of probiotics in the treatment of patients with periodontal disease was largely associated with good clinical efficacy. Resulting in statistically significant improvements in plaque index (P<0.05), periodontal probing depth (P<0.05), clinical attachment level (P<0.05), gingival index (P<0.05), bleeding on probing (P<0.05), deep probing depth (P<0.05), and levels of subgingival microbes (P<0.05) following probiotic supplementation. In summary, the results of this meta-analysis suggest that the administration of probiotics together with scaling and root planing can somewhat improve CP patient clinical outcomes and reduce levels of periodontal pathogens. However, more comprehensive experiments are needed to standardise probiotics and maximise their adjuvant therapy.
Collapse
Affiliation(s)
- J Li
- Jiamusi University, Jiamusi City 154000, Heilongjiang Province, China P.R.,Jiamusi University Affiliated Stomatological Hospital, Jiamusi City 154004, Heilongjiang Province, China P.R
| | - G Zhao
- Jiamusi University Affiliated Stomatological Hospital, Jiamusi City 154004, Heilongjiang Province, China P.R
| | - H M Zhang
- Jiamusi University, Jiamusi City 154000, Heilongjiang Province, China P.R
| | - F F Zhu
- Jiamusi University, Jiamusi City 154000, Heilongjiang Province, China P.R.,Jiamusi University Affiliated Stomatological Hospital, Jiamusi City 154004, Heilongjiang Province, China P.R
| |
Collapse
|
30
|
Teng GL, Chi JY, Zhang HM, Li XP, Jin F. Oral vs. parenteral antibiotic therapy in adult patients with community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials. J Glob Antimicrob Resist 2023; 32:88-97. [PMID: 36669558 DOI: 10.1016/j.jgar.2022.12.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2022] [Revised: 12/04/2022] [Accepted: 12/26/2022] [Indexed: 01/19/2023] Open
Abstract
OBJECTIVES Antibiotic therapy is widely used for patients with community-acquired pneumonia (CAP), and yet whether the efficacy of antibiotics differs based on the treatment mode remains unclear. This study aimed to summarize the evidence regarding the efficacy and safety of oral vs. parenteral administration of antibiotic therapy for the treatment of patients with CAP. METHODS The databases of PubMed, EmBase, and the Cochrane Central Register of Controlled Trials were systematically searched for eligible randomized controlled trials (RCTs) from inception until 11 December 2021. The effectiveness of oral vs. parenteral administration of antibiotic therapy was estimated using a random-effects model. Additional sensitivity, subgroup, and publication bias analyses were performed. RESULTS Of 912 identified articles, 12 RCTs involving 2158 patients with CAP were included in our pooled analysis. This mostly included trials with low certainty and some concerns regarding risk of bias, including lack of allocation concealment and blinding of participants and personnel. Overall, oral antibiotic therapy did not affect the incidence of clinical success at the end of treatment (relative risk [RR], 1.01; 95% confidence interval [CI], 0.98-1.05; P = 0.417), clinical success at follow-up (RR, 1.02; 95% CI, 0.98-1.06; P = 0.301), or adverse events (RR, 0.87; 95% CI, 0.56-1.35; P = 0.527). Moreover, oral antibiotic therapy had a beneficial effect on the risk of all-cause mortality (RR, 0.58; 95% CI, 0.35-0.96; P = 0.034). CONCLUSIONS Oral administration of antibiotics is associated with a reduced risk of all-cause mortality compared with parenteral therapy based on RCTs with low to moderate quality. This finding should be verified in further large-scale RCTs.
Collapse
Affiliation(s)
- Ge-Ling Teng
- Department of Respiratory and Critical Care Medicine, Shandong Public Health Clinical Center, Jinan, China.
| | - Jing-Yu Chi
- Department of Tuberculosis, Shandong Public Health Clinical Center, Jinan, China
| | - Hong-Mei Zhang
- Department of AIDS Control, District Center of Disease Control and Prevention of Laoshan, Qingdao, China
| | - Xiu-Ping Li
- Department of Nursing, Shandong Public Health Clinical Center, Jinan, China
| | - Feng Jin
- Department of chest surgery, Shandong Public Health Clinical Center, Jinan, China.
| |
Collapse
|
31
|
Cheng LH, Zhang HM, Zhou JF, Luo FX, Luo PP, Chang LY, Tian RR. [Correlation between fluid parameter and cardiovascular events in hemodialysis patients based on repeated body composition analyses]. Zhonghua Yi Xue Za Zhi 2023; 103:566-571. [PMID: 36822867 DOI: 10.3760/cma.j.cn112137-20220907-01892] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 02/25/2023]
Abstract
Objective: To explore the correlation between fluid load index and cardiovascular events in hemodialysis patients based on repeated body composition analyses. Methods: A prospective cohort study was conducted to collect the clinical data of patients undergoing maintenance hemodialysis (MHD) in the Department of Nephrology, Hangzhou Hospital of Traditional Chinese Medicine from July to September 2020. The pre-dialysis fluid overload (FO) index-overhydration (OH) was measured by bioelectrical impedance method, and the follow-up monitoring was conducted every 6 months. According to the baseline OH value, patients were divided into non-FO group (OH≤2.5 L) and FO group (OH>2.5 L). Moreover, according to the repeated measurements, the patients were divided into continuous non-FO group, continuous FO group and intermittent FO group. All patients were followed up until October 1, 2022, and the outcomes were recorded. The end point of follow-up was cardiovascular events. The cumulative incidence of cardiovascular events was calculated by the Kaplan-Meier method, and the risk factors of cardiovascular events were analyzed by Cox proportional hazards regression model. Results: A total of 289 patients were included, including 88 patients (30.4%) with FO and 201 patients (69.6%) with non-FO. There were 168 males (58.1%) and 121 (41.9%) females, with an average age of (58±13) years and an average follow-up time of (22.0±6.5) months. Kaplan-Meier analysis showed that the incidence of cardiovascular events in the baseline FO group was higher than that in the non-FO group (log-rank χ2=14.44, P<0.001). The incidence of cardiovascular events in both the continuous FO group and the intermittent FO group was higher than that in the continuous non-FO group (log-rank χ2=41.47, P<0.001; log-rank χ2=18.36, P<0.001). After adjustment for gender, age, comorbidities, and biochemical indicators, the incidence of cardiovascular events in the baseline FO group was 1.850 times of the non-FO group (95%CI: 1.046-3.271, P=0.034). The incidence of cardiovascular events in the continuous FO group was 4.679 times of the continuous non-FO group (95%CI: 2.189-10.002, P<0.001). The incidence of cardiovascular events in the intermittent FO group was 3.410 times of the continuous non-FO group (95%CI: 1.696-6.857, P=0.001). Conclusions: OH value measured by bioelectrical impedance can be used as an important reference index for clinical monitoring of cardiovascular events in MHD patients. Continuous chronic and intermittent exposures to FO are risk factors for cardiovascular events in hemodialysis patients.
Collapse
Affiliation(s)
- L H Cheng
- Department of Nephrology, Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Traditional Chinese Medicine University, Hangzhou 310007, China
| | - H M Zhang
- Department of Nephrology, Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Traditional Chinese Medicine University, Hangzhou 310007, China
| | - J F Zhou
- Department of Nephrology, Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Traditional Chinese Medicine University, Hangzhou 310007, China
| | - F X Luo
- Department of Nephrology, Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Traditional Chinese Medicine University, Hangzhou 310007, China
| | - P P Luo
- Department of Nephrology, Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Traditional Chinese Medicine University, Hangzhou 310007, China
| | - L Y Chang
- Department of Nephrology, Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Traditional Chinese Medicine University, Hangzhou 310007, China
| | - R R Tian
- Department of Nephrology, Hangzhou Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Traditional Chinese Medicine University, Hangzhou 310007, China
| |
Collapse
|
32
|
Yang SY, Lin ZX, Xian YF, Zhang HM, Xu HX. Traditional uses, chemical compounds, pharmacological activities and clinical studies on the traditional Chinese prescription Yi-Gan San. J Ethnopharmacol 2023; 302:115859. [PMID: 36280017 DOI: 10.1016/j.jep.2022.115859] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/06/2022] [Revised: 10/06/2022] [Accepted: 10/18/2022] [Indexed: 06/16/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE A widely used traditional prescription, Yi-Gan San (YGS) is a remedy for neurodegenerative disorders. The formulation consists of seven Chinese medicinal materials in specific proportions, namely Uncariae Ramulus cum Uncis (Uncaria rhynchophylla (Miq.) Miq. ex Havil.), Bupleuri Radix (Bupleurum chinense DC.), Angelicae Sinensis Radix (Angelica sinensis (Oliv.) Diels), Chuanxiong Rhizoma (Ligusticum wallichii Franch.), Poria (Poria cocos (Schw.) Wolf), Atractylodis Macrocephalae Rhizoma (Atractylodes macrocephala Koidz.) and Glycyrrhizae Radix et Rhizoma (Glycyrrhiza uralensis Fisch.). Using YGS has been shown to alleviate various behavioural and psychological symptoms of dementia (BPSD). AIM OF THIS REVIEW The goal of this review is to give up-to-date information about the traditional uses, chemistry, pharmacology and clinical efficacy of YGS based on the scientific literature and to learn the current focus and provide references in the next step. MATERIALS AND METHODS The database search room was accessed using the search terms "Yi-Gan San" and "Yokukansan" to obtain results from resources such as Web of Science, PubMed, Google Scholar and Sci Finder Scholar. We not only consulted the literature of fellow authors for this review but also explored classical medical books. RESULTS YGS has been used to cure neurosis, sleeplessness, night weeping and restlessness in infants. Its chemical components primarily consist of triterpenes, flavonoids, phenolics, lactones, alkaloids and other types of compounds. These active ingredients displayed diverse pharmacological activities to ameliorate BPSD by regulating serotonergic, glutamatergic, cholinergic, dopaminergic, adrenergic, and GABAergic neurotransmission. In addition, YGS showed neuroprotective, antistress, and anti-inflammatory effects. The majority of cases of neurodegenerative disorders are treated with YGS, including Alzheimer's disease and dementia with Lewy bodies. CONCLUSIONS Based on previous studies, YGS has been used as a traditional prescription in East Asia, such as Japan, Korea and China, and it has diverse chemical compounds and multiple pharmacological activities. Nevertheless, few experimental studies have focused on chemical and quantitative YGS studies, suggesting that further comprehensive research on its chemicals and quality assessments is critical for future evaluations of drug efficacy.
Collapse
Affiliation(s)
- Si-Yu Yang
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai, 201203, China
| | - Zhi-Xiu Lin
- School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, China; Hong Kong Institute of Integrative Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, China
| | - Yan-Fang Xian
- School of Chinese Medicine, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, China
| | - Hong-Mei Zhang
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
| | - Hong-Xi Xu
- Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
| |
Collapse
|
33
|
Li YZ, Kong SN, Liu YP, Yang Y, Zhang HM. Can Liquid Biopsy Based on ctDNA/cfDNA Replace Tissue Biopsy for the Precision Treatment of EGFR-Mutated NSCLC? J Clin Med 2023; 12:jcm12041438. [PMID: 36835972 PMCID: PMC9966257 DOI: 10.3390/jcm12041438] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2022] [Revised: 01/16/2023] [Accepted: 02/06/2023] [Indexed: 02/15/2023] Open
Abstract
More and more clinical trials have explored the role of liquid biopsy in the diagnosis and treatment of EGFR-mutated NSCLC. In certain circumstances, liquid biopsy has unique advantages and offers a new way to detect therapeutic targets, analyze drug resistance mechanisms in advanced patients, and monitor MRD in patients with operable NSCLC. Although its potential cannot be ignored, more evidence is needed to support the transition from the research stage to clinical application. We reviewed the latest progress in research on the efficacy and resistance mechanisms of targeted therapy for advanced NSCLC patients with plasma ctDNA EGFR mutation and the evaluation of MRD based on ctDNA detection in perioperative and follow-up monitoring.
Collapse
|
34
|
Zhang HM, Cui MY, Chen ZH. EMX2OS targeting IGF2BP1 represses Wilms' tumour stemness,epithelial-mesenchymal transition and metastasis. J Genet 2023; 102. [PMID: 36722215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Wilms' tumour (WT) is the most typical type of renal tumour in children, which has a poor prognosis and high recurrence rate. This study explored whether lncRNA EMX2 opposite strand / antisense RNA (EMX2OS) modulated the stemness, epithelial-mesenchymal transition (EMT) and metastasis of WTcells through the interaction with insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1). The expression levels of EMX2OS, IGF2BP1 and stem cell markers OCT4, Nanog, Sox2 and CD133 were detected by real time quantitative polymerase chain reaction (RT-qPCR). The stemness, migration and invasion of WTcells were determined by sphere formation assay, scratch and transwell assay, respectively. The levels of EMT-related proteins were detected by Western blotting. RNA pull down and RIP assays were utilized to validate the interaction between EMX2OS and IGF2BP1. The tumourigenicity of WTcells in vivo was analysed using a xenograft tumour assay. EMX2OS was downregulated in WT patients, while IGF2BP1 was upregulated. EMX2OS overexpression or IGF2BP1 knockdown suppressed WT cell sphere formation, migration and invasion. Moreover, EMX2OS could directly interact with RNA-binding protein IGF2BP1, and IGF2BP1 overexpression counteracted the inhibitory effect of EMX2OS on WT cell stemness, migration, invasion and EMT. The in vivo tumour growth, stemness and EMT were repressed by EMX2OS through the interaction with IGF2BP1. In conclusion, EMX2OS acted as a tumour suppressor for WT by interacting with IGF2BP1, which might be a novel target for WT diagnosis and therapy.
Collapse
Affiliation(s)
- Hong-Mei Zhang
- Department of Urology, Qilu Children's Hospital of Shandong University, Jinan 250022, Shandong Province,People's Republic of China.
| | | | | |
Collapse
|
35
|
Zhu JB, Li B, Zhang HM, Wang NL. Predicting the prognosis of primary orbital lymphoma by clinical characteristics and imaging features. Int J Ophthalmol 2023; 16:705-711. [PMID: 37206183 PMCID: PMC10172095 DOI: 10.18240/ijo.2023.05.06] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2022] [Accepted: 03/27/2023] [Indexed: 05/21/2023] Open
Abstract
AIM To analyze the 5-year disease-free survival (DFS) of primary orbital lymphoma (POL) by clinical characteristics and imaging features. METHODS A total of 72 patients, 43 males and 29 females, with histologically confirmed POL, were retrospectively recruited between January 2012 and May 2017. The information on clinical characteristics, imaging features, and 5-year DFS was obtained. Univariate and multivariate forward logistic regression analyses were used to identify the variables significantly associated with 5-year DFS. Kaplan-Meier was applied for survival analysis. RESULTS Univariate analysis revealed that uni- or bilateral orbital involvement, single or multiple lesions, treatment methods, and contrast enhancement pattern on images were significant for 5-year DFS (P=0.022, 0.042, <0.001, and 0.028, respectively), while in multivariate logistic regression analysis, only uni- or bilateral orbital involvement, treatment methods and contrast enhancement pattern on images were significant (r=0.453, 0.897, and 0.556, P=0.038, <0.001 and 0.022, respectively). The survival curves for DFS were obtained. CONCLUSION The majority of POL are B-cell lymphomas. Unilateral orbital involvement, homogeneous contrast enhancement on images, and the appropriate treatment schemes result to be significant factors for a good prognosis for POL.
Collapse
Affiliation(s)
- Jian-Bo Zhu
- Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing 100730, China
| | - Bin Li
- Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing 100730, China
| | - Hong-Mei Zhang
- Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China
| | - Ning-Li Wang
- Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing 100730, China
| |
Collapse
|
36
|
Wang Q, Jiang XJ, Dong H, Che WQ, He JN, Chen Y, Song L, Zhang HM, Zou YB. [Impact of interventional therapy on top of standard drug therapy on left ventricular structure and function in HFrEF patients complicating with middle aortic syndrome caused by Takayasu arteritis]. Zhonghua Xin Xue Guan Bing Za Zhi 2022; 50:1207-1213. [PMID: 36517442 DOI: 10.3760/cma.j.cn112148-20221014-00804] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Objective: To evaluate the impact of interventional therapy on top of drug therapy on cardiac function and structure in heart failure with reduced ejection fraction (HFrEF) patients complicating with middle aortic syndrome caused by Takayasu arteritis (TA-MAS). Methods: It was a retrospective longitudinal study. The data of patients with TA-MAS and HFrEF, who received interventional therapy on top of drug therapy in Fuwai Hospital from January 2010 to September 2020, were collected and analyzed. Baseline clinical data (including demographic data, basic treatment, etc.) were collected through the electronic medical record system. Changes of indexes such as New York Heart Association (NYHA) classification, N-terminal pro-brain natriuretic peptide (NT-proBNP), left ventricular end diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), left ventricular mass index (LVMI) before and after therapy were analyzed. Results: A total of 10 patients were collected. There were 8 females in this patient cohort, age was (18.4±5.0) years and onset age was (15.3±5.0) years. All 10 patients received standard heart failure medication therapy in addition to hormone and/or immunosuppressive anti-inflammatory therapy, but cardiac function was not improved, so aortic balloon dilatation and/or aortic stenting were performed in these patients. The median follow-up was 3.3(1.3, 5.6) years. On the third day after interventional therapy, the clinical symptoms of the 10 patients were significantly improved, NYHA classfication was restored from preoperative Ⅲ/Ⅳ to Ⅱ at 6 months post intervention(P<0.05). Compared with preoperation, NT-proBNP (P=0.028), LVEDD (P=0.011) and LVMI (P=0.019) were significantly decreased, LVEF was significantly increased (P<0.001) at 6 months after operation. Compared with preoperation, NT-proBNP (P=0.016), LVEDD (P=0.023) and LVMI (P=0.043) remained decreased, LVEF remained increased (P<0.001) at 1 year after operation. Conclusion: Results from short and medium term follow-up show that interventional therapy on top of heart failure drug therpay can effectively improve left cardiac function and attenuate cardiac remodeling in patients with TA-MAS comorbid with HFrEF.
Collapse
Affiliation(s)
- Q Wang
- State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - X J Jiang
- State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - H Dong
- State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - W Q Che
- Department of Cardiology, China-Japan Friendship Hospital, Beijing 100029, China
| | - J N He
- State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - Y Chen
- State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - L Song
- State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - H M Zhang
- State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| | - Y B Zou
- State Key Laboratory of Cardiovascular Disease, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China
| |
Collapse
|
37
|
Cao Z, Aharonian F, An Q, Bai LX, Bai YX, Bao YW, Bastieri D, Bi XJ, Bi YJ, Cai JT, Cao Z, Chang J, Chang JF, Chen ES, Chen L, Chen L, Chen L, Chen MJ, Chen ML, Chen QH, Chen SH, Chen SZ, Chen TL, Chen Y, Cheng HL, Cheng N, Cheng YD, Cui SW, Cui XH, Cui YD, D'Ettorre Piazzoli B, Dai BZ, Dai HL, Dai ZG, Della Volpe D, Duan KK, Fan JH, Fan YZ, Fan ZX, Fang J, Fang K, Feng CF, Feng L, Feng SH, Feng XT, Feng YL, Gao B, Gao CD, Gao LQ, Gao Q, Gao W, Gao WK, Ge MM, Geng LS, Gong GH, Gou QB, Gu MH, Guo FL, Guo JG, Guo XL, Guo YQ, Guo YY, Han YA, He HH, He HN, He SL, He XB, He Y, Heller M, Hor YK, Hou C, Hou X, Hu HB, Hu Q, Hu S, Hu SC, Hu XJ, Huang DH, Huang WH, Huang XT, Huang XY, Huang Y, Huang ZC, Ji XL, Jia HY, Jia K, Jiang K, Jiang ZJ, Jin M, Kang MM, Ke T, Kuleshov D, Levochkin K, Li BB, Li C, Li C, Li F, Li HB, Li HC, Li HY, Li J, Li J, Li J, Li K, Li WL, Li XR, Li X, Li X, Li YZ, Li Z, Li Z, Liang EW, Liang YF, Lin SJ, Liu B, Liu C, Liu D, Liu H, Liu HD, Liu J, Liu JL, Liu JS, Liu JY, Liu MY, Liu RY, Liu SM, Liu W, Liu Y, Liu YN, Long WJ, Lu R, Luo Q, Lv HK, Ma BQ, Ma LL, Ma XH, Mao JR, Masood A, Min Z, Mitthumsiri W, Nan YC, Ou ZW, Pang BY, Pattarakijwanich P, Pei ZY, Qi MY, Qi YQ, Qiao BQ, Qin JJ, Ruffolo D, Sáiz A, Shao CY, Shao L, Shchegolev O, Sheng XD, Shi JY, Song HC, Stenkin YV, Stepanov V, Su Y, Sun QN, Sun XN, Sun ZB, Tam PHT, Tang ZB, Tian WW, Wang BD, Wang C, Wang H, Wang HG, Wang JC, Wang JS, Wang LP, Wang LY, Wang R, Wang RN, Wang W, Wang XG, Wang XY, Wang Y, Wang YD, Wang YJ, Wang YP, Wang ZH, Wang ZX, Wang Z, Wang Z, Wei DM, Wei JJ, Wei YJ, Wen T, Wu CY, Wu HR, Wu S, Wu XF, Wu YS, Xi SQ, Xia J, Xia JJ, Xiang GM, Xiao DX, Xiao G, Xin GG, Xin YL, Xing Y, Xiong Z, Xu DL, Xu RX, Xue L, Yan DH, Yan JZ, Yang CW, Yang FF, Yang HW, Yang JY, Yang LL, Yang MJ, Yang RZ, Yang SB, Yao YH, Yao ZG, Ye YM, Yin LQ, Yin N, You XH, You ZY, Yu YH, Yuan Q, Yue H, Zeng HD, Zeng TX, Zeng W, Zeng ZK, Zha M, Zhai XX, Zhang BB, Zhang F, Zhang HM, Zhang HY, Zhang JL, Zhang LX, Zhang L, Zhang L, Zhang PF, Zhang PP, Zhang R, Zhang SB, Zhang SR, Zhang SS, Zhang X, Zhang XP, Zhang YF, Zhang YL, Zhang Y, Zhang Y, Zhao B, Zhao J, Zhao L, Zhao LZ, Zhao SP, Zheng F, Zheng Y, Zhou B, Zhou H, Zhou JN, Zhou P, Zhou R, Zhou XX, Zhu CG, Zhu FR, Zhu H, Zhu KJ, Zuo X, Ando S, Chianese M, Fiorillo DFG, Miele G, Ng KCY. Constraints on Heavy Decaying Dark Matter from 570 Days of LHAASO Observations. Phys Rev Lett 2022; 129:261103. [PMID: 36608208 DOI: 10.1103/physrevlett.129.261103] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Revised: 08/19/2022] [Accepted: 10/27/2022] [Indexed: 06/17/2023]
Abstract
The kilometer square array (KM2A) of the large high altitude air shower observatory (LHAASO) aims at surveying the northern γ-ray sky at energies above 10 TeV with unprecedented sensitivity. γ-ray observations have long been one of the most powerful tools for dark matter searches, as, e.g., high-energy γ rays could be produced by the decays of heavy dark matter particles. In this Letter, we present the first dark matter analysis with LHAASO-KM2A, using the first 340 days of data from 1/2-KM2A and 230 days of data from 3/4-KM2A. Several regions of interest are used to search for a signal and account for the residual cosmic-ray background after γ/hadron separation. We find no excess of dark matter signals, and thus place some of the strongest γ-ray constraints on the lifetime of heavy dark matter particles with mass between 10^{5} and 10^{9} GeV. Our results with LHAASO are robust, and have important implications for dark matter interpretations of the diffuse astrophysical high-energy neutrino emission.
Collapse
Affiliation(s)
- Zhen Cao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - F Aharonian
- Dublin Institute for Advanced Studies, 31 Fitzwilliam Place, 2 Dublin, Ireland
- Max-Planck-Institut for Nuclear Physics, P.O. Box 103980, 69029 Heidelberg, Germany
| | - Q An
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - L X Bai
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Y X Bai
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y W Bao
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - D Bastieri
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - X J Bi
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y J Bi
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J T Cai
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Zhe Cao
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - J Chang
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J F Chang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - E S Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Liang Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Liang Chen
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - Long Chen
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M J Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M L Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - Q H Chen
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - S H Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - S Z Chen
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - T L Chen
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - Y Chen
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - H L Cheng
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - N Cheng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y D Cheng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - S W Cui
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - X H Cui
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - Y D Cui
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B D'Ettorre Piazzoli
- Dipartimento di Fisica dell'Università di Napoli "Federico II," Complesso Universitario di Monte Sant'Angelo, via Cinthia, 80126 Napoli, Italy
| | - B Z Dai
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - H L Dai
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - Z G Dai
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - D Della Volpe
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, 24 Quai Ernest Ansermet, 1211 Geneva, Switzerland
| | - K K Duan
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J H Fan
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y Z Fan
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Z X Fan
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J Fang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - K Fang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - C F Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Feng
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S H Feng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X T Feng
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - Y L Feng
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - B Gao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - C D Gao
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Q Gao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Q Gao
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - W Gao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - W K Gao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M M Ge
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - L S Geng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - G H Gong
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - Q B Gou
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M H Gu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - F L Guo
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - J G Guo
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X L Guo
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Q Guo
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y Y Guo
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y A Han
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - H H He
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H N He
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S L He
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - X B He
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - Y He
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - M Heller
- Département de Physique Nucléaire et Corpusculaire, Faculté de Sciences, Université de Genève, 24 Quai Ernest Ansermet, 1211 Geneva, Switzerland
| | - Y K Hor
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - C Hou
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X Hou
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - H B Hu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Q Hu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S Hu
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - S C Hu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X J Hu
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - D H Huang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - W H Huang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X T Huang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X Y Huang
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y Huang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Z C Huang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - X L Ji
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - H Y Jia
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - K Jia
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - K Jiang
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Z J Jiang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - M Jin
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M M Kang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - T Ke
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - D Kuleshov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - K Levochkin
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - B B Li
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - Cheng Li
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Cong Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - F Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - H B Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H C Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H Y Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Jian Li
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Jie Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - K Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - W L Li
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X R Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Xin Li
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Xin Li
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Z Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Zhe Li
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Zhuo Li
- School of Physics, Peking University, 100871 Beijing, China
| | - E W Liang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Y F Liang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - S J Lin
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Liu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - C Liu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - D Liu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - H Liu
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H D Liu
- School of Physics and Microelectronics, Zhengzhou University, 450001 Zhengzhou, Henan, China
| | - J Liu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J L Liu
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - J S Liu
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - J Y Liu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M Y Liu
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - R Y Liu
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - S M Liu
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - W Liu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y Liu
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Y N Liu
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - W J Long
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - R Lu
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Q Luo
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - H K Lv
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - B Q Ma
- School of Physics, Peking University, 100871 Beijing, China
| | - L L Ma
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X H Ma
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J R Mao
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - A Masood
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Z Min
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - W Mitthumsiri
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - Y C Nan
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - Z W Ou
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - B Y Pang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - P Pattarakijwanich
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - Z Y Pei
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - M Y Qi
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y Q Qi
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - B Q Qiao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J J Qin
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - D Ruffolo
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - A Sáiz
- Department of Physics, Faculty of Science, Mahidol University, Bangkok 10400, Thailand
| | - C Y Shao
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - L Shao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - O Shchegolev
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - X D Sheng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J Y Shi
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H C Song
- School of Physics, Peking University, 100871 Beijing, China
| | - Yu V Stenkin
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
- Moscow Institute of Physics and Technology, 141700 Moscow, Russia
| | - V Stepanov
- Institute for Nuclear Research of Russian Academy of Sciences, 117312 Moscow, Russia
| | - Y Su
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Q N Sun
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - X N Sun
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - Z B Sun
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - P H T Tam
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - Z B Tang
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - W W Tian
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - B D Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - C Wang
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - H Wang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H G Wang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - J C Wang
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - J S Wang
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - L P Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - L Y Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - R Wang
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - R N Wang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - W Wang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - X G Wang
- School of Physical Science and Technology, Guangxi University, 530004 Nanning, Guangxi, China
| | - X Y Wang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - Y Wang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y D Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y J Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y P Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Z H Wang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Z X Wang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Zhen Wang
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - Zheng Wang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - D M Wei
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J J Wei
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y J Wei
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - T Wen
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - C Y Wu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H R Wu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - S Wu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X F Wu
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Y S Wu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - S Q Xi
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J Xia
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - J J Xia
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - G M Xiang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - D X Xiao
- Key Laboratory of Cosmic Rays (Tibet University), Ministry of Education, 850000 Lhasa, Tibet, China
| | - G Xiao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - G G Xin
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y L Xin
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y Xing
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - Z Xiong
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - D L Xu
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - R X Xu
- School of Physics, Peking University, 100871 Beijing, China
| | - L Xue
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - D H Yan
- Yunnan Observatories, Chinese Academy of Sciences, 650216 Kunming, Yunnan, China
| | - J Z Yan
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - C W Yang
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - F F Yang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - H W Yang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - J Y Yang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - L L Yang
- School of Physics and Astronomy (Zhuhai) and School of Physics (Guangzhou) and Sino-French Institute of Nuclear Engineering and Technology (Zhuhai), Sun Yat-sen University, 519000 Zhuhai & 510275 Guangzhou, Guangdong, China
| | - M J Yang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - R Z Yang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - S B Yang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Y H Yao
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - Z G Yao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y M Ye
- Department of Engineering Physics, Tsinghua University, 100084 Beijing, China
| | - L Q Yin
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - N Yin
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - X H You
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Z Y You
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y H Yu
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - Q Yuan
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - H Yue
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H D Zeng
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - T X Zeng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - W Zeng
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Z K Zeng
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - M Zha
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X X Zhai
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - B B Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - F Zhang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H M Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - H Y Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - J L Zhang
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - L X Zhang
- Center for Astrophysics, Guangzhou University, 510006 Guangzhou, Guangdong, China
| | - Li Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - Lu Zhang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - P F Zhang
- School of Physics and Astronomy, Yunnan University, 650091 Kunming, Yunnan, China
| | - P P Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - R Zhang
- University of Science and Technology of China, 230026 Hefei, Anhui, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - S B Zhang
- University of Chinese Academy of Sciences, 100049 Beijing, China
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - S R Zhang
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S S Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - X Zhang
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - X P Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Y F Zhang
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - Y L Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - Yi Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
| | - Yong Zhang
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - B Zhao
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - J Zhao
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - L Zhao
- State Key Laboratory of Particle Detection and Electronics, China
- University of Science and Technology of China, 230026 Hefei, Anhui, China
| | - L Z Zhao
- Hebei Normal University, 050024 Shijiazhuang, Hebei, China
| | - S P Zhao
- Key Laboratory of Dark Matter and Space Astronomy, Purple Mountain Observatory, Chinese Academy of Sciences, 210023 Nanjing, Jiangsu, China
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - F Zheng
- National Space Science Center, Chinese Academy of Sciences, 100190 Beijing, China
| | - Y Zheng
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - B Zhou
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - H Zhou
- Tsung-Dao Lee Institute & School of Physics and Astronomy, Shanghai Jiao Tong University, 200240 Shanghai, China
| | - J N Zhou
- Key Laboratory for Research in Galaxies and Cosmology, Shanghai Astronomical Observatory, Chinese Academy of Sciences, 200030 Shanghai, China
| | - P Zhou
- School of Astronomy and Space Science, Nanjing University, 210023 Nanjing, Jiangsu, China
| | - R Zhou
- College of Physics, Sichuan University, 610065 Chengdu, Sichuan, China
| | - X X Zhou
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - C G Zhu
- Institute of Frontier and Interdisciplinary Science, Shandong University, 266237 Qingdao, Shandong, China
| | - F R Zhu
- School of Physical Science and Technology and School of Information Science and Technology, Southwest Jiaotong University, 610031 Chengdu, Sichuan, China
| | - H Zhu
- National Astronomical Observatories, Chinese Academy of Sciences, 100101 Beijing, China
| | - K J Zhu
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- University of Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
- State Key Laboratory of Particle Detection and Electronics, China
| | - X Zuo
- Key Laboratory of Particle Astrophyics and Experimental Physics Division and Computing Center, Institute of High Energy Physics, Chinese Academy of Sciences, 100049 Beijing, China
- TIANFU Cosmic Ray Research Center, Chengdu, Sichuan, China
| | - S Ando
- GRAPPA Institute, University of Amsterdam, 1098 XH Amsterdam, The Netherlands
- Kavli Institute for the Physics and Mathematics of the Universe (KavliIPMU,WPI), University of Tokyo, Kashiwa, Chiba 277-8583, Japan
| | - M Chianese
- Dipartimento di Fisica "Ettore Pancini," Università degli studi di Napoli "Federico II", Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
- INFN - Sezione di Napoli, Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
| | - D F G Fiorillo
- Dipartimento di Fisica "Ettore Pancini," Università degli studi di Napoli "Federico II", Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
- INFN - Sezione di Napoli, Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
- Niels Bohr International Academy, Niels Bohr Institute, University of Copenhagen, Copenhagen, Denmark
| | - G Miele
- Dipartimento di Fisica "Ettore Pancini," Università degli studi di Napoli "Federico II", Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
- INFN - Sezione di Napoli, Complesso Univ. Monte S. Angelo, I-80126 Napoli, Italy
- Scuola Superiore Meridionale, Università degli studi di Napoli "Federico II", Largo San Marcellino 10, 80138 Napoli, Italy
| | - K C Y Ng
- Department of Physics, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong, China
| |
Collapse
|
38
|
Zhou GS, Liu JJ, Zhang HM, Zhang Q, Wang XT, Liu DW. [The relationship between left ventricular artery coupling and left ventricular work and their predictive value on prognosis in septic shock]. Zhonghua Yi Xue Za Zhi 2022; 102:3749-3755. [PMID: 36517424 DOI: 10.3760/cma.j.cn112137-20220620-01351] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/17/2023]
Abstract
Objective: To explore the relationship between left ventricular artery coupling and left ventricular work in patients with septic shock, and further clarified their predictive value for the prognosis of septic shock. Methods: In total, 56 patients with septic shock admitted in the Department of Critical Care Medicine of Peking Union Medical College Hospital were retrospectively enrolled between January 2016 and July 2021. The hemodynamic indexes and clinical data monitored by pulse indicator continuous cardiac output (PICCO) at different time points were collected. To reveal alterations of arterial elastance index (EaI), end-systolic elastance index (EesI), EaI/EesI, stroke work (SW), total cardiac function (PVA), and left ventricular ejection efficiency (LVEf) in patients with septic shock at different time points. The patients were divided into the death group (n=20) and survival group (n=36) according to the outcome of the ICU. The relationship between left ventricular work and left ventricular arterial coupling and its prognostic value were statistically analyzed. Results: A total of 56 patients were enrolled, 32 males and 24 females, aged (61±15) years. There was a significantly difference in EaI/EesI and LVEf between survivors and non-survivors with septic shock at 6 h (P<0.05). Further analysis showed that the correlation between EaI/EesI and LVEf was most evident at 6 h after intervention. EaI/EesI was negatively correlated with SW (rs=-0.500, P<0.001), and highly negative with LVEf (rs=-0.959, P<0.001). Both univariate logistic regression and multivariate regression analysis showed that EaI/EesI (adjusted OR=42.783, 95%CI: 2.725-671.819, P=0.008) and LVEf (adjusted OR=2.293, 95%CI:1.222-4.301, P=0.010) were risk factors for ICU prognosis of patients with septic shock. The receiver operating characteristic (ROC) curve analysis showed that EaI/EesI [area under the curve (AUC)=0.742±0.083, P=0.004; cut-off value 6.10, sensitivity 88.9%, specificity 65.0%] and LVEf (AUC=0.733±0.084, P=0.006; cut-off value 0.24, sensitivity 88.8%, specificity 60.0%) were both effective indicators for predicting the prognosis of patients with septic shock in the ICU. Moreover, EaI/EesI had a better prognosis value than LVEf (ΔAUC=0.120, Z=6.528, P=0.036). Conclusion: It's indicated that EaI/EesI was significantly correlated with SW and LVEf after 6 h of septic shock intervention; EaI/EesI and LVEf are risk factors and effective predictors of ICU prognosis in patients with septic shock. The predictive efficacy of EaI/EesI is greater than LVEF.
Collapse
Affiliation(s)
- G S Zhou
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100710, China
| | - J J Liu
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100710, China
| | - H M Zhang
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100710, China
| | - Q Zhang
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100710, China
| | - X T Wang
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100710, China
| | - D W Liu
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100710, China
| |
Collapse
|
39
|
Zhang W, Shi JN, Wang HN, Zhang T, Zhou X, Zhang HM, Zhu F. Identification of immune-related genes and development of a prognostic model in mantle cell lymphoma. Ann Transl Med 2022; 10:1323. [PMID: 36660618 PMCID: PMC9843426 DOI: 10.21037/atm-22-5815] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/02/2022] [Accepted: 12/08/2022] [Indexed: 12/23/2022]
Abstract
Background The immune landscape, prognostic model, and molecular variations of mantle cell lymphoma (MCL) remain unclear. Hence, an integrated bioinformatics analysis of MCL datasets is required for the development of immunotherapy and the optimization of targeted therapies. Methods Data were obtained from the Gene Expression Omnibus (GEO) database (GSE32018, GSE45717 and GSE93291). The differentially expressed immune-related genes were selected, and the hub genes were screened by three machine learning algorithms, followed by enrichment and correlation analyses. Next, MCL molecular clusters based on the hub genes were identified by K-Means clustering, the probably approximately correct (PAC) algorithm, and principal component analysis (PCA). The landscape of immune cell infiltration and immune checkpoint molecules in distinct clusters was explored by single-sample gene-set enrichment analysis (ssGSEA) as well as the CIBERSORT and xCell algorithms. The prognostic genes and prognostic risk score model for MCL clusters were identified by least absolute shrinkage and selection operator (LASSO)-Cox analysis and cross-validation for lambda. Correlation analysis was performed to explore the correlation between the screened prognostic genes and immune cells or immune checkpoint molecules. Results Four immune-related hub genes (CD247, CD3E, CD4, and GATA3) were screened in MCL, mainly enriched in the T-cell receptor signaling pathway. Based on the hub genes, two MCL molecular clusters were recognized. The cluster 2 group had a significantly worse overall survival (OS), with down-regulated hub genes, and a variety of activated immune effector cells declined. The majority of immune checkpoint molecules had also decreased. An efficient prognostic model was established, including six prognostic genes (LGALS2, LAMP3, ICOS, FCAMR, IGFBP4, and C1QA) differentially expressed between two MCL clusters. Patients with a higher risk score in the prognostic model had a poor prognosis. Furthermore, most types of immune cells and a range of immune checkpoint molecules were positively correlated with the prognostic genes. Conclusions Our study identified distinct molecular clusters based on the immune-related hub genes, and showed that the prognostic model affected the prognosis of MCL patients. These hub genes, modulated immune cells, and immune checkpoint molecules might be involved in oncogenesis and could be potential prognostic biomarkers in MCL.
Collapse
Affiliation(s)
- Wei Zhang
- Department of Hematology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China
| | - Jin-Ning Shi
- Department of Hematology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China
| | - Hai-Ning Wang
- Department of Blood Supply, Nanjing Red Cross Blood Center, Nanjing, China
| | - Ting Zhang
- Department of Hematology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China
| | - Xuan Zhou
- Department of Hematology, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China
| | - Hong-Mei Zhang
- Department of Blood Transfusion, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China
| | - Feng Zhu
- Department of Blood Transfusion, The Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, China
| |
Collapse
|
40
|
Zhao ML, Zhang FJ, Jiang WR, Xia Y, Chen C, Zhang T, Han TL, Yu XY, Mei P, Zhang HM, Jin X, Novakovic B, Leong P, Thompson M, Saffery R, Cannon RD, Zhang H, Ji P. Investigating the impact of oral health on pregnancy and offspring outcomes: protocol for the Lifetime Impact of ORal heAlth (LIORA) cohort study. BMJ Open 2022; 12:e066204. [PMID: 36446451 PMCID: PMC9710366 DOI: 10.1136/bmjopen-2022-066204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
INTRODUCTION Oral health is a fundamental component of well-being, and is closely associated with overall health and quality of life. Oral health may also affect the next generation. The children of mothers with poor oral health are likely to also have poor oral health as they go through life. We aim to investigate associations between maternal oral health and general health, pregnancy outcomes, offspring oral health and offspring general health. METHODS AND ANALYSIS The Lifetime Impact of Oral Health study is a prospective, observational cohort study being done at a single centre in Chongqing, China. A total of 1000 pregnant women will be recruited in their first trimester (11-14 weeks gestation). After obtaining informed consent, general and oral health assessments will be undertaken. Maternal lifestyle, demographic data and biospecimens (blood, hair, urine, nail clippings, saliva, dental plaque, buccal, vaginal and anal swabs) will be collected. Pregnancy outcomes will be recorded at the time of delivery. Cord blood and placenta samples will be collected. The offspring will be followed up for general and oral health examinations, neurodevelopmental assessments and biospecimen (dental plaque, saliva, buccal swabs, exfoliated primary dentition, urine, hair, nail clippings) collection until they are 15 years old. Biological samples will undergo comprehensive metabolomic, microbiome and epigenome analyses. Associations between maternal oral health and general health, pregnancy outcomes, offspring oral health and offspring general health will be investigated and the underlying mechanisms explored. ETHICS AND DISSEMINATION This project has been approved by the Research Ethics Committee of the Affiliated Hospital of Stomatology of Chongqing Medical University (CQHS-REC-2021 LSNo.23). Participants will be required to provide informed consent to participate in the study. Dissemination of findings will take the form of publications in peer-reviewed journals and presentations at national and international conferences. TRIAL REGISTRATION NUMBER ChiCTR2100046898.
Collapse
Affiliation(s)
- Mei-Ling Zhao
- Stomatological Hospital of Chongqing Medical University, Chongqing, China
| | - Feng-Jing Zhang
- Stomatological Hospital of Chongqing Medical University, Chongqing, China
| | - Wen-Rong Jiang
- Stomatological Hospital of Chongqing Medical University, Chongqing, China
| | - Yinyin Xia
- Stomatological Hospital of Chongqing Medical University, Chongqing, China
- School of Public Health, Chongqing Medical University, Chongqing, China
| | - Chang Chen
- Institute of Life Sciences, Chongqing Medical University, Chongqing, China
| | - Ting Zhang
- Stomatological Hospital of Chongqing Medical University, Chongqing, China
| | - Ting-Li Han
- Department of Obstetrics and Gynaecology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Xin-Yang Yu
- Department of Obstetrics and Gynaecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Peter Mei
- Oral Sciences, University of Otago, Dunedin, New Zealand
| | - Hong-Mei Zhang
- Stomatological Hospital of Chongqing Medical University, Chongqing, China
| | - Xin Jin
- Stomatological Hospital of Chongqing Medical University, Chongqing, China
| | - Boris Novakovic
- Murdoch Children's Research Institute, Parkville, Victoria, Australia
- Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia
| | - Pamela Leong
- Cancer, Disease and Developmental Epigenetics, Murdoch Childrens Research Institute, Parkville, Victoria, Australia
- Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia
| | - Murray Thompson
- Sir John Walsh Research Institute, University of Otago, Dunedin, UK
| | - Richard Saffery
- Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia
- Cancer and Disease Epigenetics, Murdoch Childrens Research Institute, Parkville, Victoria, Australia
| | | | - Hua Zhang
- Department of Obstetrics and Gynaecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
| | - Ping Ji
- Stomatological Hospital of Chongqing Medical University, Chongqing, China
| |
Collapse
|
41
|
Wang XX, Wu LH, Dou QY, Ai L, Lu Y, Deng SZ, Liu QQ, Ji H, Zhang HM. Construction of m6A-based prognosis signature and prediction for immune and anti-angiogenic response. Front Mol Biosci 2022; 9:1034928. [PMID: 36339715 PMCID: PMC9634552 DOI: 10.3389/fmolb.2022.1034928] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2022] [Accepted: 10/12/2022] [Indexed: 11/29/2022] Open
Abstract
Background: Increasing evidence illustrated that m6A regulator-mediated modification plays a crucial role in regulating tumor immune and angiogenesis microenvironment. And the combination of immune checkpoint inhibitor and anti-angiogenic therapy has been approved as new first-line therapy for advanced HCC. This study constructed a novel prognosis signature base on m6A-mediated modification and explored the related mechanism in predicting immune and anti-angiogenic responses. Methods: Gene expression profiles and clinical information were collected from TCGA and GEO. The ssGSEA, MCPCOUNT, and TIMER 2.0 algorithm was used to Estimation of immune cell infiltration. The IC50 of anti-angiogenic drugs in GDSC was calculated by the “pRRophetic” package. IMvigor210 cohort and Liu et al. cohort were used to validate the capability of immunotherapy response. Hepatocellular carcinoma single immune cells sequencing datasets GSE140228 were collected to present the expression landscapes of 5 hub genes in different sites and immune cell subpopulations of HCC patients. Results: Three m6A clusters with distinct immune and angiogenesis microenvironments were identified by consistent cluster analysis based on the expression of m6A regulators. We further constructed a 5-gene prognosis signature (termed as m6Asig-Score) which could predict both immune and anti-angiogenic responses. We illustrated that high m6Asig-Score is associated with poor prognosis, advanced TNM stage, and high TP53 mutation frequency. Besides, the m6Asig-Score was negatively associated with immune checkpoint inhibitors and anti-angiogenic drug response. We further found that two of the five m6Asig-Score inner genes, B2M and SMOX, were associated with immune cell infiltration, immune response, and the sensitivity to sorafenib, which were validated in two independent immunotherapy cohorts and the Genomics of Drug Sensitivity in Cancer (GDSC) database. Conclusion: We constructed a novel prognosis signature and identified B2M and SMOX for predicting immune and anti-angiogenic efficacy in HCC, which may guide the combined treatment strategies of immunotherapy and anti-angiogenic therapy in HCC.
Collapse
Affiliation(s)
- Xiang-Xu Wang
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Li-Hong Wu
- Xijing 986 Hospital Department, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Qiong-Yi Dou
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Liping Ai
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Yajie Lu
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Shi-Zhou Deng
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Qing-Qing Liu
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Hongchen Ji
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Hong-Mei Zhang
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
- *Correspondence: Hong-Mei Zhang,
| |
Collapse
|
42
|
Wang XX, Wu LH, Ji H, Liu QQ, Deng SZ, Dou QY, Ai L, Pan W, Zhang HM. A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy. Front Mol Biosci 2022; 9:1001788. [PMID: 36250008 PMCID: PMC9556951 DOI: 10.3389/fmolb.2022.1001788] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2022] [Accepted: 08/31/2022] [Indexed: 11/25/2022] Open
Abstract
Background: Copper metabolism plays an important role in the tumor microenvironment, and cuproptosis is the last discovered programmed cell death process. However, the potential mechanism of cuproptosis in regulating the immune microenvironment of HCC remains unclear. Methods: A total of 716 HCC patients with complete mRNA expression and survival information were collected from three public HCC cohorts (TCGA-LIHC cohort, n = 370; GSE76427 cohort, n = 115; ICGC-LIRI cohort, n = 231). The unsupervised clustering analysis (NMF) was performed to identify three different cuproptosis-related subtypes. The univariate-Cox, lasso-Cox and multivariate-Cox regression analyses were performed to screen the cuproptosis related and construct the cuproptosis-related prognosis signature (Cu-PS). The immune cell infiltration was estimated by both CIBERSORT and MCPcounter algorithms. Results: This study identified three distinct cuproptosis-related metabolic patterns, which presented different pathway enrichment and immune cell infiltration. The Cu-PS, a 5-genes (C7, MAGEA6, HK2, CYP26B1 and EPO) signature, was significantly associated with TNM stage, tumor mutational burden (TMB), drugs sensitivity, and immunotherapies response. Conclusion: This study performed a multi-genetic analysis of cuproptosis-related genes and further explored the regulatory mechanism of cuproptosis in HCC. The Cu-PS might be a useful biomarker for predicting immunotherapy response and enhancing the diagnosis and treatment of HCC.
Collapse
Affiliation(s)
- Xiang-Xu Wang
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Li-Hong Wu
- Xijing 986 Hospital Department, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Hongchen Ji
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Qing-Qing Liu
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Shi-Zhou Deng
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Qiong-Yi Dou
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Liping Ai
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Wei Pan
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
| | - Hong-Mei Zhang
- Department of Clinical Oncology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
- *Correspondence: Hong-Mei Zhang,
| |
Collapse
|
43
|
Huang CY, Chen NN, Zhou F, Zhang HM, Yang XR. [Effects of SIRT1 in amygdala on chronic restraint stress-induced depression-like behaviors in rats]. Zhongguo Ying Yong Sheng Li Xue Za Zhi 2022; 38:458-463. [PMID: 37088752 DOI: 10.12047/j.cjap.6306.2022.086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/25/2023]
Abstract
OBJECTIVE To investigate the effects of silent information regulator 1 (SIRT1) in amygdala on depression-like behaviors in rats using chronic restraint stress (CRS) as a model of depression. METHODS Sixty male SD rats were randomly divided into six groups (n=10 per group): control group (Control), chronic restraint stress group (CRS), CRS + fluoxetine-treated group (CRS + FLU), CRS + saline-treated group (CRS + NaCl), CRS + SIRT1-overexpression group (CRS + AAV-SIRT1), and CRS + empty vector group (CRS + AAV-EGFP). Except for the control group, rats from the other groups were exposed to chronic restraint stress for 21 days. After the modeling, rats in fluoxetine-treated group and saline-treated group were, respectively, treated with fluoxetine (10 mg/kg) or saline (10 mg/kg) by gavage every day for 3 weeks; AAV-SIRT1 or AAV-EGFP was, respectively, stereotaxically injected into the amygdala of rats in SIRT1-overexpression group and empty vector group, and the virus was expressed for 3 weeks. Rats in normal control group and CRS model group were not given any drug treatment. The depression-like behaviors of rats in each group were evaluated by sugar preference test (SPT), open field test (OFT) and forced swimming test (FST). SIRT1 expression in amygdala of rats was assessed by using immunoblot blotting. The number of SIRT1-positive cells in amygdala of rats was detected by immunofluorescence technique. RESULTS Compared with the normal control group, the level of SIRT1 protein and the number of SIRT1+ cells in amygdala of the CRS-exposed rats were decreased significantly (P<0.01), and CRS-exposed rats showed a significant decrease in sucrose preference (P<0.01), less total horizontal distance (P<0.01) and less time entered the center field (P<0.01) in the OFT, a significant increase in the immobility time of the FST (P<0.01). Fluoxetine treatment (P<0.05, P<0.01) or SIRT1 overexpression (P<0.01) partially reversed the down-regulation of SIRT1 protein and SIRT1+ cells in amygdala of CRS-exposed rats and significantly improved the depression-like behaviors of CRS rats. CONCLUSION Fluoxetine treatment partially reversed the down-regulation of SIRT1 level and the number of SIRT1+ in CRS rats, and significantly improved the depression-like behaviors. The antidepressant effect of fluoxetine treatment may be related to the up-regulation of SIRT1 in the amygdala of CRS-exposed rats.
Collapse
Affiliation(s)
- Cai-Yun Huang
- Department of Physiology, Shanxi Medical University, Key Laboratory of Cellular Physiology, Ministry of Education, Taiyuan 030001
| | - Na-Na Chen
- Department of Physiology, Shanxi Medical University, Key Laboratory of Cellular Physiology, Ministry of Education, Taiyuan 030001
| | - Fei Zhou
- Department of Physiology, Shanxi Medical University, Key Laboratory of Cellular Physiology, Ministry of Education, Taiyuan 030001
| | - Hong-Mei Zhang
- Department of Environmental Health, School of Public Health, Shanxi Medical University, Taiyuan 030001, China
| | - Xiao-Rong Yang
- Department of Physiology, Shanxi Medical University, Key Laboratory of Cellular Physiology, Ministry of Education, Taiyuan 030001
| |
Collapse
|
44
|
Ji H, Zhang Q, Wang XX, Li J, Wang X, Pan W, Zhang Z, Ma B, Zhang HM. Identification of stromal microenvironment characteristics and key molecular mining in pancreatic cancer. Discov Oncol 2022; 13:83. [PMID: 36006549 PMCID: PMC9411435 DOI: 10.1007/s12672-022-00532-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/17/2022] [Accepted: 07/07/2022] [Indexed: 11/07/2022] Open
Abstract
PURPOSE Pancreatic cancer is one of the deadliest cancers worldwide. The extracellular matrix (ECM) microenvironment affects the drug sensitivity and prognosis of pancreatic cancer patients. This study constructed an 8-genes pancreatic ECM scoring (PECMS) model, to classify the ECM features of pancreatic cancer, analyze the impact of ECM features on survival and drug sensitivity, and mine key molecules that influence ECM features in pancreatic cancer. METHODS GSVA score calculation and clustering were performed in TCGA-PAAD patients. Lasso regression was used to construct the PECMS model. The association between PECMS and patient survival was analyzed and validated in the CPTAC-3 dataset of TCGA and our single-center retrospective cohort. The relationships between PECMS and features of the matrix microenvironment were analyzed. Finally, PECMS feature genes were screened and verified in pancreatic cancer specimens to select key genes associated with the ECM microenvironment. RESULT The survival of the PECMS-high group was significantly worse. The PECMS-high group showed higher oxidative stress levels, lower levels of antigen presentation- and MHC-I molecule-related pathways, and less immune effector cell infiltration. Data from IMvigor-210 cohort suggested that PECMS-low group patients were more sensitive to immune checkpoint blockers. The PECMS score was negatively correlated with chemotherapy drug sensitivity. The negative association of PECMS with survival and drug sensitivity was validated in our retrospective cohort. KLHL32 expression predicted lower oxidative stress level and more immune cells infiltrate in pancreatic cancer. CONCLUSION PECMS is an effective predictor of prognosis and drug sensitivity in pancreatic cancer patients. KLHL32 may play an important role in the construction of ECM, and the mechanism is worth further study.
Collapse
Affiliation(s)
- Hongchen Ji
- Department of Oncology, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, 710032, China
- Faculty of Hepatopancreatobiliary Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, China
| | - Qiong Zhang
- Department of Oncology, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, 710032, China
| | - Xiang-Xu Wang
- Department of Oncology, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, 710032, China
| | - Junjie Li
- Department of Emergency, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, China
| | - Xiaowen Wang
- Department of Oncology, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, 710032, China
| | - Wei Pan
- Department of Oncology, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, 710032, China
| | - Zhuochao Zhang
- Faculty of Hepatopancreatobiliary Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, China
| | - Ben Ma
- Faculty of Hepatopancreatobiliary Surgery, Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing, China
| | - Hong-Mei Zhang
- Department of Oncology, Xijing Hospital, Fourth Military Medical University, No. 127 West Changle Road, Xi'an, 710032, China.
| |
Collapse
|
45
|
Yue J, Wang CM, Lyu JX, Jian SJ, Niu YY, Liu SS, Sun ST, Han L, Zhang HM. [Susceptibility of drug-resistant staphylococci isolated from different parts of the ocular anterior segment to common ophthalmic antibiotics]. Zhonghua Yan Ke Za Zhi 2022; 58:598-605. [PMID: 35959604 DOI: 10.3760/cma.j.cn112142-20220119-00023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Objectie To investigate the susceptibility of drug-resistant staphylococci isolated from different parts of the anterior segment to levofloxacin, tobramycin, cefazolin sodium, fusidic acid and clindamycin. Methods: Experimental Study. A total of 67 patients with anterior segment infection (33 cases of conjunctivitis, 6 cases of bacterial keratitis, 7 cases of blepharitis, 9 cases of neonatal dacryocystitis, 9 cases of neonatal dacryocystitis, 1 case of adult dacryocystitis and 11 cases of other infectious eye diseases) were collected from the conjunctival sac, cornea, eyelid margin and lacrimal sac. Minimum inhibitory concentration (MIC) determination of methicillin-resistant Staphylococcus (MRS) strains and β-lactamase-producing (β-Lac) strains by a micro-liquid-based method, according to the M100 standard of the American Institute for Clinical and Laboratory Standardization Susceptibility and resistance determinations were made. Data were statistically analyzed using Chi-square or Fisher's exact test. Results: Thirty-five MRS, 30 β-Lac and 2 β-Lac MRS isolates were identified from 67 multidrug-resistant Staphylococcus . There were 3, 9, 4, and 19 MRS isolates isolated from the lacrimal sac, cornea, eyelid margin and conjunctival sac, accounting for 3/4, 9/12, 4/8, 19/43 (44.2%) of the isolated sites respectively. There were 1, 3, 3, and 23 β-Lac isolates, accounting for 1/4, 3/12, 3/8 and 23/43 (53.5%) of the isolated sites, respectively. The highest proportion of β-Lac isolates isolated from patients with a diagnosis of conjunctivitis was 17 (25.3%) from the conjunctival sac. Among the MRS strains isolated from the cornea and lacrimal sac, 5 (7.5%) and 3 (4.5%) were from patients diagnosed with bacterial keratitis and neonatal tear, respectively. The number of MRS strains and β-Lac isolates isolated from patients with a diagnosis of blepharitis were both 3 (4.5%) from the lid margin.Among the strains isolated from the eyelid margin and the conjunctival sac, drug-resistant Staphylococcus epidermidis was the main strain, the drug-resistant Staphylococcus aureus was the major isolates in lacrimal sac and cornea. Among the 35 MRS isoaltes, 25, 24, 12, 12, and 11 were sensitive to cefazolin sodium, fusidic acid, levofloxacin, clindamycin and tobramycin, and the sensitivity rates were 71.4%, 68.6%, 34.3%, 34.3% and 31.4%, the difference was statistically significant (χ2=22.756, P<0.001), The sensitivity rates of levofloxacin, tobramycin, cefazolin sodium, fusidic acid and clindamycin against MRS isolates from the anterior segment were both statistically significant differences (χ2=18.493, 11.594, 8.906, 9.841, 16.059; all P<0.05). The susceptibility rates of MRS isolates against five antibiotics was statistically significant differences (χ2=33.080, P<0.001). Among the 30 β-Lac isolates, 27, 22, 19, 16, and 8 were sensitive to cefazolin sodium, fusidic acid, levofloxacin, tobramycin and clindamycin, and the sensitivity rates were 90.0 % , 73.3%, 63.3%, 53.3% and 26.7%, the difference was statistically significant (χ2=28.280, P<0.001). The sensitivity rates of five antibiotics against β-Lac isolates from the anterior segment were both statistically significant differences (χ2=50.971, 24.543, 48.147, 44.899, 18.676; all P<0.001). The susceptibility rates of β-Lac isolates against five antibiotics was statistically significant differences (χ2=23.383, P<0.001). The sensitivity of cefazolin sodium and fusidic acid against β-Lac isolates were higher than MRS isolates. Conclusions: Cefazolin sodium and fusidic acid may be the best choice for the treatment of drug-resistant Staphylococcus isolated from anterior conjunctival sac, cornea, eyelid margin and lacrimal sac, especially for β-Lac-producing drug-resistant Staphylococcus infection.
Collapse
Affiliation(s)
- J Yue
- Department of Ophthalmology, Henan Provincial People's Hospital of Ophthalmology, Henan Eye Hospital, Henan Eye Institute, School of Clinical Medicine, Ophthalmology Department of Henan University, People's Hospital of Zhengzhou University, Henan Provincial Key Laboratory of Ophthalmology and Visual Science, Zhengzhou 450003, China
| | - C M Wang
- Department of Ophthalmology, Henan Provincial People's Hospital of Ophthalmology, Henan Eye Hospital, Henan Eye Institute, School of Clinical Medicine, Ophthalmology Department of Henan University, People's Hospital of Zhengzhou University, Henan Provincial Key Laboratory of Ophthalmology and Visual Science, Zhengzhou 450003, China
| | - J X Lyu
- Department of Ophthalmology, Henan Provincial People's Hospital of Ophthalmology, Henan Eye Hospital, Henan Eye Institute, School of Clinical Medicine, Ophthalmology Department of Henan University, People's Hospital of Zhengzhou University, Henan Provincial Key Laboratory of Ophthalmology and Visual Science, Zhengzhou 450003, China
| | - S J Jian
- Department of Ophthalmology, Henan Provincial People's Hospital of Ophthalmology, Henan Eye Hospital, Henan Eye Institute, School of Clinical Medicine, Ophthalmology Department of Henan University, People's Hospital of Zhengzhou University, Henan Provincial Key Laboratory of Ophthalmology and Visual Science, Zhengzhou 450003, China
| | - Y Y Niu
- Department of Ophthalmology, Henan Provincial People's Hospital of Ophthalmology, Henan Eye Hospital, Henan Eye Institute, School of Clinical Medicine, Ophthalmology Department of Henan University, People's Hospital of Zhengzhou University, Henan Provincial Key Laboratory of Ophthalmology and Visual Science, Zhengzhou 450003, China
| | - S S Liu
- Department of Ophthalmology, Henan Provincial People's Hospital of Ophthalmology, Henan Eye Hospital, Henan Eye Institute, School of Clinical Medicine, Ophthalmology Department of Henan University, People's Hospital of Zhengzhou University, Henan Provincial Key Laboratory of Ophthalmology and Visual Science, Zhengzhou 450003, China
| | - S T Sun
- Department of Ophthalmology, Henan Provincial People's Hospital of Ophthalmology, Henan Eye Hospital, Henan Eye Institute, School of Clinical Medicine, Ophthalmology Department of Henan University, People's Hospital of Zhengzhou University, Henan Provincial Key Laboratory of Ophthalmology and Visual Science, Zhengzhou 450003, China
| | - L Han
- Department of Ophthalmology, Henan Provincial People's Hospital of Ophthalmology, Henan Eye Hospital, Henan Eye Institute, School of Clinical Medicine, Ophthalmology Department of Henan University, People's Hospital of Zhengzhou University, Henan Provincial Key Laboratory of Ophthalmology and Visual Science, Zhengzhou 450003, China
| | - H M Zhang
- Department of Ophthalmology, Henan Provincial People's Hospital of Ophthalmology, Henan Eye Hospital, Henan Eye Institute, School of Clinical Medicine, Ophthalmology Department of Henan University, People's Hospital of Zhengzhou University, Henan Provincial Key Laboratory of Ophthalmology and Visual Science, Zhengzhou 450003, China
| |
Collapse
|
46
|
Tan JQ, Li Z, Chen G, Wu M, Feng JL, Kong SY, Shi XQ, Zhang HM, Lao YZ, Zhou H, Zhang L, Xu HX. The natural compound from Garcinia bracteata mainly induces GSDME-mediated pyroptosis in esophageal cancer cells. Phytomedicine 2022; 102:154142. [PMID: 35623158 DOI: 10.1016/j.phymed.2022.154142] [Citation(s) in RCA: 15] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/30/2022] [Revised: 04/26/2022] [Accepted: 05/01/2022] [Indexed: 06/15/2023]
Abstract
BACKGROUND Pyroptosis, an inflammatory form of programmed cell death (PCD), is reported to play important roles in the treatment of tumors. In our previous studies, we found that neobractatin (NBT), a caged prenylxanthone isolated from edible fruits of Garcinia bracteata C. Y. Wu ex Y. H. Li, showed anticancer effects against different cancer cells. However, the effect of NBT on pyroptosis is not well understood. PURPOSE This study aims to investigate whether and how GSDME-mediated pyroptosis contributes to NBT-induced antitumor effects in esophageal cancer (EC) cells. METHODS Cell viability assay and colony formation assay were used to determine the anticancer effects of NBT in esophageal cancer cells. Lactate dehydrogenase (LDH) release assay and microscopy imaging were used to detect the main characteristic of pyroptosis. CRISPR-Cas9 knockout and siRNA knockdown were performed to verify the roles of GSDME and caspase-3 in NBT-induced pyroptosis. Flow cytometry was used to measure the reactive oxygen species (ROS) level and cell apoptosis. The changes of related protein level were detected by Western blot. Furthermore, animal experiments were used to verify the in vivo effect of NBT. RESULTS The results showed that NBT reduced the viability of EC cells mainly through GSDME-mediated pyroptosis. Morphologically, NBT induced cell swelling and formed large bubbles emerging from plasma membrane in wild type EC cells. Furthermore, NBT induced the cleavage of GSDME by activating caspase-3 in EC cells. On the other hand, caspase-3 activated by NBT also induced apoptosis especially at high dosage. Knocking down GSDME switched NBT-induced cell death from mainly pyroptosis to apoptosis in vivo and in vitro. Mechanistic studies indicated that NBT led to accumulation of ROS, which then regulated the phosphorylation of both JNK and MEK/ERK. In the absence of ROS or caspase-3, NBT-induced pyroptosis and apoptosis were completely reversed. Moreover, NBT showed a significant antitumor effect in both the KYSE150 and GSDME knockout KYSE150-/- xenograft models by inducing pyroptosis and apoptosis, respectively. CONCLUSION Our results indicated that natural compound NBT could induce GSDME-mediated pyroptosis and apoptosis in esophageal cancer cells, making it a potential therapeutic drug in clinical treatment.
Collapse
Affiliation(s)
- Jia-Qi Tan
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, PR China
| | - Zhuo Li
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, PR China
| | - Gan Chen
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, PR China
| | - Man Wu
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, PR China
| | - Ji-Ling Feng
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, PR China
| | - Si-Yuan Kong
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, PR China
| | - Xiao-Qin Shi
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, PR China
| | - Hong-Mei Zhang
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, PR China
| | - Yuan-Zhi Lao
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, PR China
| | - Hua Zhou
- Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China
| | - Li Zhang
- School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China; Engineering Research Center of Shanghai Colleges for TCM New Drug Discovery, Shanghai 201203, PR China.
| | - Hong-Xi Xu
- Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, PR China.
| |
Collapse
|
47
|
Liu Y, Wang XW, Ji HC, Yang JY, Chen Y, Wang Z, Zhang HM. Clinical characteristics, treatment and clinical outcomes of leiomyosarcoma: A retrospective study from single center. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.16_suppl.e23536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
e23536 Background: Leiomyosarcomas are genetically heterogeneous tumors with highly variable survival. The clinical efficacy of different treatments has not been determined. This retrospective study analyzed the clinical pathological features, treatments and outcomes of leiomyosarcoma patients. Methods: A retrospective review was performed of leiomyosarcoma patients between 2000 to 2021. 214 patients were initially investigated, 102 patients were excluded owing to a lack of follow-up or loss of data., and 112 patients were finally analyzed. Treatment outcomes were measured using overall survival (OS), disease-free survival (DFS) and progression-free survival (PFS). Optimal responses of first-line chemotherapies were also investigated under RECIST criteria. Results: Mean age of patients was 52.63 years, and male to female ratio was 1/2.2. Tumors mainly located in head and neck (2.68%), trunk and extremities (35.71%), abdomen and thoracic organs (16.07%), retroperitoneum (17.86%) and pelvis (27.68%). Patients with ⅠA, ⅠB, II, IIIA, IIIB and IV stage was 15.18%, 23.21%, 9.82%, 12.50%, 7.14% and 9.82% respectively. 2 patients received only chemotherapy after diagnosis, and 109 patients underwent surgery, among them 33.04% (37 cases) of patients had further radiation or chemotherapy. The median OS (mOS) of all patients was 42.65 months (95% CI 33.77-50.43). Adjuvant therapy had no significant influence on median DFS (mDFS) (28.63 months vs 30.33 months, P= 0.888). Significantly, R0 resection prolonged mDFS (33.30 months vs 7.37 months, P = 0.019) and mOS (102.5 months vs 35.83 months, P= 0.001). 32 patients occurred recurrence and all had surgery. 28 patients occurred metastases and 6 of them received surgery alone, 11 patients had systemic treatment, 6 patients received both treatments, 5 of them were untreated. In patients with metastases, the median PFS of systemic treatment (15.33 months) was shorter than median DFS of local treatment (48.83 months), while systemic treatment achieved similar survival time as surgery (78.03 months vs 79.27 months, P= 0.651). The disease control rate (DCR) of anthracycline-based regimens, ifosfamide (IFO), gemcitabine-based regimens and targeted therapy was 52.94%, 33.33%, 33.33%, 50% respectively. Conclusions: Surgery with R0 margin improved survival significantly of leiomyosarcoma patients. For survival time of patients with metastases, systemic treatment was not inferior to surgery, and anthracycline-based regimens had a higher disease control rate.
Collapse
Affiliation(s)
- Yang Liu
- Department of Clinical Oncology, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Xiao-Wen Wang
- Department of Clinical Oncology, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Hong-Chen Ji
- Department of Clinical Oncology, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Jing-Yue Yang
- Department of Clinical Oncology, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Yan Chen
- Department of Clinical Oncology, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| | - Zhen Wang
- Xijing Orthopaedic Hospital, Xi'an, China
| | - Hong-Mei Zhang
- Department of Clinical Oncology, Xijing Hospital, the Fourth Military Medical University, Xi'an, China
| |
Collapse
|
48
|
Yin MG, Wang XT, Liu DW, Chao YG, Kang Y, He W, Zhang HM, Wu J, Liu LX, Zhu R, Zhang LN. [The quality control standards and principles of the application and training of critical ultrasonography]. Zhonghua Nei Ke Za Zhi 2022; 61:631-643. [PMID: 35673743 DOI: 10.3760/cma.j.cn112138-20220111-00031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/15/2023]
Abstract
Critical ultrasonography is widely used in ICU and has become an indispensable tool for clinicians. However, besides operator-dependency of critical ultrasonography, lack of standardized training mainly result in the physicians' heterogenous ultrasonic skill. Therefore, standardized training as well as strict quality control plays the key role in the development of critical ultrasonography. We present this quality control standards to promote better development of critical ultrasonography.
Collapse
Affiliation(s)
- M G Yin
- Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China
| | - X T Wang
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - D W Liu
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - Y G Chao
- Department of Critical Care Medicine, the First Hospital of Tsinghua University, Beijing 100016, China
| | - Y Kang
- Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu 610041, China
| | - W He
- Department of Critical Care Medicine, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
| | - H M Zhang
- Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China
| | - J Wu
- Department of Critical Care Medicine, RuiJin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
| | - L X Liu
- Department of Critical Care Medicine, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China
| | - R Zhu
- Department of Critical Care Medicine, First Hospital of China Medical University, Shenyang 110001, China
| | - L N Zhang
- Department of Critical Care Medicine, Xiangya Hospital, Central South University, Changsha 410008, China
| |
Collapse
|
49
|
Lu Y, Long Z, Pan W, Deng SZ, Dou QY, Wang XX, Wang Z, Zhang HM. Time for paying attention to fluoropyrimidine-associated cardiotoxicity: A pooled data analysis for epidemiology based on 60537 cases. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.16_suppl.12071] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
12071 Background: With the rise of cardio-oncology discipline, treatment-related cardiotoxicity has become a growing concern. However, fluoropyrimidine induced cardiotoxicity has been underestimated for a long time. The aim of this study was to comprehensively investigate the incidence and profiles of the cardiotoxicity associated with fluoropyrimidine using a pooled data meta-analysis. Methods: A systematic literature review was performed using PubMed, Embase, Medline, Web of Science, Cochrane library databases and clinical trials on studies published between the establishment of each database and March 31, 2021, investigating fluoropyrimidine associated cardiotoxicity (FAC). The main outcome was pooled incidence of FAC, and the secondary outcome were specific treatment-related cardiac AEs. Random-effects or fixed-effects modeling was used for analyses according to the heterogeneity assessed by Cochran’s Q test. Subgroup analysis and meta-regression were conducted to explore the source of heterogeneity, and the incidence of FAC was compared among different clinical characteristics. The protocol was registered in PROSPERO (No. CRD42021282155). Results: Two hundred and six studies involving 60537 patients were included in this meta-analysis, covering 31 countries or regions in the world. The pooled incidence of FAC was 5.18% (95% CI 4.32%-6.10%) for all grade and 1.5% (95% CI 1.09%-1.96%) for grade 3 or higher. A total of 0.29% of patients died from severe cardiotoxicity. Cardiac ischemia and arrhythmia were the two most common cardiac AEs, occurring in 2.31% (95% CI 1.70%-3.00%) and 1.69% (95% CI 1.08%-2.42%) of patients, respectively. ECG alterations occurred in 5.85% (95% CI 3.4%-8.9%) of patients, indicating asymptomatic ECG alterations in a subset of the population. The incidence of cardiotoxicity varied among different regions, gender, cancer types and treatment regimens. Studies conducted in Asia outlined a significant higher pooled incidence of FAC than in Europe (χ2 = 4.47, p = 0.03) and America (χ2 = 4.49, p = 0.03). Female population had a lower pooled incidence than general population (χ2 = 9.90, p= 0.01). The highest pooled incidence was observed in esophagus cancer (10.53%, 95% CI 5.8%-16.35%), and the lowest occurred in breast cancer (3.66%, 95% CI 2.4%-5.12%). In addition, combination therapy, high cumulative dose, anthracycline addition, and pre-existing cardiac disorder significantly increased the risk of FAC ( p< 0.05). No obvious publication bias was detected by funnel plots and Egger’s test (p < 0.05), and the stability of our results was confirmed by the sensitivity analysis. Conclusions: FAC is not a rare condition during treatment containing fluoropyrimidines. Our results provide comprehensive global data on epidemiology of FAC, potentially representing an important reference on cancer management in clinical practice.
Collapse
Affiliation(s)
- Yajie Lu
- Xijing Hospital, Air Force Medical University of PLA, Xi'an, China
| | - Zuoyao Long
- General Hospital of Northern Theater Command, Shenyang, China
| | - Wei Pan
- Xijing Hospital, Air Force Medical University of PLA, Xi'an, China
| | - Shi-Zhou Deng
- Xijing Hospital, Air Force Medical University of PLA, Xi'an, China
| | - Qiong-Yi Dou
- Xijing Hospital, Air Force Medical University of PLA, Xi'an, China
| | - Xiang-Xu Wang
- Xijing Hospital, Air Force Medical University of PLA, Xi'an, China
| | - Zhen Wang
- Xijing Orthopaedic Hospital, Xi'an, China
| | - Hong-Mei Zhang
- Xijing Hospital, The Air Force Military Medical University, Xi'an, China
| |
Collapse
|
50
|
Long Z, Fu Z, Yunus A, Lu Y, Li M, Chen G, Li J, Zhang HM, Wang Z. The efficiency of anlotinib in osteosarcoma with chemoresistance: Exploratory therapy based on PDX models and next-generation sequencing. J Clin Oncol 2022. [DOI: 10.1200/jco.2022.40.16_suppl.11527] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
11527 Background: It’s urgent to find a new approach for the treatment of progressed osteosarcoma in neoadjuvant chemotherapy. Using patient-derived xenograft (PDX) models and next-generation sequencing (NGS), we have explored the efficiency of anlotinib in these patients. Methods: Frozen osteosarcoma tissues were used to establish PDX models. Ten samples of each PDX model were randomized to treatment or control group. The treatment group were gavaged at a volume of 0.1 ml/10g body weight for 4 weeks, while the control group were administered with vehicle at the same dose orally. Tumor volume and body weight were measured every 3 days, and the tumour were removed and weighed after 28 days. The number of mitotic cells and tumor necrosis rate were detected by Hematoxylin-Eosin (HE) staining. Immunohistochemistry (IHC) was used to evaluate the number of apoptotic cells and the expression of VEGFR-2, PDGFR-β, FGFR-1, c-Kit and their phosphorylated proteins, CD 31. Additionally, patients who had progressed during neoadjuvant chemotherapy (NAC) were treated with combination of anlotinib. After four cycles NAC, we performed salvage surgery and maintained with anlotinib. The change of tumor size was evaluated for tumor response. We used IHC and NGS to analyze the expression of drug targets. Results: 21 PDX models were established successfully from 43 samples. Tumor specimens from patients, who had pulmonary metastasis, local recurrence or chemoresistance, were easier to establish PDX models (P < 0.001, P = 0.046, P = 0.013). Six models were selected randomly for anlotinib. After anlotinib administration, the tumor inhibition rates were 18.82%, 45.98%, 85.86%, 83.38%, 84.57% and 86.42%. Anlotinib could not only inhibit the mitosis, induce tumor cell apoptosis and necrosis, but also decrease the expression of drug targets. The expression of VEGFR-2, PDGFR-β and CD31 were positively associated with tumor response. Five patients had received anlotinib during NAC. Four patients had tumor regression (69.4%, 28%, 19%, 8.7%), including two with high expression of VEGFR-2 mRNA or/and PDGFR-β and one with medium expression. Conclusions: Based on the results of PDX models and NGS, we suggested that osteosarcoma with high expression of VEGFR-2 or/and PDGFR-β was sensitive to anlotinib, which was alternative for patients progressed during NAC.
Collapse
Affiliation(s)
- Zuoyao Long
- General Hospital of Northern Theater Command, Shenyang, China
| | - Zhanli Fu
- The Third People’s Hospital, Xi'an, China
| | - Aikebaier Yunus
- The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, China
| | - Yajie Lu
- Xijing Hospital, Air Force Medical University of PLA, Xi'an, China
| | - Minghui Li
- Xijing Hospital, The Air Force Military Medical University, Xi'an, China
| | - Guojing Chen
- Xijing Hospital, The Air Force Military Medical University, Xi'an, China
| | - Jing Li
- Xijing Hospital, The Air Force Military Medical University, Xi'an, China
| | - Hong-Mei Zhang
- Xijing Hospital, The Air Force Military Medical University, Xi'an, China
| | - Zhen Wang
- Xijing Orthopaedic Hospital, Xi'an, China
| |
Collapse
|